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Bacteroides species are Gram-negative obligate anacrobes that live in the gastrointestinal 
tract of mammals and are thought to account for approximately 30% of the colonic 
microbiota. Certain Bacteroides specics, such as B. ji'agilis and to a lesser extent B. 
thetaiotaomicron, can become opportunistic pathogens and cause severe infection. The 
antibiotic of choice tor treating such infections is metronidazole, a DNA damaging agent. 
Metronidazole enters the bacterial cell as an inert prodrug, and is activated by cellular 
reduction into a cytotoxic compound which is thought to cause DNA strand breaks. 
Certain metronidazole resistant B. fragilis strains have been described, where the drug 
was not reduced inside the cell due to decreased activity of the metabolic enzymes which 
are involved in this process. Little is known about the mechanisms involved in repair of 
metronidazole damage and the potential lor resistance. In this study, two difIerent 
approaches were used to isolate and analyse Bacteroides genes involved in metronidazole 
resistance, with emphasis on DNA repair genes. These methods were transposon 
mutagenesis of Bacteroides, and functional complementation of E. coli metronidazole 
sensitive mutants with genes from B. fragilis. 
Construction of B. jj'agilis and B. Ihelaiolaumicron transposon mutant banks was 
performed. Screening of the B. fragilis mutant bank did not identifY any metronidazole 
mutants. However, tour B. Ihetaiulaumicrun metronidazole mutants were isolated, 
Mutants A and B with increased sensitivity to metronidazole, and Mutants C and D with 
increased resistance to the drug. Mutant B contained a disruption within a 
glycosyltransferase gene located in one of the capsular polysaccharide loci, and whose 
product is involved in catalysing the first step of the pathway. This suggests the 
involvement of the Bacteroides capsule in entry or uptake of metronidazole. Mutant A 
was a double integration mutant derived from Mutant 13, containing a second integration, 
a co integrate, in a different unidentified chromosomal locus. Metronidazole resistant 
Mutant C contained a disrupted two-component histidine kinase, with a putative function 
related to cytosine-specific methyltransferases. The tranposon insertion in Mutant 0 was 











putative rhamnose dissimilation gene cluster that is linked to pyruvate metabolism, 
suggesting decreased activation of the drug as a possible resistance mechanism. 
Suppression of E. coli DNA repair mutants with a B. fragilis bfl gene library was used 
for the isolation of B. fragilis genes involved in the DNA repair of metronidazole 
damage. The presence of an AraC family transcriptional regulator, ORF2, was sufficient 
to confer increased metronidazole and mitomycin C resistance to the metronidazole 
sensitive E. coli uvrA and uvrB DNA repair mutants, but had no effect on the resistance 
of E. coli uvrC or recA DNA repair mutants. It is possible that ORF2 might be regulating 
E. coli genes to exert a heterologous effect. A gene, ORFl, whose product had high 
amino acid sequence identity to the RecQ DNA helicases, was located upstream of 
ORF2. These proteins are involved in DNA repair, replication and stabilization of the 
genetic material. Although this gene was not involved in the resistance phenotype of the 
E. coli uvrA and uvrB mutants, the presence of such gene, upstream of ORF2, is of 
interest. 
The transcriptional regulation of ORF2 in B. fragilis was examined by primer extension 
and northern blot analysis. The promoter study revealed a single transcriptional start site, 
an adenine, 59 bp upstream of the putative ORF2 start codon, as well as putative 
promoter consensus sequences. ORF2 was expressed as a single transcript of 600 
nucleotides. There was no significant difference in expression of ORF2 following 
metronidazole exposure of the cells. Expression of ORFl, however, was dramatically 
decreased when cells were exposed to the drug. Further work is needed in order to 
elucidate the function of ORFI and ORF2 in B. fragilis, as well as the mechanism of 
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1.1 Bacteroides species 
Members of the genus Bacteroides are normal commensals of the gut. However, under 
certain circumstances, some species, especially B. fragilis, can become opportunistic 
pathogens and even cause death. Treatment of B. fragilis infections involves the use of 
metronidazole, a drug specific for anaerobic cells causing bacterial death through DNA 
damage. The objectives of this research were to identifY Bacteroides genes involved in 
metronidazole resistance, with particular emphasis on genes involved in DNA repair. 
This introduction, therefore, comprises three main topics, including an introduction to the 
Bacteroides (Section 1.1), the mode of action of metronidazole (Section 1.2) and the 
mechanisms used by prokaryotic cells for DNA repair (Section 1.3). 
1.1.1 Introduction to Bacteroides species 
Humans are part of a microbial world, and it has been estimated that the number of 
microbes in the mucosal surfaces of a human adult is larger than the number of somatic 
and germ cells (Savage et ai, 1977). Of all the organs in the human body, the intestine is 
the most densely populated with microbes, and since it has a relatively low level of 
oxygen, these microbes are mainly anaerobes (Moore et al., 1978). One of the most 
abundant members of this gut microbiota is the genus Bacteroides. 
Members of the genus Bacteroides are described as Gram negative, saccharolytic, 
nonpigmenting, obligately anaerobic, non-spore forming rod-shaped bacteria (Shah and 
Collins, 1989). Their DNA G+C content varies from 39 to 48%. The most medically 
important member of the Bacteroides genus is Bacteroides fragilis, which accounts for 
more than half of the anaerobes found in clinical specimens (Frank and Dennis, 1977). 
Bacteroides distasonis, B. thetaiotaomicron and B. ovatus are also opportunistic 
pathogens, but to a lesser extent (Salyers, 1984). The Bacteroides species have very 
similar biochemical characteristics and were originally clustered together as the same 
species (Shah and Collins, 1983). However, it has been shown that they do not share 
more than 30% DNA homology using DNA-DNA hybridisation studies (Robert et al., 
1987). B. fragilis itself is divided into two divisions based on conserved differences on 











(Gutacker et al., 2002). Division I is also associated with the presence of the cepA gene, 
coding for a serine-~-lactamase, while Division II contains the cfiA gene, coding for a 
metallo-~-Iactamase. The Bacteroides form part of the Bacteroidaceae family. This 
family has been divided into three clusters according to rRNA gene sequence analysis: 
the Prevotella cluster including species found in the rumen, the Porphyromonas cluster 
having species present in the oral cavity and the Bacteroides cluster described above 
(Paster et al., 1994). The Bacteroidaceae family is grouped together with the Cytophaga 
and the Flavobacterium according to both 16S and 5S rRNA analysis (Weisburg et al., 
1985; Van den Eynde et al., 1989). This group, called the Bacleroidetes, forms one of the 
10 phyla of the Eubacteria. These are more closely related to each other than to other 
groups, and share many characteristics in both rRNA sequence and other structures 
(Weisburg et al., 1985). This phylum is thought to have branched off from the main 
eubacterial group before the divergence of Gram-negative and Gram-positive bacteria 
(Woese, 1987; Weisburg et al., ) 985). The Fibrobacteres, Chlorobi and Bacteroidetes 
phyla form a superphylum called the FeB group. These three phyla are thought to have 
diverged from a common ancestor, as shown by signatures in specific proteins such as 
DNA Gyrase B, the A TPase-a-subunit, the FtsK protein and the UvrB protein, present in 
only these three groups (Gupta, 2004). 
1.1.2 Bacteroides, commensals or symbionts? 
The human intestinal tract contains a large number of bacteria, with the majority in the 
proximal colon having 500 to 1000 different bacterial species (Savage, 1977). It is 
difficult to assign numerical values due to the fact that a large number of bacterial species 
are non-culturable. The intestine is largely devoid of oxygen explaining the fact that 
99.9% of the cultivable bacteria in the intestine are obligate anaerobes (Moore and 
Holdeman, ] 974). By comparing 16S rRNA analysis and culture methods, it was 
predicted that 60 to 70% of the bacteria in the human gut could not be cultured (Hayashi 
et al., 2002; Suau et al., 1999). Of those that could be cultured, the predominant genera 
included Bacteroides, Eubacterium, Clostridium, Ruminococcus, Peptococcus, 
Peptostreptococcus, Bifidobacterium and Fusobacterium (Suau et al., 1999), while the 











culturable detected species were within the Bacteroides group, the Clostridium coccoides 
group and the Clostridium leptum subgroup. Bacteroides are thought to account for 
approximately 30% of the colonic bacteria (Salyers, 1984; Sghir et al., 2000; Marteau et 
al., 2001). The most numerous Bacteroides species found in the gut include B. vulgatus, 
B. distasonis and B. thetaiotaomicron, with smaller numbers of B. fragilis, B. ovatus and 
B. uniformis (Salyers, 1984). 
These bacterial species are known as commensals of the human gut, where neither of the 
two members of the relationship is harmed. The gut microbiota do, however, also appear 
to benefit the host in various ways and this includes the Bacteroides. For example, B. 
thetaiotaomicron colonization of the gut of germ free mice improved the host's nutrient 
absorption by increased expression of genes involved in lipid and micronutrient 
absorption (Hooper et ai., 2001). It was also involved in reinforcing the hosts' mucosal 
barrier as well as increasing the submucosal capillary network. Colonization also affected 
the enteric nervous system and intestinal motility. B. thetaiotaomicron is also able to 
degrade plant polysaccharides which are indigestible to the host (Hooper et at., 2002). In 
exchange, the host supplies B. thetaiotaomicron with nutrient sources. B. 
thetaiotaomicron is able to instruct the host to produce hydrolysable fucosylated glycans 
on the epithelial cell surface which are used as carbon source by the bacterium (Hooper et 
ai., 1999). The successful adaptation of B. thetaiotaomicron to this ever-changing 
environment is probably due to its complex sensory and glycolytic systems identified 
with the sequencing of its genome (Xu et ai., 2003). B. fragilis is a smaller component of 
the human intestinal microbiota. However it also has an intricate sensory and glycolytic 
structure allowing it to be competitive in this harsh environment. 
1.1.3 Bacteroides physiology and metabolism 
The Bacteroides, including B. fragilis, B. thetaiotaomicron, B. vulgatus and B. distasonis 
are able to utilize simple sugars, such as glucose, as well as haeme, vitamin B 12, 
minerals and ammonium chloride (Yarel and Bryant, 1974). However, the majority of 
simple sugars are absorbed in the small intestine and are seldom available as carbon 











polysaccharides, such as plant polysaccharides that the host is unable to digest, or host-
derived polysaccharide products (Salyers et ai., 1 977a; Salyers et aI., 1 977b). A large 
number of polysaccharide degrading enzymes have been identified from Bacteroides, 
such as amylases from B. thetaiotaomicron and B. ovatus (Anderson and Salyers, 1989; 
Degnan et aI., 1997), pullulanases from B. thetaiotaomicron (Smith and Salyers, 1989; 
Smith and Salyers, 1991), and xylanase, xylosidase and arabinosidase from B. ovatus 
(Weaver et ai., 1992). 
Most studies on Bacteroides polysaccharide utilization have been done on B. 
thetaiolaomicron and the genome analysis of this bacterium provides an insight into the 
incredible repertoire of enzymes involved in this process. The B. thetaiotaomicron 
proteome contains 172 glycosylhydrolases, more than any other sequenced prokaryote 
(Xu and Gordon, 2003). It also possesses at least 1 t enzymes involved in degradation of 
host-derived products (Comstock and Coyne, 2003), including mucin-degrading 
hydrolases and chondroitin sulphatases (Xu and Gordon, 2003; Linn et al., t 983). The 
capacity to utilize such mucopolysaccharides must confer a distinctive competitive 
advantage over the rest of the microflora in the gut. The proteome also includes 163 outer 
membrane polysaccharide-binding proteins and 20 sugar-specific transporters (Comstock 
and Coyne, 2003). The best studied of these is the starch utilization pathway, the sus 
operon, which binds starch on the cell surface and transports it into the periplasm for 
further degradation (Reeves et al., 1997; Shipman et ai., 2000). Many of the outer 
membrane-binding proteins are paralogous to the sus enzymes and probably serve a 
similar function with other polysaccharides (Comstock and Coyne, 2003). 
Apart from polysaccharide utilization, bacteria are thought to be actively involved in 
metabolism of nitrogen compounds in the intestine (Macfarlane et ai., 1988). Bacteroides 
is thought to play an especially important role in this. The proteolytic activity of B. 
fragilis is intracellular during exponential growth, while it becomes extracellular as the 
bacterium reaches stationary phase (Gibson and Macfarlane, 1 988a). The proteolytic 
activity is due to three main proteases, one exopeptidase and two endopeptidases (Gibson 
and Macfarlane, 1988b). These seem to be constitutively expressed, but are upregulated 











I 992}. A fibrinogenolytic protease has also been identified in having a much higher 
activity in B. fragilis than the other non-pathogenic Bacteroides, suggesting a possible 
role in pathogenesis (Chen et al., 1995). Bacteroides is unable to use peptides or amino 
acids as a sole carbon source. Ammonia and peptides are used as a nitrogen source but 
not free amino acids (Yarel and Bryant, 1974). The primary metabolic pathway for 
assimilation of ammonia in Bacteroides is thought to be via the use of glutamate 
dehydrogenases (G DH) (Yamamoto et al., 1984; Baggio and Morrison, 1996). Both B. 
fragilis and B. thetaiotaomicron have two different GDH proteins, GdhA and GdhB, that 
function under low and high nitrogen conditions respectively (Abrahams and A bratt, 
1998: Baggio and Morrison, 1996). There seems to be low or no GOGA T activity 
(Yamamoto et al., 1984; 1987). The B. Ji-agilis glutamine synthetase, GS, encoded by the 
ginA gene, is a novel GSlII protein differing from the other two forms of GS found in 
eukaryotes and prokaryotes (Southern et ai., 1986; Hill ef al., \989). This, once again, 
suggests the early divergence of the Bacteroides. 
1.1.4 Bacteroides pathogenicity and virulence 
As mentioned earlier, B. fragilis is an opportunistic pathogen, with other Bacteroides 
species such as B. thetaiotaomicron acting as pathogens to a lesser extent When a 
rupture occurs in the wall of the intestine, a mixture of colonic bacterial species enter the 
abdomen causing infection. B. fragilis is one of the most important organisms in these 
infections (Frank and Dennis, 1977). The Bacteroides, especially B. fragilis are thought 
to possess an array of virulence factors involved in infection. 
1.1.4.1 Bacteroides capsule as a virulence factor 
The B. fragilis capsule is thought to be one of the main virulence factors of this 
bacterium. The capsular polysaccharide on its own is able to promote the formation of 
intra-abdominal abscesses, while the lipopolysaccharide is not (Onderdonk et ai., 1977; 
Kasper et al., 1984). The capsular polysaccharide is also thought to facilitate adhesion of 
B. fragilis to the epithelial cells (Gibson et ai., 1998) and possibly interfere with 
phagocytic killing of cells (Onderdonk et al., 1990). The capsule might also be involved 











survived better aerobically than non-capsulate strains, while there was a negligible 
difference in survival between the two types anaerobically. B. fragilis has a complex 
capsular variation as shown by different populations containing large capsules, small 
capsules or an electron-dense layer. Studies done in a mouse model showed that these 
different capsular populations were able to vary their capsular status, where a large 
capsule population became non-capsulate within 24 hours (Patrick et al., 1995). 
A large number of B. fragilis strains were examined and found to have complex capsules 
consisting of at least two different polysaccharides and these were found to be 
antigenically diverse among the strains (Pantosti et al., 1993). B. fragilis NCTC 9343 was 
shown to possess two distinct capsule polysaccharides, PS A and PS B. These were 
surface exposed and had different physiochemical properties (Pantosti et al., 1991). 
Polysaccharide A was a neutral zwitterionic polysaccharide, with tetrasaccharide 
repeating units possessing a positively charged free amino group and a negatively 
charged pyruvate substituent (Tzianabos et al., 1992). Polysaccharide B had an overall 
negative charge, and contained hexasaccharide repeat units with negatively charged 
galacturonic acid and a substituent with both a negative and positive charge. These two 
polysaccharides were held together by ionic interactions in a PS A: PS B ratio of 1:3 and 
were co-expressed on the cell surface. Polysaccharides possessing oppositely charged 
groups have potent abscess-inducing properties, as is the case with B. fragilis (Tzianabos 
et ai., 1994). These zwitterionic polysaccharides elicit a potent CD4+ T-cell response, 
which is dependent on the free amino and carboxyl groups on the repeating units 
(Tzianabos et al., 2000). One of the capsule polysaccharides from B. fragilis strain 638R, 
PS A2, was found to have zwitterionic pentasaccharide repeats and was also able to cause 
abscesses (Wang et al., 2000). The capsular polysaccharides of B. fragilis 638R are 
known to be immunological1y distinct from those of B. fragilis 9343 (Comstock et ai., 
J999a). 
It was only in 1999 that the genes regulating the formation of these polysaccharides 
started being revealed, and it has turned out to be a fascinating and complex story. Using 
transposon mutagenesis of B. fragilis 638R and 9343, Comstock et al. (1999b) identified 
an operon in B. fragilis 9343 containing 16 open reading frames coding for proteins 
involved in polysaccharide biosynthesis. This locus was found to form a new 











abscesses. The equivalent locus was identified in B. fragilis 638R, PS C2 (Comstock et 
al., 1999a). It contained genes involved in polysaccharide biosynthesis and conferring 
charged groups to polysaccharides, but it was distinct from the PS C 1 locus of B. fragilis 
9343. The PS Aland PS B 1 loci from B. fragilis 9343 were isolated and shown to 
contain open reading frames with homologues of polysaccharide biosynthesis proteins 
(Coyne et al., 2000 and 2001). Deletion of PS A 1 decreased the ability of B. fragilis 9343 
to cause abscesses, suggesting that polysaccharide A is an important virulence 
determinant (Coyne et aI., 2001). The incomplete sequence of the B. fragilis 9343 
genome allowed Krinos et al. (2001) to identify a total of 8 loci involved in capsular 
polysaccharide biosynthesis, PS A-PS H. The first two genes of these operons were 
extremely conserved, upxY (where x represents the PS locus) and upxZ and were thought 
to be involved in transcriptional regulation of their corresponding locus. Variable 
expression of polysaccharides in the capsule of B.fragilis is thought to involve regulation 
of these different loci. Complete sequencing of the B. fragilis 9343 genome 
(www.sanger.ac.uk/projects/b fragilis) and the published genome of B. fragilis YCH46 
(Kuwahara et al., 2004) has revealed a ninth operon, PS I or PS-9, respectively. These 
loci seem to undergo phase variation resulting in a reversible on-off phenotype. An 
invertible region of DNA,jin, upstream of upxY in polysaccharide biosynthesis loci PS 1-
7 (A, B, D-H) was shown to have inverted repeats at each end (Patrick et al., 2003). 
These inverted repeats, designated fixL and fixR, were AT-rich and 30 to 32 bp in length. 
The region between fixL and frxR contained a functional promoter (Krinos et al., 200 1; 
Patrick et al., 2003). Inversion of this region would position the promoter in the correct 
orientation for transcription of the operon or not. A chromosomally-encoded serine site-
specific recombinase, Mpi, was shown to be involved in inverting these 7 polysaccharide 
biosynthesis loci as well as other promoters distributed throughout the genome (Coyne et 
al., 2003). A B. fragilis 9343 plasmid-borne Hin invertase homologue, FinB, has also 
been shown to bind to those regions (Patrick et al., 2003). Polysaccharide biosynthesis 
locus C and I, also named PS-2 and PS-7 (Kuwahara et al., 2004), did not have the 












Capsular variation has also been reported in B. thetaiotaomicron, as identified by 
populations forming non encapsulated or encapsulated cells (Burt et al., (978). 
Sequencing of the B. thetaiotaomicron genome identified 7 capsule polysaccharide 
biosynthesis loci, each having t or 2 regulatory upxYand upxZ homologues (Xu et ai., 
2003). An invertible promoter was found in four of these loci as well as the presence of 
an integrase upstream of the 4 operons (Xu et aJ., 2003, Kuwahara et aI., 2004). Gene 
BT4624 was not linked to any of the polysaccharide loci, but coded for a putative 
resolvase having high similarity to the B. fragilis Mpi recombinase. This suggests that B. 
thetaiotaomicron is also able to alter its capsular composition. This system might allow 
B. fragilis and B. thetaiotaomicron to camouflage themselves from other members of the 
intestinal flora as well as from the host to evade the immune system. 
1.1.4.2 Other Bacteroides virulence factors 
The oxygen tolerance of Bacteroides is thought to be an important virulence factor, since 
the abdominal cavity is aerobic. B. fragilis has a complex redox stress response involving 
a redox regulator, OxyR (Rocha et al., 2000). This regulator controls various redox genes 
such as katB, encoding for a catalase (Rocha and Smith, ] 995), dps, ahpCF, encoding for 
a hydroperoxide reductase, tpx and ccp, encoding for peroxidases (Herren et al., 2003), as 
well as ftnA, the ferritin gene which is upergulated in response to oxygen and iron levels 
(Rocha and Smith, 2004). Tang et al. (1999) also identified the Batl operon with 
unknown function, involved in aerotolerance. B. thetaiotaomicron is also aerotolerant. 
Under aerobic conditions, fumarase and pyruvate:ferredoxin oxidoreductase, involved in 
central metabolism, are inactivated but remain stable for long periods (Pan and Imlay, 
2001). Once anaerobic conditions are restored, these enzymes are rapidly repaired 
allowing B. thetaiotaomicron to recover from oxygen exposure. 
Bacteroides produce enzymes which affect the host and are, therefore, considered 
virulence factors. B. fragilis is known to produce a protease when heme is limited, which 
degrades the host's hemopexin providing a heme source (Rocha et al., 2001). B. fragilis 
also produces a neuraminidase (Goddoy et al., 1993; Russo et al., 1990), while B. 
thetaiotaomicron produces a chondroitin sulphatase (Salyers and Kotarski, 1980; Cheng 











These degrade the host's cell surface components. B. fragilis has even been shown to 
induce cytokine expression in the host, a signal which leads to inflammation and abscess 
formation (Kim el ai., 2000). 
Certain B. fragilis strains produce an extracellular zinc metalloprotease known as 
fragilysin or BFT, which cleaves the host's intercellular proteins between the epithelium 
resulting in fluid secretion (Vines et al., 2000). The B. fragilis strains secreting BFT are 
known as enterotoxigenic (ETBF). Three isotypes of BFT have been identified and these 
are encoded by distinct loci within the B. fragilis pathogenicity island present in ETBF 
only (Sears, 200 I). The bfi gene is located within a novel conjugative transposon, which 
might allow transfer of this virulence factor (Franco, 2004). 
1.1.5 Bacteroides Genetics 
Bacteroides species are in contact with a large number of other organisms and this may 
account for the fact that they contain an array of genetic elements from diverse sources 
(Smith et ai., 1998). Bacteroides contains a large number of compatible small cryptic 
plasmids (Odelson et ai., 1987) that possess oriT and trans-acting mobilization genes, 
and they are thought to be transferred by conjugation. These do not seem to be involved 
in antibiotic or heavy metal ion resistance. However, plasmids conferring resistance to a 
large number of antibiotics have been identified and will be discussed below, as well as 
transposons and IS elements. 
Plasmid construction seems to be modular in Bacteroides (Smith et ai., 1998). Plasm ids 
share replication cassettes, mobilisation cassettes and IS elements. This suggests that 
Bacteroides genetic elements are from diverse sources. Another observation supporting 
the wide genetic diversity of Bacteroides is the fact that different plasmids have different 
replication mechanisms as well as different G+C content, implying different origins. 
The presence of plasmids allows transfer of genetic material, which can be exploited in 
the laboratory. However, genetic manipulation of Bacteroides is problematic. Due to its 











control which seems to be different from that in Gram positive and Gram negative 
bacteria (Smith et ai., J 992). This is supported by the fact that Bacteroides possess 
unusual promoter recognition sequences (Bayley et ai., 2000). Using transposable 
elements, several E. coli-Bacteroides shuttle vectors have been designed that allow gene 
expression in Bacteroides. However, transformation is rare in Bacteroides, especially in 
clinical strains of B. fragilis (Smith, 1995), and it is thought that DNA is degraded due to 
secretion of DNases and due to restriction modification systems. Electroporation has been 
used to transform into B. fragilis, as described by Smith et ai. (1990), but plasmid DNA 
from E. coli seems to be inefficient. Apart from their importance as experimental tools, 
Bacteroides genetic elements are involved in conferring resistance to a wide range of 
antibiotics. 
1.1.6 Antibiotic resistance 
Bacteroides are resistant to a large number of antibiotics and many of the genes 
responsible for this are present on mobilizable elements. 
The enzyme involved in penicillin G resistance is a metallo-J3-lactamase, encoded by the 
cerA gene (Rasmussen et ai., 1990; \991). This enzyme is able to inactivate nearly every 
class of J3-lactam antibiotic and it is also insensitive to J3-lactamase blocking agents. 
Macrolide (erythromycin)-Lincosamide (c1indamycin)-Streptogramin (MLS) resistance 
is encoded by the erm genes. These code for an rRNA methylase that acts on adenine 
residues in the 23s rRNA subunit (Arthur et aI., 1987), reducing the affinity between the 
antibiotic and the 50S ribosomal subunit. In the 1960's nearly all B. fragilis strains were 
sensitive to tetracycline, but by the early 1980' s resistance had increased to 60% (Tally 
and Malamy, 1982). Resistance to tetracycline is divided into different classes. Classes A 
to E, as well as F and L, are due to decreased accumulation of tetracycline by resistant 
cells (Speer et al., 1991). Resistance of classes M to 0 and Q are ribosomal protection 












The ermF(c») gene for MLS resistance is found on the closely related compound 
transposons Tn4351, Tn4400 and Tn4551 (Smith et 01., 1998). Tn4351 and Tn4551 are 
flanked by the insertion element IS4351, while Tn4400 contains IS4400, which is almost 
identical to IS4351. In addition to conferring MLS resistance, these transposons seem to 
confer tetracycline resistance on E. coli when grown aerobically, while anaerobic E. coli 
or B. fragilis remain tetracycline sensitive. Under anaerobic conditions, the gene involved 
in resistance is transcribed but the product is non-functional (Speer et 01., 1991). These 
transposons are carried on plasmids such as pBF4, pBFTM 1 0 and pB1136. Plasmid 
pBFTM 10 encodes an additional tetracycline resistance gene, telF, which is only 
expressed aerobically (Robillard et 01., 1985; Park and Levy, 1988). 
Transfer of tetracycline resistance can sometimes occur together with the transfer of MLS 
resistance. This transfer is not plasmid encoded and the conjugal elements involved in 
transfer are bel ieved to be chromosomal (Salyers and Shoemaker, 1995). The frequency 
of transfer increases when the donor is exposed to low concentrations of tetracycline. The 
conjugal elements involved in this transfer are called Tcr elements. These are conjugative 
transposons that integrate into the chromosome. Tetracycline resistance is mediated by 
the tetQ gene that confers resistance by a ribosome protection mechanism. Tcr elements 
are not only able to self-transfer but they also mediate transfer of elements that are not 
self-transmissible and need to be mobilised. 
All these genetic elements make B. fragilis infcctions very difficult to treat using the 
commonly used antibiotics. One of the few drugs which still has an effcct on B.fragilis is 
metronidazole, although resistance is already starting to appear. 
1.2 Metronidazole 
1.2.1 Introdnction 
Metronidazole, 1-2' -hydroxyethyl-2-methyl-5-nitroimidazole (Appendix 1), has had an 
incredible impact on the treatment of anaerobic protozoan and bacterial infections. Its 
discovery, development and use as a broad-spectrum antibiotic took many years and was 











In 1955, crude extracts of Streptomyces were found to kill the pathogen Trichomonas 
vaginalis, due to the compound azomycin (Despois et ai., 1956). Two years later, 
metronidazole, related to azomycin, was chemically synthesised. This was followed by a 
series of synthetic relatives referred to as 5-nitroimidazoles. In 1959, it was introduced 
clinically for treatment of Trichomonas vaginalis infections (Ingham et ai., 1980). It was 
only years later, in 1962, that Shinn reported its effectiveness in Vincent's disease, acute 
ulcerative gingivitis caused by Fusobacterium necrophorum. In the early 1970's, it was 
found to have antibacterial activity against anaerobic bacteria, including all strains of B. 
fragi/is (Noble and Tally, 1984). Following those findings, metronidazole was routinely 
used to treat anaerobic infections and as a prophylactic agent in the prevention of 
postoperative infections following gastrointestinal and gynecological surgery (Willis et 
ai., 1976; Willis et ai., 1977). Overall, it has been recognised to have a broad spectrum of 
activity against Gram positive and Gram negative bacteria, protozoa, helminths and even 
hypoxic tumours (Edwards, 1980). 
In 1975, the use of the drug was questioned by Dykers following reports that 
metronidazole caused mutagenicity in bacteria and carcinogenicity in mice (Voogd et ai., 
1974; Rustia and Shubik, 1972). The Ames test and the SOS chromotest found it to have 
mutagenic and genotoxic activity (De Meo et ai., 1992). However, the benefits of the 
drug seem to outweigh its risk factors and metronidazole is still used in the treatment and 
prophylaxis of anaerobic infections. 
Metronidazole is an inert prodrug which, upon reduction of its nitro group, forms an 
active intermediate with bactericidal activity (Ings et al., 1974). This activation of the 
drug influences its mode of action of the drug, including its mechanism of entry into the 
cell, its activation, its cellular targets as well as its selective toxicity towards anaerobic 
organisms and the incidence of resistance. 
1.2.2 Entry of metronidazole 
Indirect evidence suggests that metronidazole enters cells by passive diffusion (lngs et 











drug concentration intracellularly and this increased the transmembrane concentration 
gradient allowing metronidazole to keep entering the cell. This was supported by studies 
done by MOller and Lindmark (1976) showing a linear relationship of accumulation 
inside the cell to the extracellular drug concentration in Trichomonads. Tally et af. (1978) 
showed metronidazole uptake in both resistant and susceptible bacteria, however, the rate 
of uptake and accumulation was higher in the susceptible ones. Metronidazole is of low 
molecular weight and is thought to penetrate all cell membranes (Noble and Tally, 1984). 
A number of B. fragilis strains resistant to metronidazole have shown decreased uptake of 
the drug (Britz and Wilkinson, 1979; Ingham et al., 1978; Willis et al., 1978). However, 
this was believed to be due to decreased activity of nitroreductases involved in activating 
metronidazole. 
Since there is no direct evidence that metronidazole enters the cell by diffusion, the 
possibility of entry due to active transport must not be discarded. Moore et al. (1995) 
showed that a number of related imidazole compounds inhibited metronidazole uptake in 
Helicobacter pylori, suggesting the possibility for a transport system specific for that 
group of molecules. However, no further work has been done and there is, as yet, no 
evidence of any such system. 
1.2.3 Activation of metronidazole 
As mentioned previously, metronidazole itself has no cytotoxic activity, and its nitro 
group must be reduced to an active intermediate (lngs et aI., 1974). It was believed to 
have selective toxicity specific to anaerobic organisms only, because only they would 
have a sufficiently low redox potential to reduce the nitro group (Rowley et al., 1976). 
Following various contradictory reports on the cytotoxicity of metronidazole on 
facultative anaerobes, Ingham et al. (1980) showed that metronidazole had activity 
against these but only under strict anaerobic conditions. The lowest redox potential of 
aerobic cells is -350 m V (Edwards et al., 1973) while that of metronidazole is -486 m V 
(Smith and Edwards, 1995). For this reason metronidazole cannot be reduced in aerobic 











The reduction process is not fully understood and seems to be slightly different in 
anaerobes, facultative anaerobes and microaerophiles. However, in all these organisms, 
the reduced toxic derivative is short-lived (MUlier, 1983) and converted into inactive end 
products, acetamide (Koch et al., 1979) and N-(2-Hydroxyethyl)-oxamic acid (Koch and 
Goldman, 1979). 
Most studies on reduction of metronidazole have been done on anaerobes. Reduction is 
thought to occur in one-electron steps where the nitro moiety of metronidazole (RN02) is 
reduced to form a free radical anion (RN02'- ) (MUller, 1983). This reaction is reversible 
in the presence of O2 (Perez-Reyes et ai., 1980). The subsequent steps are irreversible 
and form a nitroso derivative (RNO), a nitroso free radical (RNO'-) and a hydroxylamine 
derivative (RNHOH). Any of these derivatives could be the cytotoxic species. The first 
hint on how metronidazole was reduced inside the cell came from Edwards and Mathison 
(1970). T vaginalis normally produces H2 and CO2 gas, but in the presence of 
metronidazole, only CO2 was emitted. This was also observed in Clostridium 
pasteurianum (Lockerby et al., 1985). These gases are by-products of the pyruvate 
phosphoroclastic system in anaerobes (Mortenson et al., 1963) where pyruvate is 
enzymatically oxidized to acetyl phosphate and CO2 causing reduction of ferredoxin. 
Reduced ferredoxin is then oxidized releasing H2• In the presence of metronidazole, 
reduced ferredoxin was found to donate its electrons to metronidazole, reducing it 
(Edwards et al., t 973; Lindmark and MUlier, 1976). Lindmark and MUlier (1976) showed 
that metronidazole accepted electrons from reduced ferredoxin in the absence of any 
enzymes in vitro allowing for the possibility that electron transport proteins with a low 
redox potential, such as ferredoxin, were involved in reducing metronidazole. Evidence 
also suggests that enzymes, termed nitroreductases, are involved in reduction of 
metronidazole inside the anaerobic cell. In C. pasteurianum hydrogenase I, the enzyme 
involved in oxidation of reduced ferredoxin releasing Fh, has been shown to reduce 
metronidazole by oxidizing ferredoxin without the release of H2 (Lockerby et al., 1985; 
Church et al., \988). The hydrogenase enzyme in T vaginalis and Tritrichomonasfoetus 
plays a role in metronidazole reduction as shown by resistant strains lacking hydrogenase 











pyruvate:ferredoxin oxidoreductase, also seems to be involved in reduction of 
metronidazole since B. fragilis and Clostridium perfringens strains resistant to the drug 
had a decreased activity of the enzyme (Britz and Wilkinson, 1979; Diniz et ai., 2004; 
Sindar et ai., 1982). This enzyme is a pyruvate dehydrogenase that uses ferredoxin as an 
electron acceptor and is also involved in metronidazole resistance in T. vaginalis and T. 
foetus (Kulda et ai., 1993; Cerkasovova et al., 1984). Narikawa (\986) tested 41 different 
species, spanning 19 genera, and found that the distribution of metronidazole 
susceptibility was the same as that ofpyruvate:ferredoxin oxidoreductase activity. 
As mentioned previously, facultative anaerobes are susceptible to metronidazole but only 
in the absence of O2 (Ingham et al., 1980). In the presence of O2, the radical anion 
(RN02'-) is re-oxidised to metronidazole (RN02) and the superoxide anion (02'-) is 
produced in a process known as "futile cycling" (Perez-Reyes et ai., \980). Superoxide 
can be changed by superoxide dismutase into hydrogen peroxide and O2• In the presence 
of iron or other metals hydrogen peroxide and superoxide can react to form the highly 
reactive hydroxyl free radicals, that can indirectly also cause DNA damage. 
The mechanism of reduction of metronidazole in facultative anaerobes has not been 
completely characterized. Studies done on Actinobacillus actinomycetemcomitans 
showed the absence of ferredoxin-linked pyruvate oxidoreductase activity, however there 
was nitroreductase activity which appeared to be responsible for the susceptibility of the 
bacterium to metronidazole under anaerobic conditions (Pavicic et al., 1995). Yeung et 
al. (1984) found that E. coli mutants that were unable to reduce nitrate and chlorate and 
had DNA repair mutations were more resistant to metronidazole than the strains 
containing the DNA repair mutations alone. E. coli has two types of nitroreductases, type 
I and type II (Peterson et al., 1979). Type I nitroreductases are oxygen-insensitive 
because they convert organic nitro compounds into stable products by a 2-electron step 
reduction. This does not allow futile cycling and production of superoxide. Type II 
nitroreductases are oxygen-sensitive because they catalyse univalent reduction resulting 
in nitro radical anions which can be re-oxidised in the presence of oxygen to form 
superoxide. Metabolism via the 2-electron reduction of the nitro moiety produces nitroso 











oxygen-insensitive nitroreductases have been characterized in E. coli, NfsA, the major 
nitroreductase and Nf..<;B, the minor one. NfsA is a flavin mononucleotide containing 
protein and uses NA DPH as an electron donor (Zen no et a!., 1996). It has a broad 
specificity for nitro-substituted compounds. NfsB is a flavin mononucleotide flavoprotein 
which can use either NADH or NADPH (Michael et al., 1994) and has been linked to the 
reduction of metronidazole (Goodwin et al., 1998; Verdijk et al., 2004). Interestingly, 
NfsB has amino acid sequence similarity to the H pylori RdxA nitroreductase (Whiteway 
et al., 1998), the nitroreductase involved in reduction of metronidazole in H pylori. 
Unlike obligate or facultative anaerobes, microaerophiles such as H pylori, require 2-
17% oxygen for growth. Microaerophiles are susceptible to metronidazole (Hoff and 
Sticht-Groh, 1984), an unexpected result since the amount of oxygen in that environment 
should interfere with metronidazole reduction. The mechanism of action of 
metronidazole was thought to be due to futile cycling, where reactive oxygen species 
accumulated and were responsible for cell killing (Lacey et al., 1993; van Zwet et al., 
1995). This hypothesis was discarded following reports showing that the presence or 
absence of catalase did not affect the efficacy of metronidazole in H pylori, and sensitive 
strains were able to reduce metronidazole (Jorgensen et al., 1998). There are various 
nitroreductases involved in reduction of metronidazole in H pylori. The main 
nitroreductase is RdxA, an oxygen-insensitive chromosomally encoded NADPH 
nitroreductase (Goodwin et al., ] 998). It reduces metronidazole in a 2-electron step 
reduction into hydroxylamine, preventing futile cycling from occurring. Other 
nitroreductases involved in metronidazole reduction are FrxA, a NAD(P)H flavin 
oxidoreductase as well as FdxB, a ferredoxin-like protein (Kwon et a!., 2000). 
Metronidazole resistant H pylori becomes sensitive again anaerobically (Smith and 
Edwards, 1995). This suggests the presence of other nitroreductases that are involved in 
metronidazole reduction anaerobically. Goodwin et al. (1998) proposed that pyruvate 
oxidoreductase could be such an enzyme. Whether reduced in a l-electron step in 
anaerobic environments, or 2-electron reduction in microaerophiles, the cytotoxic 











1.2.4 Metronidazole targets and cytotoxicity 
It is now widely accepted that the main target of reduced metronidazole is DNA. Reports 
showing that metronidazole caused mutagenicity in bacteria and carcinogenicity in mice 
(Voogd et aI., 1974; Rustia and Shubik, 1972) hinted at the possibility that the main 
target of metronidazole was DNA. Plant and Edwards (1976) showed that metronidazole 
caused in vivo degradation of DNA in Clostridium bifermentas, and DNA synthesis was 
inhibited. RNA synthesis was not affected by the presence of metronidazole. Various in 
vitro studies demonstrated that reduced metronidazole caused single strand breaks in 
DNA, while unreduced metronidazole did not (Edwards, 1977; Knight et aI., 1978; 
Rowley et al., 1979). The reactive intermediate did not act as an intercalator or cross-
linking agent (Edwards et al., 1977), and organisms with a high A-T % seemed to be 
more susceptible to metronidazole (Rowley et aI., 1980). Zahoor et al. (1987) proposed 
that the protonated l-electron nitro radical anion would act as an electron acceptor from 
DNA in regions of thymidine residues causing strand breaks and release of thymidine. 
Hydroxylamine is known to cleave sites with thymidine residues (Yamamoto et al., 
1993), so the hydroxylamine derivative of metronidazole cannot be ruled out as the 
possible cytotoxic derivative. Diniz et al. (2000) and Sisson et al. (2000) reported high 
level of DNA breakage and fragmentation in B. fragilis and H pylori, respectively. 
Indirect evidence suggesting that DNA is the main target of metronidazole came from E. 
coli and H pylori DNA repair mutants. E. coli strains with mutations in the DNA repair 
gene uvrB and recA were more susceptible to metronidazole than the WT (Jackson et al., 
1984; Yeung et al., 1984). Inactivation of the recA gene in H. pylori greatly enhanced the 
sensitivity of that strain to metronidazole (Thompson and Blaser, 1995). Metronidazole 
also caused morphological changes in E. coli and B. fragi/is cells which were consistent 
with DNA damage and the SOS response: sharp growth end-point and cell elongation due 
to the inhibition of cell division (Jackson et al., 1984; Skarin and Mardh, 1981). 
Interestingly, an E. coli tag mutant, containing a deficient 3-methyladenine-DNA-
glycosylase gene involved in repair of DNA damage due to alkylating agents, was not 
found to be more sensitive to metronidazole than its WT strain (Yeung et al., 1984). This 
suggests that the DNA damage caused by metronidazole is specifically repaired, and 











protein involved in general DNA repair and recombination, but not 3-methyladenine-
DNA -glycosylase. 
Other cellular components also seem to be affected by metronidazole. MUlier and 
Lindmark (1976) suggested that metronidazole also interacted with proteins. In C. 
pasteurianum, the rapid killing of cells following exposure to high metronidazole 
concentrations could not be due to DNA damage (Church et al., 1991). It was proposed 
that metronidazole interacted with the cell membrane causing cell lysis. 
Even though DNA seems to be the major target of metronidazole, the drug is able to 
interact with other cellular macromolecules and affect cells in different ways. 
1.2.5 Metronidazole resistance 
High-level metronidazole resistance IS rare m anaerobes but surprisingly high in H. 
pylori. In developing countries, more than half of H. pylori strains are resistant to the 
drug and in developed countries 10-30% (Goodwin et al., 1998). 
The major cause of metronidazole resistance is lack of activation of the drug due to 
decreased activity of cellular enzymes involved in reducing metronidazole into its active 
intermediate. 
In T. vaginalis, resistance was caused by abolition of the activity of the pyruvate 
ferredoxin oxidoreductase system (Cerkasovova et al., 1988). Under normal metabolic 
conditions in Trichomonas, one third of the pyruvate is oxidized in the cytosol to lactate 
and ethanol while the rest enters the hydrogenosome to be oxidized to acetate. In resistant 
Trichomonas, 97% of the pyruvate was oxidized to lactate in the cytosol by lactate 
dehydrogenase, to compensate for the decreased activity of pyruvate ferredoxin 
oxidoreductase. While there have been no metronidazole resistant Clostridia reported 
clinically (Sindar et al., 1982), a strain of C. perfringens was made resistant by mutation. 











The first reported case of Bacteroides metronidazole resistance appeared in 1977 
(Chardon et al., 1977). In vitro studies showed decreased uptake of the drug due to 
decreased activity of ferredoxin-linked pyruvate oxidoreductase in a B. fragilis resistant 
strain, now called NCTC 11295 (Britz and Wilkinson, 1979). This caused an alteration in 
the end products of glucose metabolism, which in tum caused slower growth of the 
resistant strain. In order to compensate for the decreased activity of the oxidoreductase 
and to generate A TP for cell survival, it had increased levels of lactate dehydrogenase 
activity and increased levels of lactate, as seen in Trichomonas (Narikawa et al., 1991). 
Capsules of highly resistant B. fragilis mutants, with MICs higher than 100 j.lg/ml, were 
larger than the parent or than the moderately resistant mutants (MICs of 25 j.lg/ml) (Britz 
and Wilkinson, 1979). Both the highly resistant and moderately resistant mutants had 
impaired metronidazole reduction. This could imply that the larger capsules prevented 
entry of metronidazole into the cell by acting as a barrier, and this would explain the 
difference in metronidazole resistance. 
Metronidazole resistant B. fragilis strains were selected for in the laboratory by passage 
in the presence of metronidazole (Diniz et a!., 2004). These mutant strains contained 
changes, such as upregulation of lactate dehydrogenase, down regulation of flavodoxin, 
and impaired pyruvate ferredoxin oxidoreductase activity. 
The metA gene of B. fragilis was found to confer resistance to metronidazole (Dachs et 
a!., 1995). The MetA protein reduced DNA breakage caused by metronidazole, but it did 
not inactivate metronidazole. This suggested that its mode of action could be by repairing 
the damage. A recA mutant of B. thetaiotaomicron was found to be more sensitive to 
metronidazole than the wild type (Cooper el al., 1997), once again suggesting the 
involvement of DNA repair systems. 
Genes involved in moderate levels of nitroimidazole resistance, nim genes, have been 
identified in Bacteroides species (Haggoud et al., 1994; Trinh et a!., 1995; Trinh and 
Reysset, 1996). Three of the four genes are plasmid-borne, nimA in plP417 from B. 
vulgatus BY-17, nimC in pIP419 from B. thetaiotaomicron BT-13 and nimD in pJP421 
from B. fragilis BF-F239, while nimB was found in the chromosome of B. fragilis BF-S. 











to each other, suggesting a common ancestral gene. They contain insertion sequences (IS) 
upstream of their start codon, and transcription is thought to be directed by promoters on 
the right ends of these IS elements. All four genes are transferable by conjugation (Trinh 
and Reysset, 1996). Haggoud et al. (1994) reported a similar uptake of metronidazole in 
B. fragilis 638R, with or without the presence of nimA and nimB, indicating that these 
genes were not involved in preventing entry of the drug. Carlier et al. (1997) have 
suggested that the nim genes code for a nitroimidazole reductase that converts 4- or 5-
nitroimidazoles into 4- or 5-aminoimidazole and not forming the cytotoxic nitroso 
radicals. 
Metronidazole resistance is often found in H pylori. Inactivationofthe rdxA gene, coding 
for a nitroreductase, by missense or nonsense point mutations increased the MIC of 
susceptible strains from 8 to 32 Jlg/ml (Kwon et al., 2000a). Further inactivation ofjdxB, 
a gene coding for ferredoxin-linked protein, doubled the MIC to 64 Jlg/ml. Inactivation of 
another nitroreductase alone, frxA, increased the MIC to 32 llg/mJ, while double 
inactivation of rdxA and frxA produced high level resistance, with MIC larger than 100 
Jlg/ml. This would explain the different levels of resistance found in H pylori isolates. 
Growth of H pylori in metronidazole-containing medium caused decreased expression of 
ferredoxin oxidoreductase gene and rdxA, moderate decreased expression of pyruvate 
oxidoreductase and jdxB, and unchanged expression of ferredoxin and flavodoxin genes 
(Kwon et al., 2000b). This implies that metronidazole resistance could be acquired by 
regulation of gene expression. 
Metronidazole resistance has also been related to efficient DNA repair and the 
involvement of the RecA protein (Chang et al., J 997). 
The involvement of DNA repair genes in metronidazole resistance in B. fragilis and H. 
pylori indicates the importance of DNA repair in resistance. Repair mechanisms induced 
by other DNA damaging agents have been widely studied in E. coli. Some of these will 
now be discussed with a view to understanding how the strand breaks caused by 











1.3 DNA repair 
Preservation of its genomic material is vital for the survival of the individual cell. DNA is 
constantly under attack from environmental stresses, as well as from intrinsic mistakes by 
the cellular machinery. Despite all this, mutations are rare in a population. This is 
achieved through the constant survei \lance of the genome and the immediate response to 
damage of the DNA. 
Very little is known about the DNA repair systems of Bacteroides species. The recent 
publication of the B. thetaiotaomicron genome (Xu et ai., 2003) and the B. fragilis 
YCH46 genome (Kuwahara et al., 2004) will give a better insight on the possible 
mechanisms that these organisms use to protect and repair their genomic material. Due to 
the fact that DNA repair systems in obligate anaerobes are virtually unknown, some of 
the well-studied E. coli DNA repair pathways will be discussed, with the emphasis on 
those possibly having a role in repairing metronidazole induced DNA strand break 
damage. 
1.3.1 Recombinational Repair 
1.3.1.1 RecA 
The RecA protein catalyses the central reaction in all types of recombination, whether it 
is for genetic diversity or for repair. It is also the central protein involved in induction of 
the SOS response (Radman, \974; Kuzminov, 1999). The SOS system controls the 
induction of a number of cellular responses, including DNA repair, damage-induced 
mutation (Witkin, 1969) and filamentation of cells (Green et ai., 1969), following DNA 
damage or disruption during replication. The system involves a network of 31 known 
genes and 38 putative genes, under the control of two key proteins, RecA and LexA 
(Fernandez de Henestrosa et ai., 2000). Under normal growth conditions, the LexA 
repressor binds to the SOS box in promoters of the SOS genes, preventing transcription 
(reviewed by Kuzminov, 1999). When replication is inhibited, the SOS response is 
induced. Single stranded DNA accumulates when replication is blocked, and the RecA 
protein forms filaments on the DNA in the presence of A TP and becomes activated. 











al., 1980). This decrease in the level of LexA bound to the SOS boxes allows 
transcription of the SOS genes. 
The fact that B. thetaiotaomicron and H pylori recA mutants are sensitive to 
metronidazole suggests an involvement of RecA in reducing the effect of the drug 
(Cooper et al., I 997;Chang el aI., 1997). 
In recombination, the ssDNA-bound RecA filament is involved in finding a DNA duplex 
which is homologous to the ssDNA. It is not known how RecA is able to find 
homologous DNA. It is thought to have more than one DNA binding site to 
accommodate the ssDNA and its homologous duplex DNA (Cox, 1995). 
Once it has found a homologous duplex DNA, it catalyses the exchange of strands. The 
ssDNA forms hydrogen bonds with the complementary strand of the duplex DNA. This 
displaces the other strand of the DNA duplex. RecA is assisted at all times by Single 
Strand Binding protein (SSB). Whenever single stranded DNA is present, SSB quickly 
complexes with it, covering it (Kuzminov, 1999). It is thought to help RecA to form 
filaments on the ssDNA by preventing formation of secondary structures. Once strand 
exchange has occurred and the other strand of the duplex is displaced, SSB is likely to 
bind to it. This pairing of DNA strands causes the formation of Holliday junctions which 
must be removed. These are removed by Ruv ABC resolvase or by RecG helicase 
(Kuzminov, 1999). 
RecA is often targeted to sites of recombinational repair by different protein complexes. 
According to the type of repair needed, there are different pathways involved, such as the 
RecF, involved in repair of daughter strand gaps, or the RecBCD pathway, involved in 
the repair of single and double strand breaks and a possible system involved in repair of 
metronidazole damage. 
1.3.1.2 The ReeF Pathway 
When the replication machinery encounters a non-coding lesion, the replication fork is 
blocked. Replication is known to reinitiate downstream of the lesion causing a single 











by the RecF pathway in a RecA-dependent manner. The RecF pathway consists of three 
repair proteins, RecF, RecR and RecO. 
RecF has been shown to bind linear single stranded DNA with a preference for the ends 
(Griffin and Kolodner, 1990). In the presence of A TP and Mg2+, it is able to bind both 
single and double stranded DNA (Madiraju and Clark, 1992). RecO binds both single and 
double stranded DNA in the presence of Mg2+ and is able to promote renaturation of 
complementary DNA strands. Very little is known about the biochemistry of RecR. The 
genes coding for these proteins are on different loci in the chromosome, however each of 
these genes is located adjacent to genes coding for subunits of the replication machinery 
(Kuzminov, 1999). 
When a single stranded gap is formed on the daughter strand, SSB binds to it 
immediately. ReeF and RecR form a complex which is thought to be involved in sensing 
for a stalled repl ication fork (Kuzminov, 1999). The RecFR complex brings RecO to the 
SSB-covered single strand gap. The RecOR complex is thought to bind the SSB-covered 
DNA at the junction between the single strand and duplex DNA (Sandler and Clark, 
1994). This allows RecA to form filaments on the single stranded gap. The RecA 
filament then finds an intact duplex homologous to the gap and pairs them. 
Recombination of these strands then takes place. 
The function of ReeF is thought to be that of directing the repair to the daughter strand. 
The RecR protein seems to act as a mediator between RecF and RecO, while RecO is 
then involved in recruitment of RecA for recombination to take place (Kuzminov, 1999). 
RecF, RecO and RecR are required to stabilize the replication fork. RecQ, a DNA 
helicase and RecJ, an ssDNA exonuclease, are involved in degradation of the nascent 
lagging strand (Courcelle and Hanawalt, 1999). This is thought to increase the ssDNA 
substrate for RecA binding and prevent illegitimate recombination. In the absence of 
RecFOR, Red and RecQ are involved in degradation of the replication fork and RecQ is 











1.3.1.3 The RecBCD Pathway 
When a replication fork encounters a single stranded break, it collapses and this forms 
double stranded interruptions (Kuzminov, 1999). This suggests that unrepaired single 
stranded breaks lead to double stranded breaks. Repair of double stranded breaks is 
achieved by the RecBCD recombinational repair pathway. Metronidazole is thought to 
cause single stranded DNA breaks and possibly double stranded breaks. It is possible 
then, that the RecBCD pathway is involved in repair of metronidazole DNA damage. 
As an overview of the pathway, double stranded DNA (dsDNA) ends are degraded by 
Exo V, also known as RecBCD (Kuzminov, 1999). Once RecBCD encounters a Chi site 
in the DNA, it continues degrading the DNA, but only the 5' ending strand, leaving a 3' 
single stranded overhang. This is the target for SSB. RecBCD promotes RecA binding to 
the SSB-covered ssDNA. RecA is then involved homologous recombination. 
ExoV (RecBCD) is a heterotrimer of RecB, RecC and RecD held together by Mg2~ 
(Taylor and Smith, 1995a; Wright et al., 1971). The recB and reeD genes form an 
operon, with the nearby recC gene having its own promoter (Kuzminov, 1999). None of 
these genes are SOS inducible. RecBCD has potent DNA helicase activity, dsDNA 
exonuclease and ssDNA exonuclease activity. Unlike most other exonucleases, it requires 
A TP hydrolysis and Mg2+ for degradation of DNA. Both exonuclease activities degrade 
the DNA to oligonucleotides, but the dsDNA exonuclease activity does so much faster. 
RecB and RecD are DNA-dependent A TPases containing A TP-binding sites (Masterson 
et al., 1992; Chen et aI., 1997). RecB alone is also a weak helicase, unwinding DNA in a 
3'-5' direction. RecB controls the hydrolysis of the 3'end strand, while RecD is involved 
in degradation of the 5'end strand. 
When encountering a dsDNA break, RecB binds to the 3'end strand while the RecC and 
RecD subunits sit on the 5'end strand (Taylor and Smith, 1995b). The RecBCD enzyme 
moves along the DNA, unwinding and degrading both strands. The DNA is degraded 
unevenly with the 3'end strand receiving most of the cuts due to the positioning of the 
enzyme. As the dsDNA is degraded, the 3'end is thought to form a single stranded loop 











more slowly (Telander-Muskavitch and Linn, 1982). The reason for the loop formation is 
to prevent ExoI, an ssDNA-specific nuclease which degrades in a 3' to 5' direction, from 
degrading the strand. As the enzyme moves along, it comes across a Chi site on the DNA. 
In E. coli, Chi sites are 8 nucleotides regions with the sequence 5'-GCTGGTGG-3' 
(Smith ef al., 1981). In other bacteria, the Chi sequence is different but also short without 
repeats (Kuzminov, 1999). The Chi site is only recognised by RecBCD from the 3' end. 
Recognition of the Chi site stops the dsDNA exonuclease activity and turns the enzyme 
into a recombinase. This is thought to be done by ejection of the RecD subunit, however 
it has not been established whether the subunit is completely lost. This allows RecBCD to 
degrade the 5' end strand only. Degradation of only one strand causes the formation of 
ssDNA which is immediately bound by SSB. RecBCD interacts with RecA and promotes 
RecA tilamentation on the SSB-covered ssDNA. 
The recBC mutants are deficient in homologous recombination and sensitive to DNA 
damaging agents. However, additional suppressor mutations are able to switch on 
alternative pathways for double strand end repair via the RecE pathway and a modified 
RecF pathway. 
1.3.1.4 Alternative double strand end repair via the RecE and ReeF Pathways 
Two suppressor mutations sbe (for suppressor of reeB and recC) are able to compensate 
for recBC mutants that are unable to achieve double strand break repair. The first 
mutation, named sbcA, activates part of a cryptic Rac prophage in E. coli (Campbell, 
1994). Two phage proteins are produced, the RecE and the RecT proteins. This pathway, 
termed the RecE pathway, is dependent on RecA, RecE, RecF, RecO, RecR, RecJ and 
RecT. The mechanism by which double strand breaks are repaired is still unknown. The 
RecE protein is a dsDNA-specific exonuclease which is able to degrade duplex DNA 
from the 5'end strand causing formation of 3' overhangs (Joseph and Kolodner, 1983). 
RecE can act on blunt ends or ends with a long 3'overhang. It is also able to act on short 
5' overhangs, but ends with long 5' overhang are not substrates for RecE. Removal of the 
long 5' overhangs is thought to be achieved by Red, an ssDNA-specific exonuclease 











able to form the 3' overhang. RecT then binds to the overhang and promotes annealing of 
complementary DNA, as well as protecting it from ExoI degradation. 
The second mutation shcB allows the RecF pathway, described previously, to handle 
double strand breaks (Kuzminov, 1999). This is achieved by inactivation of two cellular 
nucleases, ExoI which is able to degrade ssDNA 3'ends (Lehman and Nussbaum, 1964) 
and SbcCD, and ATP-dependent dsDNA exonuclease related to RecBCD (Exo V) (Lloyd 
and Buckman, 1985). This pathway involves a large number of proteins, RecA, ReeF, 
RecO, RecR, RecJ, RecN. The RecQ, UvrD and HelD proteins are DNA helicases which 
are also involved. In this alternative pathway, the combined action of RecQ helicase and 
RecJ ssDNA exonuclease is thought to generate 3' overhangs (Kuzminov, \999). The 
Exol and SbcCD nucleases would probably degrade these ends preventing 
recombinational repair. These two alternative pathways are thought to interact and have 
joint elements. 
The RecF pathway and the Nucleotide Excision Repair pathway (discussed below) are 
thought to work together in recovery of replication (Courcelle et al., 1999) The RecF is 
thought to push the replication machinery past the lesion, allow fill ing in of the daughter 
strand gap by recombination, while the Nucleotide Excision Repair is then involved in 
removing the lesion. It has also been proposed that RecFOR, RecA, RecQ and Reel 
together with Nucleotide Excision Repair are involved in repair and recovery of 
replication without recombination (Courcelle and Hanawalt, 200 I). 
1.3.2 Nucleotide Excision Repair 
E. coli strains deficient in nucleotide excision repair (NER) have been shown to be more 
sensitive to metronidazole (Yeung et al., 1984; Jackson et al., 1984). This suggests an 
involvement of the nucleotide excision repair in dealing with metronidazole damage of 
DNA. 
Nucleotide excision repair occurs when the DNA is damaged in a double stranded, non-











excised and the gap is filled in by using the complementary strand of the DNA. This 
occurs by the joint action of the UvrA, UvrB, UvrC and UvrD proteins, followed by Poll 
and DNA ligase. The type of damage recognised by NER is usually that which causes 
distortion of the DNA helix (Friedberg et al., 1995). 
The uvrA gene is constitutively expressed at low levels and is inducible by the SOS 
response (Friedberg et al., 1995). The UvrA protein contains both ATPase and DNA 
binding motifs. In the absence of ATP, it is found as a monomer, however it dimerises 
when A TP is present causing a conformational change. Dimeric UvrA is able to bind 
DNA containing various types of damages, and the N-terminus is then able to bind UvrB. 
The uvrB gene is unlinked to uvrA (Friedberg et al., 1995). It is also SOS inducible, 
however it also possesses a SOS-independent promoter (Friedberg et ai., 1995). The 
UvrB protein contains 5 difTerent domains (Theis et al., 2000). Domains la and 3 are 
involved in binding A TP and have high structural similarity to helicases of superfamily I 
and II. Domains 2 and 4 are distinct from helicases and are thought to be involved in 
interactions with UvrA and UvrC. Domain 1 is involved in DNA binding. A TP binding 
and hydrolysis is thought to move the domains. In the (UvrA)2UvrB complex which will 
be discussed later, the domain motions lead to translocation of the complex along the 
DNA to probe for damage. In the tight UvrB-DNA preincision complex, the motions lead 
to distortion of the 3'incision site. This preincision complex is formed by the insertion of 
flexible ~-hairpins between the two DNA strands (Theis et al., 1999) and bound by UvrC. 
The uvrC gene is not inducible by DNA damage and is not part of the SOS regulon 
(Friedberg et al., 1995). UvrC is unable to associate with UvrA or UvrB in solution, 
however it has a high affinity for the UvrB-DNA preincision complex. The N-terminus 
contains the catalytic site for the 3' incision (Moolenar et al., 2002). The C-terminus of 
UvrC is involved in the 5' incision. 
The mechanism of excision repair has been extensively studied and is well known. The 
UvrA dimers bind to UvrB in solution (Friedberg et al., 1995). This (UvrA)2UvrB 











moves along the DNA using the UvrB helicase activity. When damage is encountered, 
UvrA dissociates leaving a stable UvrB-DNA complex. This complex causes bending of 
the DNA. UvrC which has high affinity for the UvrB-DNA complex binds to UvrB and 
hydrolyses the Sth or 4th phosphodiester bond 3' to the lesion. This is followed by the 
hydrolysis of the 8th phosphodiester bond 5' to the DNA lesion. The UvrD protein, also 
known as Helicase [I, which gene is SOS-controlled, is required for excision of the 
oligonucleotide fragment containing the DNA damage. This also displaces the UvrC 
protein, while the UvrB remains bound and is released during the synthesis of the missing 
nucleotides by Poll. DNA ligase completes the reaction. 
It is interesting to note that a protein, Cho, with homology to the N-terminus of UvrC has 
been identified in E. coli (MooJenaar el ai., 2002). The gene coding for it, ydjQ, is SOS 
inducible, unlike uvrC. Cho can incise DNA compJexed with UvrB at 3' of lesion, 
however the incision is 4 nucleotides further away from the UvrC 3' lesion. This is most 
likely due to the fact that Cho and UvrC bind to different domains of uvrB. Cho is able to 
incise certain damaged substrates which are poorly incised by Uvrc' 
The UvrA, UvrB and UvrD proteins have also been involved in a replication backup 
sytem that replaces Poll (Moolenaar et ai., 2000). UvrA and UvrB are also thought to be 
involved in suppression of illegitimate recombination, in a pathway shared with RecQ 
(Hanada et al., 2000). 
1.3.3 DNA Repair in Bacteroides 
DNA repair systems of obligate anaerobes have been given little attention and very little 
is known about the DNA repair capabilities of Bacteroides. With the recent publications 
of the B. Ihetaiotaomicron VPI-S482 genome (Xu et ai., 2003) and the B. fragilis YCH46 
genome (Kuwahara et ai., 2004), the presence of certain DNA repair genes may in the 
future assist in elucidating the DNA repair systems present in these organisms. Both B. 
fragilis and B. thelaiotaomicron have a RecA protein (Goodman et aI., 1987; Cooper et 
aL 1997). This protein is likely to be involved in DNA repair since B. thetaiotaomicron 











(Cooper et al., 1997). This mutant is also more sensitive to oxygen, suggesting that DNA 
repair might be involved in aerotolerance of both Bacteroides species. Bacteroides is not 
likely to have an E. coli-like SOS response, since UV damage did not induce expression 
of RecA in B. fragilis (Goodman et aI., 1987), a characteristic which is also evident with 
the Porphyromonas gingivalis RecA, a close relative to the Bacteroides (Liu and 
Fletcher, 200 I ). 
B. fragilis has a constitutive thymine dimer excision system which operates under both 
anaerobic and aerobic conditions (Abratt et al., 1986). This excision repair system 
involves strand breakage as well as postincision replication (Abratt et al., t 990). 
Physiological evidence suggests that this system might not be the only excision repair 
system in B. fragilis (Abratt et aI., 1985). It seems that the excision repair systems that 
recognise UV and Mitomycin C damage are linked but are not the same pathway. 
1.4 Aims and Objectives 
Bacteroides are a predominant bacterial genus found in the gut, and B. fragilis, and to a 
lesser extent B thetaiotaomicron, are medically important opportunistic pathogens 
involved in anaerobic infections. The high incidence of antibiotic resistance in the 
Bacteroides makes it impossible to treat such infections with conventional antibiotics. 
Metronidazole, a DNA damaging agent active under anaerobic conditions, is the drug of 
choice at the moment due to minimal resistance. B. fragilis metronidazole resistance has 
been identified involving a lack of activation of the drug. However, very little research 
has been done on the mechanism of repair of metronidazole damage and its possible role 
in resistance. The published genome sequences of B. thetaiotaomicron and B. fragilis as 
well as the incomplete genome sequence of B. fragilis NCTC 9343 were only available at 
the last stages of this work. For this reason, indirect approaches were used for 
identification of target genes at the initiation of this study. 
The aims of this study were, therefore, to identifY B. fragilis and B. thetaiotaomicron 











involved in repair of metronidazole DNA damage. Two approaches were used to achieve 
these objectives. The first approach involved the construction of Bacteroides transposon 
mutant libraries and the screening of these libraries for isolation of metronidazole 
sensitive or resistant mutants, with a view to identifying the disrupted genes. The second 
method involved functional complementation of E. coli nucleotide excision repair 
mutants, which are sensitive to metronidazole, using a B. fragilis gene library, to isolate 
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Bacteroides species are numerous In the gastrointestinal tract and they account for 
approximately 30% of colonic bacteria. The best studied Bacteroides species are B. 
fragilis, an opportunistic pathogen and B. thetaiotaomicron, a commensal of the gut. B. 
fragilis infections are treated using metronidazole, however the potential for resistance is 
increasing. In order to isolate Bacteroides genes involved in metronidazole resistance, 
construction of transposon mutant banks of both B. fragilis and B. thetaiotaomicron was 
undertaken. Attempts to generate a B. fragilis representative mutant bank were not very 
successful due to the reluctance of this organism to take up foreign DNA, and no 
metronidazole resistant or sensitive mutants were isolated. However, a significant number 
of B. thetaiotaomicron transposon mutants were generated. Screening of the B. 
thetaiotaomicron mutant bank identified two mutants, Mutant A and B, with increased 
sensitivity to metronidazole. Both mutants had the same disruption within a capsular 
polysaccharide locus suggesting the involvement of the Bacteroides capsule in 
metronidazole resistance. Mutant A contained a second insertion of the cointegrate 
plasmid in a different locus of the chromosome. This insertion caused a further increased 
sensitivity to mitomycin C. Attempts to identifY the insertion of the cointegrate were, 
however, unsuccessfu1. Two B. thetaiotaomicron metronidazole resistant mutants were 
also isolated, termed Mutants C and D. Mutant C contained a disruption within a putative 
two-component histidine kinase with a possible link to methyltransferases and mismatch 
repair. Insertion of the transposon in Mutant D was intergenic between the fucO gene and 
the downstream transcriptional regulator of the putative rhamnose metabolism gene 
cluster. The fucO gene codes for lactaldehyde reductase, an essential enzyme in the 
metabolism of rhamnose and fucose, and also involved in energy relations within the cell. 
Further studies are needed to analyse these mutants more closely and determine how the 












Bacteroides jragilis IS a normal commensal of the gut. However, it is also an 
opportunistic pathogen, and it is the predominant anaerobe found in abdominal infections 
(Frank and Dennis, 1977). The most effective drug used to combat B. jragilis infections 
is metronidazole (reviewed in Section 1.2, Chapter 1). There are three possible stages at 
which a cell could become metronidazole resistant: Firstly, at the cell entry stage, 
whereby the drug could either be prevented from entering the cell, or pumped out once it 
entered. Secondly, at the activation stage, where the inert metronidazole would not be 
changed into the active form of the drug. Thirdly, at the DNA repair stage, where the 
DNA damage caused by metronidazole could be repaired at a faster rate. 
The construction of B. jragilis metronidazole resistant mutants would be useful in 
studying the possible mechanisms of metronidazole resistance. Transposon mutagenesis 
allows a single gene disruption and provides the presence of a selectable marker for 
isolation of the disrupted gene. B. fragilis is not readily amenable to genetic 
manipulations or introduction of foreign DNA (Salyers el ai., 1999), but protocols have 
been published for transposon and site directed mutagenesis (Shoemaker et ai., 1986; 
Tang and Malamy, 2000; Baughn and Malamy, 2003). In order to circumvent the 
problems associated with introducing transposons into B. jragilis, an alternative route is 
the use of B. thetaiotaomicron, a close relative of B. jragilis for construction of mutants. 
B. thetaiotaomicron is more easily manipulated and foreign DNA is able to enter the cell 
and integrate at a higher rate than B. jragilis (Salyers et al., 2000; Hooper et ai., 2001). 
The recent publication of the B. thetaiotaomicron genome (Xu et ai., 2003) would allow 
easy identification of the interrupted genes. This would then allow searching for B. 
fragilis homologues of the putative genes and further characterisation of their mode of 
action in metronidazole resistance in B. jragilis. A possible shortcoming of this approach 
is that although these Bacteroides species are closely related, there is evidence of 
divergence of the genomes and suitable homologues may not be present. 
A modified Tn4400 transposition system, described by Tang and Malamy (2000), was 
chosen due to its recent publication at the time of initiation of this study. The Tn4400 
compound transposon, which confers erythromycin (Erm) resistance to Bacteroides, was 











together with a tetQ gene cassette, which confers tetracycline (Tet) resistance to 
Bacteroides but no E. coli. Conjugation of this plasmid, p YT646, into Bacteroides could 
cause three possible transposition events to occur: tranposition of the Tn4400 conferring 
Erm resistance, or transposition of the inverse transposon named Tn4400 " which 
included the IS4400 sequences with the tetQ gene, conferring Tet resistance, or finally, 
cointegrate formation where the whole p YT646 plasmid would integrate into the 
chromosome conferring both Erm and Tet resistance. Inverse transposition was found to 
occur more frequently than the other two events (Tang and Malamy, 2000). 
This chapter describes the construction of B. fragilis and B. thetaiotaomicron transposon 
mutants using the inverse transposition system described by Tang and Malamy (2000). 
These mutant libraries were then screened for metronidazole sensitivity or resistance to 











2.3 Materials and Methods 
2.3.1 Bacterial strains, plasmids and growth conditions 
B. thetaiotaomicron VPI-5482 (ATCC 29148) and B.jragilis 638R (Privitera et al., 1979) 
were grown anaerobically at 37°C using Difco brain heart infusion broth or agar (1.5%), 
supplemented with haemin, menadione and cysteine (BHIS) (Holdeman and Moore, 
1972). Gentamicin, tetracycline or erythromycin were added to the medium at final 
concentrations of 200 Jlg/ml, 2 Jlg/ml and 2 Jlg/ml, respectively when necessary. Cultures 
were grown in an anaerobic chamber (Model 1024, Forma Scientific Inc., Marietta, Ohio) 
containing an atmosphere of oxygen-free N2, C02 and H2 (85:10:5 by volume). 
Escherichia coli JM 1 09 (Yanisch-Perron et al., 1985) and HB 101 (Sambrook et aI., 
1989) were used for mating experiments. The transposon delivery vector p YT646B was 
described by Tang and Malamy (2000). The broad-host-range mobilising IncP plasmid 
RK231 (Guiney et aI., 1984) was used to transfer pYT646B. E. coli strains were grown 
aerobically at 37°C on Luria-Bertani (LB) broth or 1.5% (w/v) agar (Sambrook et al., 
1989) supplemented with ampicillin (100 Jlg/ml) when transformed with p YT646B, or 
tetracycline (10 Jlg/ml) when carrying pRK231. 
2.3.2 General recombinant DNA procedures 
E. coli plasmid DNA was prepared by the alkali-hydrolysis method of Ish-Horowicz and 
Burke (1981) or using the QIAprep® Spin Miniprep Kit (50) and QIAGEN® Plasmid 
Midi Kit (25) (QIAGEN). B. fragilis and B. thetaiolaomicron genomic DNA was 
prepared according to the method described by Wehnert et al. (1992). All DNA 
modifications were performed according to standard procedures (Sambrook et ai., 1989). 
2.3.3 E. coli-Bacteroides conjugation 
The transposon delivery vector p YT646B was transferred into Bacteroides by conjugal 
transfer from E. coli to Bacteroides as described by Tang and Malamy (2000). The E. coli 
donor strain containing pYT646B and E. coli HBI01 bearing the mobilizing plasmid 
RK231 were grown aerobically in LB broth to an optical density (aD) (600 nm) of 0.2. 
Bacteroides recipients were grown anaerobically in BHIS broth to an OD6oo of 0.2. The 











centrifugation. The mixture was resuspended in 0.2 ml BHIS broth and placed on a sterile 
0.45 flm filter (HA WP02500, Millipore Corp.) on a BHIS agar plate without cysteine. 
The conjugation mixture was incubated aerobically at 37°C for 16 hours. The cells were 
resuspended in 3 ml BHIS broth and incubated aerobically at room temperature for 45 
min. Selection of transconjugant colonies was performed anaerobically by plating the 
conjugation mixture on BHIS agar plates containing gentamicin (200 Ilglml) and 
tetracycline (2 Ilg/ml) or erythromycin (2 flglml). 
2.3.4 Construction of the B. thetaiotaomicron and B. tragi/is 638R Tn4400' 
transposon mutant libraries 
Construction of the B. thetaiotaomicron and B. fragilis 638R transposon mutant libraries 
involved two E. coli-B. thetaiotaomicron and ten E. coli-B. .fragilis conjugation 
experiments for each library, as described in section 2.3.3. Tetracycline resistant 
transconjugants were replica-plated onto BHIS agar plates containing erythromycin (2 
Ilglml) in order to calculate the percentage of cointegrate formation. Only tetracycline 
resistant (Te{) erythromycin sensitive (ErmS) transconjugants were selected as Tn4400' 
transposon mutants and these were divided into 5 pools and stored in BHIS broth at -
70°C. 
2.3.5 Southern hybridization 
Genomic DNA from B. thetaiotaomicron and B. fragilis 638R (20 Ilg each), as well as 
pYT646 plasmid DNA (20 ng) was digested to completion with the appropriate 
restriction endonucleases. The DNA was fractionated by electrophoresis on a 0.8% 
agarose gel in TRIS-Acetate-EDT A buffer and transferred to a Hybond N+ nylon 
membrane (Arnersham Pharmacia Biotech) according to the manufacturer's instructions. 
DNA probes were purified on 0.8% agarose gel and random primed labeled with 
Digoxigenin-l1-dUTP (DIG) using the Digoxigenin Labeling and Detection Kit (Roche 
Diagnostics). DNA hybridization with the DIG-labeled probe was performed overnight at 
68°C using a standard hybridization buffer as stated in the Roche Diagnostics DIG 
System User's Guide. Signals were detected using chemiluminescent detection with 











Stripping of the membrane to remove previously bound probe was done by washing 
twice with 0.2 N NaOH and 0.1 % SDS at 37°C. The membrane was then hybridized to 
the new probe and detection took place as described above. 
2.3.6 Screening of the Bacteroides transposon mutant libraries for metronidazole 
and mitomycin C resistant or sensitive mutants. 
B. thetaiotaomicron and B. fragilis 638R transposon mutants from all 5 pools were 
diluted in BHIS and plated onto BHIS agar plates to obtain single colonies. First-level 
screening involved replica-plating of these individual colonies onto BHIS plates 
containing 0.2 J..lg/ml metronidazole (for sensitivity) or 1.0 flg/ml metronidazole (for 
resistance), or 0.05 flg/ml Mitomycin C (MTC) (for sensitivity) or 0.5 J..lg/ml MTC (for 
resistance). For second-level screening, stationary phase putative metronidazole and 
MTC B. thetaiotaomicron mutants from the first-level screening were diluted 
appropriately and plated onto BHIS agar containing either mitomycin C or 
metronidazole. The minimum inhibitory concentration (MIC) was determined after 48 
hours incubation at 37°C, anaerobically. 
2.3.7 Metronidazole broth assays 
Stationary phase B. thetaiotaomicron mutants were diluted to an OD6oo of 0.1 and 
inoculated into 10 ml BHIS broth containing increasing concentrations of metronidazole 
(0-3 J..lg/ml). The OD600 was measured after 24 hours incubation at 37°C anaerobically 
and the MIC was determined. These experiments were repeated 6 times. 
2.3.8 Determination of the site of transposon insertion by plasmid rescue 
Chromosomal DNA from each mutant was digested to completion using HindIlI and the 
chromosomal fragment adjacent to the transposon was isolated by plasmid rescue a..;; 
described by Tang and Malamy (2000). The resulting ampicillin resistant plasmids (Fig 











(Stratagene, La Jolla), or by using an internal primer modified from primer L 78 (Chen et 
ai., 2000) (5'-CAA TAA TCG ACC TCG TAA AAG-3') for sequencing. 
bla IS4400(R) Bacteroides chromosomal DNA 
900bp 
Figure 2.1 Diagrammatic representation of a plasmid resulting from the rescue of the chromosomal DNA 
of the B. Ihelaliolaomicron mutant adjacent to the inverse transposon using Hindi II. The black line 
represents the part of the inverse transposon containing the E. coli ori. The ampicillin resistance (bla) gene 
is shown in green. The bold blue line represents the chromosomal DNA from the B. Ihetaiotaomicron 
mutant. The black arrow represents the internal primer modified from primer L 78. 
2.3.9 Nucleotide Sequencing 
Sequencing reactions were performed using the DYEnamjc ET Dye terminator Cycle 
sequencing Kit for MegaBACE (Molecular Dynamics), wruch is based on traditional 
dideoxynucleotide chain termination chemistry (Sanger et al., 1977). All reactions were 
performed according to the manufacturer's instructions and cycle sequenced on a 
GeneAmp PCR System 9700 (Perkin Elmer, Applied Biosystems) using the uruversal 
Ml3 sequencing forward and reverse primers or the modified L78 primer (Chen et ai., 
2000) at concentrations of 5 ~M each and hybridization temperature of 68°C. The 
sequencing reaction products were analysed on the MegaBACE 500 sequencer 
(Molecular Dynamics, Amersham Pharmacia Biotech, Amersham Biosciences), which is 
an automated capillary DNA sequencing system. The nucleotide sequences were 
analysed using the MegaBACE 500 Sequence Analyser v2.4 software and the software 
program DNAMAN, version 4.l3 (Lynnon BioSoft). Sequence similarity searches were 
done using the NCBI BLAST program (Altschul et aI., 1997). The B. thetaiotaomicron 
genome was used for analysis (Xu et ai., 2003) and the prelimjnary B. fragilis 9343 












2.4 Results and Discussion 
2.4.1 Construction and analysis of the B. thetaiotaomicron and B. fragilis 638R 
transposon mutant libraries 
2.4.1.1 Enumeration of transposition frequencies 
Transposon mutagenesis of Bacteroides was attempted using the delivery vector p YT646 
containing the inverse transposon Tn4400' constructed by Tang and Malamy (2000). 
Two separate E. coli-B. thetaiotaomicron conjugation experiments were performed with 
transconjugation frequencies ranging from 2x 1 0-6 to 4x 1 0-5 per E. coli donor celL The 
frequencies of inverse transposition of Tn4400' ranged from 2.5x 10-6 to 2.5x 10-5 per 
donor cell. while the frequencies of Tn4400 normal transposition were between 3x 10-6 
and 2x 10-5 per donor ceiL Table 2.1 shows the transposition results from the most 
efficient conjugation experiment in B. thetaiotaomicron. 
Table 2.1 Transposition results from a single conjugation of p YT646 into B. thetaiotaomicron 
Te{ phenotypell Te{ IErms phenotype!> Ermr phenotypef 
(transconjugants) (Tn4400'mutants) (transconjugants) 
Number of 
colonies 1143 698 800 
Transfer 
frequency (per 
E. coli donor 4xl0-5 2.3xl0-5 2.5xl0-5 
cell)d 
! 
a The full conjugation mix was plated on BHIS with tetracycline (2 Jlglml) and gentamicin (200 
Jlglm I) and the total number of colonies counted. 
b All Tel' colonies from the conjugation experiment were replica plated onto BHIS erythromycin 
plates (2 Jlglml). 
c A 100111 sample from the conjugation mix was plated on BHIS with erythromycin and gentamicin 
and the total number of colonies counted, to calculate the frequency of Ermr transconjugants. 
d The number of E. coli donor cells was scored by plating the donor mix on BHIS plates containing 












Ten E. coli-B. fragilis 638R conjugation experiments were performed but these resulted 
in very low transconjugation frequencies ranging from 7x 10.9 to 1 x 1 0-7 per E. coli donor 
cell. The frequencies of inverse transposition of Tn4400' ranged from 7x 10-10 to 7x 1 0-8 
per donor cell, while the frequencies of cointegrate formation were between 6xlO-1O and 
7x 10-8 per donor cell Crable 2.2). Co integrate formation occurs when the entire p YT646 
plasmid integrates into the chromosome, carrying both Ermf and T e{ markers. An 
average of 40% of B. thetaiotaomicron and B. fragilis 638R Tetf transconjugants were 
co integrates, a much higher figure compared to the 4% co integrate formation in B. 
fragilis achieved by Tang and Malamy (2000) and the 10% cointegrate formation in 
Porphyromonas gingivalis (Chen et al., 2000), using the same Tn4400' mutagenesis 
system. This figure resembles the 50% cointegrate formation reported by Shoemaker et 
al. (1986), using a transposon vector containing the Tn4351 transposon. 
Table 2.2 Transposition results from total of 10 conjugation experiments of p YT646 into B. jragilis 638R. 
. .. __ .. -:;--
Te{lErms phenotypeb I Te{lErn{ phenotypeb-Te{ phenotypea 
I 
(transconjugants) (Tn4400'mutants) (co integrates) 
Number of I 
colonies 1043 513 530 
Transfer 
frequency (per 






I ~ransconjugants I 100 50 50 
a The full conjugation mix was plated on BHIS with tetracycline (2 Ilg/ml) and gentamicin (200 
Ilg/ml) and the total number of colonies counted. 
b All Tetr colonies from the conjugation experiment were replica plated onto BHIS erythromycin 
plates (2 Jlg/ml). 
c The number of E. coli donor cells was scored by plating 100 III of the donor mix on BHIS plates 











A total of 1500 Tn4400' B. thetaiotaomicron transposon mutants were accumulated and 
these were divided into 5 pools of 300 mutants each. Due to the low frequency of inverse 
transposition, a total of only 600 Tn4400 ' B. fragilis 638R transposon mutants were 
obtained. The B. fragi/is 638R mutants were divided into 5 pools of 120 mutants each. 
The Ter Ennf colonies could only be due to a cointegrate inserted in the chromosome, 
since pYT646 is unable to replicate in Bacteroides (Tang and Malamy, 2000). A total of 
1000 B. thetaiotaomicron and 500 B. fragilis 638R co integrates were also divided into 
pools and stored. 
2.4.1.2 Analysis of integration events within random Tn4400' B.fragilis mutants 
Southern hybridization analysis was used in order to investigate the number of copies of 
Tn4400 ' inserted in the B. fragilis 638R chromosome and whether this had occurred in a 
random way. The nature of the B. fragilis putative co integrate mutants was also analysed. 
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Figure 2.2 Partial restriction map of pYT646B (Tang and Malamy, 2000). The PvuII restriction site was 
located by double restriction enzyme digests of pYT646B. The bold black lines represent the tetQ and 











Five Tn4400' B. fragilis Tn4400' mutants, 1 a to 1 e, were chosen at random, as well as 
five B. fragilis cointegrate mutants, 2a to 2e. Their chromosomal DNA was digested with 
PvuTI, which has one restriction enzyme site in p YT646B, within the tetQ gene (Fig 2.2). 
The presence of the tetQ gene (Fig 2.3A) and ermF gene (Fig 2.3B) in the selected 
mutants was investigated in order to ensure that the Tn4400' mutants were in fact true 
inverse transposons containing the tetQ gene and lacking the ermF gene, while the 
suspected co integrate mutants contained both antibiotic markers. 





Figure 2.3 Southern blot analysis of B. jragilis genomic DNA containing Tn4400' or co integrates using the 
(A) tetQ probe, and (B) ermF probe. Molecular mass markers are shown on the right (kb). Lanes 1-5, B. 
jragilis Tn4400' mutants la to Ie genomic DNA digested with PvuII, respectively; Lanes 6-10, B. jragilis 
cointegrate mutants 2a to 2e genomic DNA digested with PvuH, respectively; Lane 11, B. jragilis 638R 











The 0.9 kb SacI-EcoRV internal tetQ probe (Fig 2.2) hybridized to the genomic DNA of 
the five Tn4400' mutants resulting in two bands, as expected for a single insertion (Fig 
2.3, Lanes I-5A). No major signals were visible for these Tn4400' mutants when probing 
with the 0.75 kb HindIII-HindIII internal ermF probe (Fig 2.3, Lanes 1-58). The tetQ 
probe and ermF probe hybridized to the genomic DNA of four of the five co integrate 
mutants. 2a to 2d (Fig 2.3, Lanes 6-9A and Lanes 6-98, respectively). Mutant 2e did not 
result in a signal with any of the probes (Fig 2.3, Lane lOA and B) and was probably a 
false positive. The tetQ DNA probe hybridized to the positive control, p YT6468 digested 
with BglH (Fig 2.2), resulting in multiple bands due to incomplete digestion, with the 
main band of an expected size of 4.5 kb (Fig 2.3, Lane 12A). The ermF probe also 
hybridised to the positive control as shown by the expected 8.7 kb band (Fig 2.3, Lane 
128). Genomic DNA from WT B. fragilis 638R was used as a negative control and did 
not hybridise to either of the two probes (Fig 2.3, Lane I1A and B). 
Since the Tn4400' mutants (Mutants la to Je) all had two signals when probed with the 
tetQ probe, this implied they had only one copy of the tetQ gene, showing a single 
integration of the inverse transposon. The sizes of the two bands were different for each 
transposon mutant, suggesting that integration of the transposon occurred randomly into 
different chromosomal loci. The absence of the ermF gene in these mutants confirmed 
their nature as true inverse transposon mutants. The first four cointegrate mutants 
(Mutants 2a to 2d) showed more than 2 signals, however some bands were very faint, 
suggesting partial digestion of the genomic DNA. This suggested that a single copy of the 
tetQ gene was present. These mutants were shown to be co integrate mutants by the 
presence of both the tetQ and ermF genes in the same chromosomal Pvull fragment, as 
shown by the fact that the same sized bands are detected with the two probes. This shows 
that these mutants contain a co integrate integration, where the entire p YT646 plasmid is 
integrated at one site in the chromosome, rather than a double integration of a normal 
Tn4400 transposon, containing ermF, and an inverse Tn4400' transposon, containing 
tetQ, into different loci of the chromosome. The growth of cointegrate mutants 2e on 











2.4.2 Isolation of metronidazole resistant and sensitive B. /ragiJis and B. 
thetaiotaomicron Tn4400' mutants 
2.4.2.1 Screening of the Bacteroides mutant libraries for metronidazole mutants 
In order to isolate Bacteroides genes involved in resistance to metronidazole, all 5 pools 
from the B. Ihelaiolaomicron and B. fragilis 638R Tn4400' mutant library were screened 
for metronidazole and mitomycin C sensitive or resistant mutants. No drug sensitive or 
resistant B. fragilis 638R Tn4400' mutants were identified. However, four B. 
thetaiotaomicron mutants were isolated. These were a metronidazole (Met) and 
mitomycin C (MTC) sensitive mutant, Mutant A (Table 2.3), a metronidazole sensitive B. 
thetaiotaomicron Mutant B, and two metronidazole resistant B. thetaiotaomicron 
mutants, Mutants C and 0 (isolated by Ms Lynthia Paul), both with a metronidazole MIC 
on plates of 8 I-lg/ml (Table 2.3). These four B. thetaiotaomicron mutants were further 
analysed with a view to their being used to identify B. .fragilis homologous genes. 
Table 2.3. Susceptibility to metronidazole and mitomycin C of B. thetaiotaomicron transposon mutants. A 
representative set of data is shown from 10 experiments. 
B. thetaiotaomicron Metronidazole MICa Mitomycin C MIC MetlMTC 
I 
Tn4400' mutants (J.lg/ml) (J.lg/ml) Phenotype 
B. thetaiotaomicron 0.5 ! 0.3 WT 
I 
Mutant A 0.2 0.05 MetslMTCs 
Mutant B 0.3 0.3 MetS 
Mutant C 8 NO Metf 





a Minimal inhibitory concentration (MIC) determined on BHIS agar plates anaerobically. 
ND Not determined. 











2.4.2.2 Metronidazole Broth resistant assays 
The survival of the four B. thetaiotaomicron mutants ill different concentrations of 
metronidazole was compared to that of the wild type B. thetaiotaomicron. Mutant A was 
most sensitive to metronidazole, reaching 10% survival (as a percentage of absorbance at 
o Ilg/ml metronidazole) at approximately 0.75 J.1g/ml (Fig 2.4). The metronidazole 
sensitivity of Mutant B was very similar to that of Mutant A. WT B. thetaiotaomicron 
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Figure 2.4 Susceptibility in broth of B. thetaiotaomicron Mutants A and B at different concentrations of 
metronidazole. B. thetaiotaomicron was used as a measure of WT metronidazole resistance. Error bars 
represent the ±S.D. of the mean. 
Mutants C and D were both highly resistant to metronidazole as compared to the wild 
type B. thetaiotaomicron, with 10% survival closer to 1.75 J.1g/ml (Fig 2.5). 
These results confirmed Mutant A and B as metronidazole sensitive mutants and Mutant 
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Figure 2.5 Susceptibility in broth of B. lhetaiotaomicron Mutants C and D at different concentrations of 
metronidazole. B. thetaiotaomicron was used as a measure of WT metronidazole sensitivity. Error bars 
represent the ±S.D. of the mean. 
2.4.2.3 Analysis of integration number of transposon mutants A, B, C and D 
It was necessary to demonstrate that the phenotype of these mutants was due to 
disruption of a single gene. Southern hybridization analysis was used to identifY the 
number of trans po son integration sites in each B. thetaiotaomicron mutant A, B, C and D. 
Hybridisation of the 900 bp SacI-EcoRV tetQ probe (Fig 2.2) to Pvull-digested genomic 
DNA from a Tn4400' mutant containing a single insertion within its chromosome would 
give 2 bands. The results are shown in Figure 2.6. The WT B. thetaiotaomicron genomic 
DNA did not hybridise to the probe (Lane 2), showing the absence of the transposon in 
the chromosome. Mutants D (Lane 3), C (Lane 4) and B (Lane 5), all contained a single 
insertion of the inverse transposon Tn4400' at different sites within their chromosome, 
as shown by the two, different sized bands. Hybridisation of the probe to Mutant D 
genomic DNA resulted in a doublet made up of 2 bands of very similar sizes (Lane 3). 
Mutant A, however, (Lane 6) contained 3 bands, two of which seemed to be the same 
size as Mutant B. This suggested the possibility of two different integration events had 
occurred within the chromosome, one of which could be the same as in Mutant B. Mutant 
A was plated on erythromycin and tetracycline and found to be resistant to both 











containing a nonna! Tn4400' insertion, the same as in Mutant B, as well as a partial 
co integrate or a nonnal Tn4400 transposon, containing only part of the tetQ gene which 
would explain the third band. Plasmid rescue and sequencing of the chromosomal 
fragments were done to identify the genes disrupted by the transposon in each of the 
mutants. 
MW (kb) 1 2 3 4 5 6 
8.7 ..... 
4.5 ..... 
Figure 2.6 Southern blot analysis of B. Ihelaiolaomicron Tn4400 ' mutants A, B, C and D genomic DNA 
using the lelQ probe. Molecular mass markers are shown on the left (kb). Lane I, pYT646B digested with 
BgnI; Lane 2, B.lhelaiolaomicron genomic DNA digested with PvuII; Lane 3-6, Mutants D, C, B, and A 
genomic DNA digested with PvuII, respectively. 
2.4.3 Sequence analysis of disrupted genes from Mutants A, B, C, D, and 
relationship to metronidazole phenotype 
2.4.3.1 Sequence analysis of the disrupted gene in Mutant B 
Plasmid rescue of the chromosomal region flanking the Tn4400' insertion site in Mutant 











that fragment yielded a plasmid containing part of the inverse transposon and a 
chromosomal fragment (Fig 2.1, Section 2.3.8). A single plasmid of approximately 9 kb 
in size was isolated. Sequence analysis of the Mutant B chromosomal DNA adjacent to 
the inverse transposon revealed that Tn4400' had integrated 650 bp within the B. 
thelaiotaomicron gene BT1339. The BT1339 gene product annotated as an 
undecaprenyl-phosphate-alpha-N-acetylglucosaminyltransferase m the B. 
thetaiotaomicron VPI-5482 genome (Accession Number NC_004663.l), had sequence 
identity to a glycosyltransferase group 4 family protein PG0106 from Porphyromonas 
gingivalis (37% identity and 59% similarity in 362 amino acid residues), TagO, a 
putative undecaprenyl-phosphate-N-acetylglucosaminyltransferase from Bacillus sublilis 
(31 % identity and 47% similarity in 328 residues), and to BT2888, a putative 
glycosyItransferase from B. thetaiotaomicron VPI-5482 (45% identity and 65% similarity 
in 340 residues). 
The BT1339 gene product of 368 ammo acids contained the Rfe family conserved 
domain. This family is made up of members such as the E. coli WecA (formerly known 
as Rfe), B. sublilis TagO as well as the B. fragilis WecA (also known as WcfL) among 
others (Amer and Valvano, 2001; Saldo el al., 2002). Members of this family are crucial 
in multi-enzyme complexes involved in synthesis of surface polysaccharides in both 
prokaryotes and eukaryotes (Amer and Valvano, 2001). The capsular polysaccharide has 
been implicated in promoting drug exclusion and Femebro et al. (2004) showed that 
capsular polysaccharides contributed to antibiotic tolerance in pneumococci. It is, 
therefore, possible that capsular modification is playing a role in the metronidazole 
sensitivity of Mutant B. It is, then, of interest to review the literature on the part played 
by this family of enzymes in capsular polysaccharide biosynthesis and to see whether B. 
thetaiotaomicron and B. fragilis might have similar systems. 
The bacterial members of the Rfe family catalyse the first step in the synthesis of surface 
polysaccharides, the linking of a membrane-associated undecaprenyl-phosphate to N-
acetylhexosamine-l-phosphate. The product formed is used as an acceptor for the 
addition of sugars by other glycosyltransferases, to form the polysaccharide repeating 
subunits. The best-characterized Rfe family protein is the E. coli WecA. It contains 11 











(Arner and Valvano, 2001). These cytosolic regions are also found in the other members 
of the family, including BT1339 gene product (Fig 2.7). Within motif II and III, there are 
two highly conserved aspartic acid residues (DJ06 and 107, and Dl70 and Dl73 in BT1339, 
respectively, Fig 2.7). These are thought to be involved in interactions with the 
undecaprenyl-phosphate-N-acetylhexosamine products as well as with Mg2+ and Mn2+ 
ions needed for enzymatic activity, and for catalytic activity, respectively (Arner and 
Valvano, 2002). Within motif V, there are highly conserved residues, such as an arginine 
(R284 in BT1339, Fig 2.7) and HIHH sequence involved in binding the nucleotide 
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Figure 2.7 Multiple sequence alignment of the B. thetaiotaomicron BT1339 gene product with the Rfe 
famjly proteins. A: Rfe proteins consensus (Accession munber COG0472); B: B. thetaiotaomicron BTl339 
gene product CNP_8\o252); C: B. subtilis TagO CNP_391433). The inverse transposon is inserted into 
BTl339 gene product foIlowing amino acid residue 216, as shown by the red arrow. Cytosolic motifs I to V 
are underlined in red. Shading identity shown as 100% (black), 50% (blue), 33% (yellow), with the 











BT1339 forms part oflocus 4 (Fig 2.8), one of the seven polysaccharide biosynthesis loci 
present in B. thetaiotaomicron (Xu et al., 2003). Since disruption of this gene in B. 
thetaiotaomicron results in the metronidazole sensitivity phenotype, it is interesting to 
examine the B. fragilis genome for the presence of a homologous gene which might serve 
a similar function. 
Capsular polysaccharide biosynthesis loci have been well characterized in B. fragilis 
(reviewed in Section 1.1.4.1). Both the B .. fragilis and B. thetaiotaomicron capsular 
polysaccharide biosynthesis loci contain homologous genes coding for carbohydrate 
biosynthetic enzymes, such as tlippases and glycosyltransferases. However, the B. 
thetaiotaomicron genetic arrangement within the loci is different to the B. fragilis 
arrangement, and the B. thetaiotaomicron genes homologous to the B. fragilis ones are 
not clustered in the same loci as in B. fragilis but are scattered within the different B. 
thetalotaomicron loci. This is clearly seen by the fact that B. thetaiotaomicron contains 7 
such loci while B. fragilis contains 9 loci. The BT1339 gene codes for an undecaprenyl-
phosphate-alpha-N-acetylglucosaminyltransferase. As mentioned previously, this is the 
initiating enzyme within the pathway. Almost every capsule biosynthesis locus in B. 
thetaiotaomicron and B. fragilis contains a gene coding for that type of enzyme. The 
closest B. fragilis homologue to BT1339 is BF3464 of B. fragilis 9343 (72% identity, 
81 % similarity in 365 amino acid residues), coding for a putative LPS biosynthesis 
related glycosyltransferase within the PS_HlPS_3 locus (gene c, Fig 2.8), and BF3665 of 
B. fragilisYCH46 (72% identity and 82% similarity in 363 amino acid residues), coding 
for an undecaprenyl-phosphate-alpha-N-acetylglucosaminyltransferase within the PS-8 
locus (Kuwahara et al., 2004). 
In B. fragilis, capsule polysaccharide biosynthesis genes are transcribed as an operon 
from a promoter upstream of upxY (Krinos el aI., 2001). B. thetaiotaomicron seems to 
have a similar mechanism of regulation of these loci (Xu et al., 2003; Comstock and 
Coyne, 2003). The lack of the undecaprenyl-phosphate-alpha-N-
acetylglucosaminyltransferase in Mutant B would prevent formation of the capsular 
polysaccharide formed by locus 4, since this enzyme is the initiating enzyme for the 
formation of the polysaccharide. E. coli mutants with a disruption in their wecA (rfe) gene 













Barna et al., 2002). One of these mutants was found to be sensitive to acetic acid (Barua 
et al., 2002). It was suggested that surface polysaccharides were indispensable for 
resistance to acetic acid and other short chain fatty acids. There are no reports in the 
literature linking sensitivity to metronidazole to the loss of capsular polysaccharides. 
Britz and Wilkinson (1979) isolated B. fragilis mutants highly and moderately resistant to 
metronidazole. Both types of mutants were unable to activate the drug, but the highly 
resistant mutants were also found to have larger capsules. There is a possibility that the 
thick capsule decreases the entry of metronidazole into the cell by acting as a physical 
barrier. Visual microscopy indicated the presence of a thick capsule in Mutant B. Loss of 
a polysaccharide involved in capsule formation in Mutant B might affect the capsule 
structure and composition, allowing better entry of the metronidazole and therefore 
causing it to be more sensitive than the WT parent. 
B. thetaiotaomicron VPI-S482 capsule polysaccharide biosynthesis locus 4 




B.fragilis 9343 capsule polysaccharide biosynthesis locus PS_HlPS_3 
From BF3466 to BF3451 
Figure 2.8 Genetic arrangement of the (i) B. lhelaiolaomicron VPI-S482 capsule polysaccharide 
biosynthesis locus 4 containing BT1339 and (ii) B. fragilis 9343 PS_HIPS_3 locus containing the BTl339 
homologue. Insertion of the inverse transposon Tn4400' within BT1339 (T) in Mutant B is shown by a thin 
black line. The B. fragilis 9343 homologue to BTl339, BF3464 (c) is indicated by a purple junction arrow. 
B. lhelaiolaomicron genes BTl358 to BTl338 are represented by elements A-U. B. fragilis 9343 genes 
BF3466 to 3451 are represented by elements a-po Genes a and b represent uphY and uphZ respectively, 
while A and B represent the B. lhelaiolaomicron upxY and upxZ bomologues. Glycosyltransferases are 
sbown in red, transport proteins in blue, epimerases in black, dehydratases in turquoise, dehydrogenases in 
horizontal stripes, flippases in white, synthases in white cross-hatching, capsule proteins in green and 











2.4.3.2 Sequence analysis of the disrupted genes in Mutant A 
In section 2.4.2.3, it was suggested that the double mutant A might share an integration 
site with Mutant B, in addition to a further integration event. In order to investigate the 
validity of this assumption, identification of the genes mutated in Mutant A was 
attempted by the HindTII plasmid rescue technique (Fig 2.1, Section 2.3.8). Plasmid 
rescue yielded two different species of plasmids, one of approximately 9 kb in size and 
the other 5.8 kb. This confIrmed the previous result which suggested that Mutant A was a 
double insertion mutant. Plasmid rescue was attempted using PvuII, a restriction enzyme 
which does not cut within p YT646, however this was unsuccessful. 
Sequencing of the linearised HindTII-digested 5.8 kb plasmid revealed a sequence with 
identity to vector pBSL168 followed by the ~-lactamase protein. This was expected and 
corresponded to the transposon end of the HindTII-digested fragment, containing the bla 
gene and the IS4400R (Fig 2.2). Sequencing of the other end of the plasmid resulted in 
sequence with identity to the end of the ermF gene from Tn4551, followed by the end of 
the tetX gene in the opposite orientation. This corresponded exactly to the sequence of 
p YT646B following the HindTII site at the end of the ermF gene (Fig 2.2). This plasmid 
therefore contained the HindIII internal fragment of p YT646B, containing the ampicillin 
resistance gene (Fig 2.9). Since p YT646B is unable to replicate in Bacteroides, this could 
only be a result of a cointegrate being present within the chromosome of Mutant A. The 
region pf p YT646 where the cross-over occurred for the integration of the co integrate in 
the chromosome could not be identified. Southern hybridisation and peR was used to 
attempt to fmd it (Results not shown). The presence of the second integration prevented 
the identification of this region, and therefore the chromosomal fragment disrupted by 






Figure 2.9 Map of the 5.8 kb rescue plasmid from Mutant A, representing an internal fragment of 











Sequence analysis of the chromosomal region adjacent to the IS4400(R) of the 9 kb 
plasmid revealed that Tn4400' had integrated 650 bp downstream of the A TG start codon 
of B. thelaiotaomicron gene BTl339. This meant that Tn4400' had integrated at the exact 
same position, within the same gene in both Mutant A and B, an event which is unlikely 
to have happened, unless it is a hotspot for integration. A more likely explanation for this 
result would be that Tn4400' integrated into the B. thetaiotaomicron chromosome, 650 
bp from the start of BT1339 forming Mutant B. Following a few rounds of cell division, a 
Mutant B cell had a cointegrate plasmid inserted at a different position in its 
chromosome, forming Mutant A. Mutant A is also sensitive to Mitomycin C relative to 
Wildtype B. thetaiotaomicron while Mutant B is not (Table 2.3). This suggests that the 
sensitivity to Mitomycin C might be due to disruption of the unknown chromosomal 
region by insertion of the cointegrate. 
2.4.3.3 Sequence analysis of the disrupted gene in Mutant C 
Mutant C was shown to have a single insertion of Tn4400 , (Fig 2.6, Lane 4), and this was 
confirmed by the rescue of a single species of plasmid, of approximately 4.4 kb in size. 
Sequencing of the chromosomal DNA adjacent to the inverse transposon identified the 
insertion site as 1500 bp downstream of the ATG of B. thetaiotaomicron gene BT4755. 
Gene BT4755 had an open reading frame of 2612 bp, encoding a putative protein of 870 
amino acid residues. This putative protein was annotated in the published sequence as a 
2-component system sensor histidine kinase (Accession No NP _8l3666) but had low 
sequence identity to other histidine kinases and DNA mismatch repair proteins (Table 
2.4). The BT4755 gene product contained the HATPase_c conserved domain in the last 
100 amino acid residues of the protein. This domain is the histidine kinase domain of the 
sensor protein involved in phosphorylation (Xu et al., 2004). The N-terminus of the 
predicted protein had the HtpG conserved domain of molecular chaperones. However, the 
N-terminus of the protein also seemed to have similarity to DNA mismatch repair 
proteins (Table 2.4). 
BT4755 was followed by an open reading frame, BT4756 whose 231-residue product had 
low sequence identity to a response regulator from Cytophaga hutchinsonii (36% identity 











part of a classical two-component system as described by Xu et al. (2004). The gene 
immediately preceding BT4755 was described as a putative cytosine-specific 
methyltransferase and contained both DNA_methylase and Cyt_C5_DNA_meth 
conserved domains. These genes were preceded by a cluster of proteins similar to DNA 
methylases and methyltransferases (Fig 2.10). 
Table 2.4. Sequence identity and similarity ofBT4755 gene product to proteins from various organisms. 
Gene Product 0/0 % BT4755 residues 
Identity Similarity with identity 
Wolinella succinogenes hypothetical 26% in 47% in 414 Residue 15 to 
protein, signal transduction histidine 414 residues 412 
kinase residues 
Erwinia carotovora putative signal 27% in 44% in 236 Residue 15 to 
transduction protein 236 residues 194 
residues 
Erwinia crotovora hypothetical 31% in ! 47% in 149 Residue 26 to 
protein weakly similar to S. pombe 149 residues 149 
DNA mismatch repair protein residues 
Streptococcus mutans UA159 25% in 44% in 425 Residue 5 to 429 
possible DNA mismatch repair 425 residues 
protein residues 
Streptococcus mutans UA159 23% in 43% in 160 Residue 700 to 
putative two-component sensor 160 residues 857 
protein residues 
The fact that BT4755 is located immediately downstream of a putative cytosine-specific 
methyltransferase, and its N-terminus has sequence similarity to DNA mismatch proteins 
suggests that BT4755 is part of a two-component system possibly involved in 
methylation of DNA and mismatch repair. This suggests a possible connection between 
mismatch repair and metronidazole DNA damage. No genes with significant identity or 
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Figure 2.10 Genetic arrangement of the B. thetaiotaomicron VPI-5482 region containing BT4755. BT4748 
to BT4757 are represented by elements A-J . A: similarity to putative DNA methylase; B: putative DNA 
methylase; C: hypothetical protein; D: similarity to methyltransferases; E: conserved protein with similarity 
to proteins adjacent to DNA topoisomerases and methylases; F: hypothetical protein; G: putative cytosine-
specific methyltransferase (BT4754); H: Histidine kinase (BT4755); 1: similarity to response regulator 
(BT4756); J: hypothetical protein. 
2.4.3.4 Sequence analysis of the disrupted gene in Mutant D 
As shown in Figure 2.6 (Lane 3), Mutant D also contained a single insertion of the 
inverse transposon Tn4400 '. Plasmid rescue of the flanking chromosomal DNA fragment 
resulted in a 4.5 kb plasmid. Analysis of the DNA sequence at the junction between the 
transposon and the Mutant D chromosomal DNA revealed that Tn4400 ' had integrated in 
an intergenic region, 11 bp downstream of the putative stop codon of B. thetaiotaomicron 
gene BT3767 and 131 bp upstream of the putative start codon of BT3768. The 1154 bp 
BT3767 gene codes for a putative protein of 384 amino acids, described in the annotated 
B. thetaiotaomicron VPI-5482 genome as a lactaldehyde reductase, also known as FucO. 
This is followed by the 899 bp BT3768 gene coding for a protein with 299 amino acid 
residues with sequence identity to an AraClXylS Family transcriptional regulator. These 
two genes are part of the putative B. thetaiotaomicron rhamnose gene cluster (Fig 2.12, 
E). B. thetaiotaomicron is able to grow on L-fucose and L-rhamnose (Salyers and Pajeau, 
1989), however little is known on the exact assimilation pathways of these 2 sugars. In 
order to analyse a possible reason why a disruption in this pathway might result in 
metronidazole resistance, the well-studied E. coli L-fucose and L-rhamnose assimilation 
pathways are used as the paradigm for further comparison. 
In E. coli, L-rhamnose and L-fucose are metabolized in parallel (Fig 2.11) (Boronat and 
Aguilar, 1981). Each pathway has a permease (FucP and RhaT for fucose and rhamnose 
respectively), an isomerase (Fuel and RhaA), a kinase (FucK and RhaB) and an aldolase 











chromosome (Fig 2.12, A and D). The last step, catalysed by the aldolase cleaves the 6-
carbon sugars into dihydroxyacetone-phosphate and L-Iactaldehyde (Fig 2.11). 
Dihydroxyacetone is channeled onto the general metabolism to generate energy. Under 
aerobic conditions, L-lactaldehyde is oxidized to L-lactate by an NAD-dependent 
lactaldehyde dehydrogenase, encoded by the aId gene, and then to pyruvate by a flavin-
linked lactate dehydrogenase (Fig 2.11). Under anaerobic conditions, L-lactaldehyde has 
to be sacrificed as a hydrogen acceptor and it is reduced to L-1 ,2-propanediol (Fig 2.11 ). 
This is catalysed by an NAD-linked oxidoreductase, FucO. The gene coding for this 
enzyme,JucO, is part of the fucose regulon (Fig 2.12, A). 
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Figure 2.11 The catabolism pathways for L-fucose and L-rhamnose in E. coli (Chen and Lin, 1984). 
The E. coli Juc regulon consists of two divergent operons, Jucp IK and JucA 0 (Fig 2.12, 
A). These are under the positive control of FucR, which is activated by L-fuculose-l-
phosphate, as well as CRP, the cyclic AMP receptor protein (Chen et al., 1989; Podolny 
et ai., 1999). L-rhamnose induces the rha regulon (Power, 1967) and anaerobically it also 
induces expression of not only fucO but also the whole Juc regulon (Chen and Lin, 1984; 
Chen et al., 1987). L-lactaldehyde is needed for cross-induction of the L-fucose enzymes 
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Figure 2.12. L-fucose and L-rhamnose dissimilation pathway genes in E. coli, B. thelaiolaomicron and B. 
fragilis. A: E. coli Juc regulon; B: B. lhelaiolaomicron fucose regulon; C: B. Jragi/is putative fucose 
operon; 0: E. coli rha regulon; E: B. lhelaiolaomicron putative rhamnose gene cluster. Black, kinases; 
turquoise, isomerases; yellow, penneases; green, aldolases; red, reductases; blue, regulatory proteins; 
striated white arrows, hypothetical proteins. 
Under aerobic conditions, FucO is present in the cell but is inactive (Chen and Lin, 
1984). This is due to the fact that FucO is a group ill Fe2+-dependent alcohol 
dehydrogenase (Lu et at., 1998). This group of enzymes contains a putative iron-binding 
motif with 3 conserved His residues (Fig 2.l3, red arrows), 2 of them in a HXXXH motif 
(Obradors et at., 1998). These residues are necessary for catalytic activity. A conserved 
Cys residue (Fig 2.13, blue arrow) is involved in protein stabilization. During aerobic 
growth, H20 2 reacts with Fe
2+ fonning the highly reactive OR radical (Lu et at., 1998). 
This radical is thought to damage certain amino acid residues near the catalytic centre, 
causing decreased affinity for NAD. This is thought to be an adaptive self-destruct 
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Figure 2.13. Multiple sequence alignment of the B. thetaiotaomicron BT3767 gene product with other 
FucO proteins. A: B. thetaiotaomicron BT3767 gene product (Accession number NP _ 812678); B: B. 
fragilis NCTC 9343 putative FucO; C: E. coli FucO (AAB40449). The red arrows indicate conserved His 
residues and the blue arrow, a conserved Cys residue. Shading identity is represented as 100% in black with 
the consensus as lower case below the alignment, 50% in blue and 33% in yellow. 
The B. thetaiotaomicron VPI-5482 published genome data was used to analyse the 
putative L-rhamnose and L-fucose pathways. As is the case with E. coli, B. 
thetaiotaomicron contains two different pathways for the dissimilation of these two 
sugars but they both share the FucO protein. Unlike E. coli, the fucO gene is part of the 
putative rhamnose operon (Fig 2.12, E). The fucose regulon consists of 2 operons, 
fucRiAK andfucP (Fig 2.12, B) (Hooper et al., 1999). In the absence ofL-fucose, FucR 
binds to the fucRIAK promoter causing repression of those genes. L-fucose prevents 
FucR from binding to its own promoter allowing expression of fucRIAK. The putative 
rhamnose operon contains putative genes for the dissimilation of L-rhamnose (Fig 2.12, 











utilization as is the case in E. coli. The putative rhamnose operon contains a regulator, 
designated R. It is very likely a positive regulator since it is part of the AraClXylS Family 
of transcriptional regulators which tend to be positive regulators (Gallegos et al., 1997). 
Within the intergenic region between fucO and the regulator, there are various putative 
consensus sequences for Bacteroides promoters, suggesting the possibility that the 
regulator has its own promoter (data not shown). Insertion of the inverse transposon 
downstream of the fucO gene could have disrupted expression of the regulator assuming 
it had its own promoter. Assuming it was a positive regulator of the rhamnose operon, 
there would not be expression of any of the genes, including JucO. The inverse 
transposon might have affectedJucO, preventing formation of an active FucD protein. 
In Prevotella ruminicoIa, L-rhamnose is fermented to acetate, formate, succinate and 1,2-
propanediol (Turner and Robertson, 1979). L-Iactaldehyde is one of the intermediates of 
this fermentation, suggesting a similar fermentation mechanism as that in E. coli. B. 
fragilis is known to have a very similar metabolism to P. ruminicola, as shown by their 
carbohydrate utilisation and end products of such utilisation (Macy et al., 1978). 
Assuming B. thetaiotaomicron also follows a similar pathway, disruption of FucD would 
force the pathway into lactate production. Metronidazole resistant Bacteroides fragilis 
mutants unable to activate the drug were found to have increased levels of lactate (Britz 
and Wilkinson, 1979; Narikawa et ai., 1991). This was also the case in metronidazole 
resistant Clostridium perfringes (Sindar et al., 1982). All of these mutants were also 
shown to have slower growth, a characteristic also present in Mutant 0 (data not shown). 
The disruption of the lactaldehyde reductase, FucD, could have disrupted the electron 
transfer of the cell, preventing activation of metronidazole. B. fragilis does not have a 
rhamnose pathway, however it does contain a fucose dissimilation pathway (Fig 2.12, C) 
containing a JucO gene. It would be interesting to see whether disruption of that gene 












Due to its genetic intractability, construction of a large, representative B. fragilis 
transposon mutant library was not successful and no metronidazole mutants were 
isolated. The fact that introduction of foreign DNA into B. fragilis is difficult (Salyers et 
al., 1999) makes the use of transposon mutagenesis problematic. It is necessary to 
introduce the transposon at very high frequency, to get a high number of insertions into 
the chromosome in order to have a large enough pool which might include the genes of 
interest. This is difficult to achieve in B. fragilis. 
For this reason, B. thetaiotaomicron was chosen for construction of the transposon bank. 
B. fragilis and B. thetaiotaomicron are part of the same genus and at the time of this 
research project, they were thought to be closely related. The assumption was made that 
any genes of interest identified using the B. thetaiotaomicron mutant bank may have a B. 
fragilis homologue of similar function. This would then allow further characterisation of 
the B. fragilis homologue by direct mutagenesis. The published genome of B. 
thetaiotaomicron (Xu et al., 2003), and both the incomplete genome sequence of B. 
fragilis NCTC 9343 (www.sanger.ac.uk/Projects/B fragilis) and the recently published 
sequence of B. fragilis YCH46 (Kuwahara et al., 2004), however reveal that these two 
organisms are not as genetically similar as previously thought. The genome size of B. 
fragi/is is around 5.2 Mb while that of B. thetaiotaomicron is 6.26 Mb. Browsing through 
the genomes also reveals a large number of genes which are unique to each species. This 
diversity was evident in the identification of the disrupted genes in the B. 
thetaiotaomicron metronidazole mutants. In order to identify B. fragilis genes involved in 
metronidazole resistance, a more direct approach would be more useful in the future, 
such as the construction of specific mutants by insertion or deletion mutations. 
The isolation of four B. thetaiotaomicron mutants with a different metronidazole MIC as 
the wildtype gives an insight into some possible mechanisms of metronidazole resistance. 
Two mutants with increased sensitivity to metronidazole were isolated, Mutant A and 
Mutant B. Both these mutants had an insertion of the transposon within the same gene, 
suggesting that these were siblings. Mutant A however, had an additional cointegrate 
insertion in a different chromosomal locus. Due to the lack of suitable restriction 











transposon Tn4351 was able to insert by itself or carrying the vector forming a 
cointegrate. The two different types of insertions occurred at a frequency of 
approximately 50%. Tang and Malamy (2000) also reported cointegrate formation with 
the inverse transposon Tn4400' used in this study, however the frequency of cointegrate 
formation was much lower than that found with Tn4351 or that found with Tn4400' in 
this study. 
The Tn4400' transposon insertion present in Mutant A and Mutant B was within one of 
the seven capsule polysaccharide loci of B. thetaiotaomicron. B. fragilis contains nine 
capsule polysaccharide and these are different to those from B. thetaiotaomicron. It was, 
therefore, not possible to compare the disrupted polysaccharide locus of B. 
thetaiotaomicron with the B. fragilis loci. Although the identification of a B. 
thetaiotaomicron gene involved in metronidazole resistance cannot be extrapolated 
directly to B. fragilis, it can give insight into possible mechanisms of metronidazole 
resistance. Disruption of a capsular polysaccharide locus caused increased metronidazole 
sensitivity in B. thetaiotaomicron Mutants A and B. This suggests that the capsule might 
be involved, possibly preventing entry of metronidazole into the cell. Further work is 
needed to test this hypothesis, such as doing a comparison of drug uptake in the wildtype 
B. thetaiotaomicron and Mutants A and B. 
Metronidazole resistant mutants of B. thetaiotaomicron were also identified. Mutant C 
contained an insertion within a gene coding for a putative histidine kinase. This two-
component sensor gene was located within a cluster of cytosine-specific 
methyltransferases and possible mismatch genes. Homologues of the putative histidine 
kinase gene or the downstream and upstream genes, coding for the receptor component 
and the methyltransferase respectively, however were not present in B. fragilis. 
B. thetaiotaomicron Mutant D was also more resistant to metronidazole than the wild 
type. The transposon insertion was not within a coding region but within the intergenic 
region between the lactaldehyde reductase and transcriptional regulator of the B. 
thetaiotaomicron putative rhamnose gene cluster. The transposon insertion was only 11 
nucIeotides downstream of the stop codon of the lactaldehyde reductase gene, also known 
as jucO, and 131 bp upstream of A TG of the transcriptional regulator. Insertion of the 











protein. Assuming the rhamnose locus is an operon and the transcriptional regulator does 
not have its own promoter, insertion of the transposon downstream ofJucO might cause a 
polar effect by interrupting transcription of the regulator. The regulator is likely to be a 
positive regulator since it forms part of the AraC Family of positive regulator (Gallegos 
et al., 1997). This would then decrease expression of the rhamnose operon and therefore 
decreased expression of JucO. Various putative promoter sequences have been identified 
upstream of the transcriptional regulator suggesting it has its own promoter. Insertion of 
the transposon might have disrupted promoter sequences needed for efficient expression 
of the regulator, once again causing decreased expression of the operon. Assuming B. 
thetaiotaomicron follows a similar fucose/rhamnose pathway to E. coli (Chen and Li, 
1984), decreased levels of lactaldehyde reductase in the cell would cause disruption of 
the electron flow, as well as increased levels of lactate. This phenomenon has been found 
in Clostridium and B. fragilis cells resistant to metronidazole (Sindar et ai., 1982; Britz 
and Wilkinson, 1979; Narikawa et ai., 1991), suggesting a similar mechanism in Mutant 
D. B. fragilis does not have genes for rhamnose metabolism, however it has a cluster of 
genes that may be involved in fucose metabolism containing the JucO homologue. 
Disruption of the B. fragilis JucO by insertion or deletion mutations would confirm the 
hypothesis that the phenotype seen in Mutant D is due to lack of expression of FucO, 
directly or indirectly. Analysis of both B. thetaiotaomicron and B. fragilis JucO mutants 
might give some insight the pathway(s) used by the cell to activate metronidazole. 
Genetic studies are helpful to prove hypotheses supported by biochemical analysis as 
well as to discover novel pathways which are not identified using a biochemical 
approach. Transposon mutagenesis is a good method to achieve this. However, 
transposon mutagenesis is difficult in B. fragilis, and the use of close relatives such as 
was done in this study is sometimes not successful. Since no DNA repair genes involved 
in metronidazole resistance were identified, other genetic approaches were explored in 
Chapters 3 and 4, such as complementation of E. coli DNA repair mutants, to identify B. 
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Metronidazole, a DNA damaging agent, is the antibiotic of choice for treating B. fragilis 
infections. Isolation of B. fragilis bfI DNA repair genes involved in metronidazole 
resistance was attempted by multicopy suppression of E. coli DNA repair mutants with a 
B. fragilis gene bank. A construct, pAN2, conferring mitomycin C and metronidazole 
resistance on E. coli uvrA-, in the presence and absence of oxygen, was isolated. This 
construct was also able to increase the resistance of E. coli uvrB- to metronidazole, both 
aerobically and anaerobically, but had no effect on E. coli uvrC or recA-. However, 
pAN2 did not affect the resistance of any of the E. coli mutants to ultraviolet light. 
Sequencing of pAN2 revealed the presence of three open reading frames, ORFl, ORF2 
and ORF3. ORFI coded for a truncated protein with high amino acid sequence similarity 
to the RecQ DNA helicases, involved in DNA repair, replication and suppression of 
illegitimate recombination caused by certain DNA damaging agents. Expressed in a 
divergent manner, ORF2 coded for a putative AraC Family transcriptional regulator. 
ORF3 was located downstream of ORF2 and coded for a protein with 23% sequence 
identity to dipeptidyl peptidase III metalloproteases. Deletion studies showed that ORF2 
alone was sufficient to confer metronidazole and mitomycin C resistance on E. coli uvrA-
and uvrB-. This suggests the possibility that ORF2 might be interacting with E. coli genes 












Metronidazole is one of the major drugs used to combat Bacteroides fragilis infections. 
Metronidazole resistance mechanisms have been studied with the focus mainly on the 
genes involved in reduction and activation of the drug (reviewed in Section ).2 of 
Chapter 1). Other possible resistance mechanisms, such as the repair by DNA repair 
enzymes of the DNA damage caused by metronidazole, have not been addressed. To 
date, no B. fragilis DNA repair genes involved in metronidazole resistance have been 
isolated although a recA mutant of B. thetaiotaomicron has been shown to be 
metronidazole sensitive (Cooper et ai., 1997). In addition, E. coli nucleotide excision 
repair mutants have been shown to be more sensitive to metronidazole than the wild type 
isogenic strain (Yeung et al., 1984; Jackson et al., 1984). 
The DNA damaging agent, mitomycin C, causes interstrand DNA crosslinks (Iyer and 
Szybalski, 1963). This type of damage is repaired by the nucleotide excision repair 
system (Friedberg et al., 1995; Van Houten et al., 1986). Since coli nucleotide 
excision repair mutants are more susceptible to metronidazole (Yeung et al., 1984; 
Jackson et al., 1984), there is a possibility that both metronidazole and mitomycin C 
damage is repaired using the same enzymes. Increased resistance to mitomycin C could, 
therefore, be used as an indirect selection procedure for metronidazole repair genes. Since 
metronidazole is only activated anaerobically (Ingham et aI., 1980), mitomycin C also 
allows the screening to be done under aerobic conditions. The gene(s) isolated could then 
be further analysed anaerobically for resistance to metronidazole, as done by Dachs et al. 
(1995). 
This approach was used in the present study. E. coli nucleotide excision repair mutants 
were used to screen a B. fragilis DNA library on mitomycin C, with the intention of 
finding B. fragilis DNA repair genes involved in metronidazole resistance. Although 
transcription of B. fragilis genes in E. coli can be inefficient, presumably due to 
differences in transcriptional signals (Smith et al., 1992). Despite these differences, a 
large number of B. fragilis genes have been isolated by complementation into E. coli 
mutants, such as the B. fragilis ginA (Southern et al., t 986), gdhB (Abrahams and Abratt, 











3.3 Materials and Methods 
3.3 .• Bacterial strains and plasmids 
B. fragiZis bfl was described by Mossie et aZ. (1979). The E. coli isogenic strains used in 
the screening for DNA repair genes are listed in Table 3.1. E. coli JM 109 (Yanisch-
Perron et al., 1985) was used for transformation of recombinant plasmids. The B. fragilis 
gene library was constructed using the suicide vector pEcoR251 (Appendix 2) (Zabeau 
and Stanley, J 982) as described by Southern el aZ. (1986). The recombinant plasmid 
pAN2, and its deletion derivatives, contained B. fragilis DNA cloned into pEcoR251. 
Plasmid pMTI04, which contains an insertion within the EcoRl gene of pEcoR251 
inactivating it (Wehnert et aI., 1992), was used as a negative control. 
Table 3.1. E coli K 12 strains used for screening B. fragilis gene library. 
E. coli strain Genotype Relevant Reference or 
genotype source 
ABt 157 rac', ara, argE, del(gpt-proA)62, uvr ATCC 29055 
galK, hisG, kdgK, lac Yl , leuB6, recA' DeWitt and 
mgl51 , mill, qsr, rjbDl, rpsL, Adelberg (1962) 
· supE44, thit, thr I, tsx33, xyl5 
AB1884 uvrC34 uvrC' Howard-Flanders et 
(AB1 157 derivative) al., ]966 
AB]885 uvrB5 uvrB- Howard-Flanders et 
(AB1157 derivative) aJ., 1966 
------. 
AB1886 uvrA6 uvrA' Howard-Flanders et 
(AB 1157 derivative) al., 1966 
AB2463 recA13 recA - Howard-Flanders et 
L (AB 1 157 derivative) aI., 1966 
3.3.2 Media and growth conditions 
B. fragilis was grown as described in Section 2.3. I . E. coli strains were grown aerobically 
as described in Section 2.3.1. Screening of the gene library was conducted on LB agar 
(Sambrook el aZ., 1989) supplemented with ampicillin (Ap) (l00 !lglml), and mitomycin 











3.3.3 Construction of the B. /ragilis recombinant DNA library and screening for 
DNA repair genes 
The construction of the B. fragilis DNA library has been described by Southern et al. 
(1986). Recombinant plasm ids from pools of clones (about 10 000 per pool) were 
transformed into competent E. coli ABl884 (uvrC -), ABl885 (uvrB -), ABl886 (uvr£) 
and AB2463 (recA-) mutants. Mitomycin C resistant transformants were selected on LB 
agar containing 1 00 ~glml Ap and MTC at concentrations above the minimum inhibitory 
concentration (MIC) for each mutant, 0.6 ~glml for AB1886; 0.8 ~glml for AB1885; 0.8 
~glml for AB 1884; and 0.25 ~glml for AB2463. E. coli AB 1157 (pMT104) was used as 
the wild type repair control. 
3.3.4 General recombinant DNA procedures 
Procedures for plasmid and genomic DNA extraction, and DNA manipulations and 
modifications were described in Section 2.3.2. 
3.3.5 Measurement of cell survival during mitomycin C treatment 
Stationary phase cultures of E. coli AB 1886 (pAN2), as well as E. coli AB 1157 and 
ABl886 containing pMTI04, were diluted 10-2 into one-quarter strength Ringer's 
solution (22.5% NaCI, 1.05% KCI, 1.2% CaCI, 0.5% NaHC03) containing mitomycin C 
at I 0 ~g/ml. Samples were removed at various time intervals and suitable dilutions were 
plated on LB agar. 
3.3.6 Mitomycin C and metronidazole resistance assays 
Stationary phase cultures of the E. coli strains described in Table 3.1, containing pAN2 or 
pMT104, were diluted appropriately and plated onto LB agar containing Ap (1 00 ~g/ml) 
and either mitomycin C (0-2.4 ~glml) or metronidazole (0-1 000 ~g/ml) to a colony 
density of 100 cfuJplate. The MIC was determined after 24 hours incubation at 37°C 











yeast-tryptone (YT) agar supplemented with 0.5% glucose and 0.2% sodium nitrate, 
containing Ap (lOO ~g/ml) and metronidazole (0-260 J..lg/ml) and incubated for 48 h at 
37°C in an anaerobic chamber. 
3.3.7 Ultraviolet (UV) resistance assays 
Stationary phase E. coli cells were diluted appropriately and plated onto LB agar 
containing Ap (100 J..lg/ml). The inoculated plates were irradiated with a Cole-Parmer, 
9815-Series UV lamp (Cole-Parmer Instruments Co, Chicago) at a UV (254nm) dose rate 
of 1.0 Joules.m-2.sec-1, as measured with a Blak-Ray® UV Meter (UltraViolet Products 
Inc., California). The MIC was determined after 24 h incubation at 37°C (Hanada et al., 
2000). 
3.3.8 Southern bybridization 
Southern hybridization of B.fragilis genomic DNA was performed as in Section 2.3.5. 
3.3.9 Nucleotide sequencing 
Subclones of pAN2 were constructed using the plasmid vector pBluescript II SK(+) 
(Stratagene, La Jolla). Sequencing reactions were performed as described in Section 
2.3.9, using the universal M13 sequencing forward and reverse primers. The B. fragilis 
9343 and 638R preliminary genome sequences produced by the Sanger Centre 
Sequencing group (www.sanger.ac.ukiprojects/b fragilis) were also used for analysis. 
3.3.10 peR of B.fragilis bfl ORFI and ORF2 
To clone the complete ORFl, the B. fragilis bfl recQ homologue (Section 3.4.5), two 
oligonucleotide primers were designed based on the preliminary genome sequence of B. 
fragilis 9343 (www.sanger.ac.uklprojects/b fragili s): These were the recQF forward 
primer, 5'-CCT TAG CTG AAT AGT CCG-3 ' at positions -409 to -391 upstream of the 











AGC-3' at positions +1956 to +1939 downstream of the ORFI ATG start codon. PCR 
amplification was done in 50 J..ll reaction volumes containing 100 ng of B. fragilis 
chromosomal DNA, 0.8 J..lM of each primer, 2.5 mM Mg2+, 250 J..lM deoxynuc\eotide 
triphosphates and 2.5U Taq I polymerase (Roche Diagnostics). The samples were 
amplified for 30 cycles as follows: 94°C for 1.5 min; 50°C for I min and 72°C for 1.5 
min with a final elongation at noc for 5 min. PCR products were purified using the High 
Pure PCR Product Purification Kit (Roche Diagnostics). The amplified product was 
blunted and ligated into pEcoR25 I (Zabeau and Stanley, 1982) to construct pRecQ. 
To clone ORF2, the transcriptional regulator homologue (Section 3.4.5), two primers 
were designed based on the preliminary genome sequence of B. fragilis 9343 
(www.sanger.ac.uklprojects/b fragilis): These were the RegBgnI forward primer, 5'-
GGT TGT GGA AGA TCT CTT CC-3' at positions -306 to -287 upstream of ORF2 
ATG start codon and the AraCEnd reverse primer, 5'-CAA GAT TAC GGT TGC AGC-
3' at positions +599 to +582 downstream of ORF2 A TG start codon. PCR amplification, 
DNA purification and cloning were done as for ORF 1, resulting in the recombinant 
plasmid pE2Reg. 
3.3.11 Construction of deletion subclones of pAN2 for resistance assays 
Plasmids pAl\.rBB, pANC and pANH were constructed by subcloning the 2.5 kb HindllI-
BgnI fragment, the 1.4 kb HindI1I-PvuII fragment and the 1.9 kb HindIII-BamHI 
fragment from pAN2 respectively into pEcoR251. Plasm ids pRecQ and pE2Reg were 











3.4 Results and Disussion 
3.4.1 Isolation of B. fragilis DNA repair genes by complementation in E. coli DNA 
repair mutants 
Mitomycin C (MTC) causes DNA damage which is repaired by the nucleotide excision 
repair system in E. coli (Van Houten et aZ., 1986). In order to isolate B. fragilis DNA 
repair genes, a B. fragiZis gene library (Southern et al., 1986) was screened for increased 
mitomycin C resistance in E. coli DNA repair mutantsAB1886 (uvrA-), AB1885 (uvrB -), 
AB1884 (uvrC) and AB2463 (recA-). Ten E. coli AB1886 uvrA- transfonnants were 
isolated on plates containing 0.6 J1g/mJ MTC. Plasmid DNA was isolated from each 
transfonnant and restriction analysis of the plasmids showed that they were all the same 
species (data not shown). The recombinant plasmid was designated pAN2. 
Retransfonnation of pAN2 into E. coli AB1886 uvrA- confinned that the plasmid 
conferred both Ap and MTC resistance. The restriction map of pAN2 (Fig 3.1) revealed 
that a 4.5 kb DNA fragment of B. fragilis genomic DNA was inserted into pEcoR251. 
The presence of the recombinant plasmid did not alter the growth rate of the E. coli host. 
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0' s8 0' 
0' 
0' OF> Q~ 0' OF> '0 OF>Q .... 0' e- .... Qa- .... a-or. OF> e- O' t:. .... - ~ .... Q .... .... on - ~ ~ .... e- .... 
iii! :;; 
;;. ~;;. ;;. 
-~ :; ~ t:. ~ a: =a: a: a:-
0 .s 0 ,. 0 0 0:: :; c ';:l 0 r ~ ~f f ;f ~ i f .i: " I ow I I I 
7900 
Figure 3.1. Restriction enzyme map of pAN2. Blue line, B. fragilis genomic DNA insert; thin black line, 
pEcoR251 vector; solid bar, EcoRV-PvulI fragment used as a probe for Southern hybridization analysis. 
3.4.2 Measurement of cell survival after mitomycin C treatment 
The survival of E. coli AB1886 uvrA- containing pAN2, exposed to 10 J1g/ml MTC was 
compared to that of E. coli AB1886 uvrA- transfonned with the control plasmid pMT104 
(Fig 3.2). E. coli AB1l57 (PMTI04) was the wildtype control. E. coli AB1886 (PAN2) 
showed increased resistance to MTC compared to E. coli AB1886 (PMTI04), but did not 











expression or incomplete complementation of the B. fragilis gene in E. coli. However, it 
is also possible that the gene involved in conferring resistance did not complement the 
uvrA- mutation specifically. In order to ascertain this, it was necessary to assess the effect 
of pAN2 in the other E. coli DNA repair mutants. 
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Figure 3.2. Mitomycin C survival curve of E coli AB 1886 transformed with pAN2 (.&) or the control 
plasmid pMTI 04 (.). E coli AB 1157 transformed with pMTI 04 was used as a measure of WT resistance 
to MTC (.). 
3.4.3 Mitomycin C, metronidazole and UV resistance assays 
The possibility of pAN2 conferring resistance to various DNA damaging agents on other 
E. coli DNA repair mutants was investigated. Transformation with pAN2 conferred MTC 












in E. coli AB 1884 uvrC and E. coli AB2463 rec£ (Table 3.2). Transformation with 
pMTl04, the control plasmid, did no influence the MIC's of the E. coli DNA repair 
mutants. This data showed no variation at all in the 10 replicate experiments. 
Table 3.2. Susceptibility of E. coli strains transformed with pAN2 to various DNA damaging agents. A 
representative set of data is shown from 10 experiments. 





AB 1157 (pAN2) 2.4 800 NO 40 
ABl157 (pMT104) 1.8 800 ND 40 
AB 1886 (pAN2) 0.7 400 50 1.5 
AB1886 (pMT104) 0.5 300 35 1.5 
AB 1885 (pAN2) 1.1 950 250 2.5 
AB1885 (pMTl04) 0.7 600 220 2.5 
AB 1884 (pAN2) 0.7 300 NO 2.5 
ABI884 (pMTI04) 0.7 300 NO 2.5 
AB2463 (pAN2) 0.25 45 NO ND 
AB2463 (pMTl 04) 0.25 45 NO NO 
, 
~~~ 
a The minimal inhibitory concentration (MIC) to the various DNA damaging agents was determined 
on LB agar plates under aerobic conditions, unless specified. 
b The MIC's were determined under aerobic conditions (02) or anaerobic conditions in prereduced 
media (An02)' 
NO Not determined. 
Metronidazole resistance was increased in E. coli AB 1886 uvrA- and AB 1885 uvrB" 
containing pAN2, but not in E. coli AB 1884 uvrC, AB2463 recA- nor AB 1157 (Table 
3.2). The metronidazole MIC's E. coli AB1886 (pAN2) and AB1885 (pAN2) were 
determined under anaerobic conditions. This was done to ensure that the metronidazole 
resistance was due to the damage caused by the reduced active metronidazole and not to 
damage by Reactive Oxygen Species formed during oxidation of reduced metronidazole 











resistance to metronidazole in both E. coli uvrA- and uvrB- by a small but reproducible 
amount as determined by 10 replicate experiments. The ability of pAN2 to confer 
resistance to far UV irradiation was also investigated in the uvr E. coli mutants. None of 
the uvr E. coli mutants were more resistant to UV irradiation when transformed with 
pAN2 (Table 3.2). The MIC's of the E. coli strains transformed with the control plasmid 
pMTl 04 were the same as those with no plasmid. 
The finding that the presence of pAN2 conferred higher MTC resistance to both E. coli 
uvrA- and uvrB- suggested that the gene(s) in the pAN2 insert was not complementing the 
E. coli mutation specifically. However, no increased resistance was noticed for E. coli 
uvrC or recA- mutants. In the Nucleotide Excision Repair system of E. coli, the UvrA2-
UvrB complex is thought to bind to DNA, where the UvrA dimer recognises the DNA 
lesion and targets the UvrB subunit to the site of damage (Lin and San car, 1992). UvrC is 
involved in causing incisions of the DNA lesion, once the UvrB-DNA complex is formed 
(reviewed in Section 1.3.2, Chapter I). The B. fragilis genes on pAN2 involved in 
conferring MTC resistance might be involved in recognition of DNA damage caused by 
MTC and, therefore, complementing the uvrA- and uvrB- mutants but not the uvrC E. 
coli. Apart from their role in Nucleotide Excision Repair (NER), UvrA and UvrB seem to 
have other functions in the cell. They are thought to be involved in suppression of 
illegitimate recombination in a pathway that is independent from the NER (Hanada et al., 
2000). DNA damaging agents which cause breaks in the DNA strand(s) directly, such as 
metronidazole, or indirectly by repair of the crosslinks, such as MTC, induce illegitimate 
recombination. UvrA and UvrB have also been implicated in a DNA replication backup 
system that replaces Polymerase I (Poll) and where UvrC is not involved (Moolenaar e/ 
al., 2000). The possibility of the B. fragilis gene(s) on pAN2 complementing these 
functions of UvrA and UvrB cannot be discarded. 
The pAN2 construct increased the resistance of the uvrA- and uvrB- E. coli mutants to 
metronidazole under aerobic and anaerobic conditions. This suggests that the resistance is 
to metronidazole damage itself and not to Reactive Oxygen Species generated under 











3.4.4 Southern hybridization analysis 
Southern hybridization analysis was used to confirm that the pAN2 insert DNA 
originated from B. fragilis . A 980 bp EcoRV-PvuII internal DNA fragment from pAN2 
was used as a probe (Fig 3.1) and hybridized to the B. fragilis genomic DNA digested 
with EcoRV-PvuII, resulting in a single band of an expected size of ~l kb (Fig. 3.3, Lane 
2). The equivalent sized band was detected for pAN2 DNA digested with the same 
restriction endonuc1eases (Fig 3.3, Lane3). B. fragilis genomic DNA digested with 
EcoRV alone resulted in a single band of ~ 1.2 kb, as expected from Figure 3.1 (Fig 3.3, 
Lane1). The pAN2 probe did not hybridise to pMTI04 DNA (Fig 3.3, Lane 4). This 
confirmed the origin of the pAN2 insert as B.fragilis DNA. 
MW(kb) 1 2 3 4 
1.70 • 
II( 1.2 
1.09 • II( 1.0 
0.81 • 
Figure 3.3 Southern blot analysis of B. fragilis genomic DNA and plasmid DNA probed with the internal 
EcoRV-PvuII fragment ofpAN2. Molecular mass markers in kilobases (kb) are shown on the left. Lane I, 
B. fragilis bfI genomic DNA digested with EcoRV; Lane 2, B. fragilis bfI genomic DNA digested with 
EcoRV-PvuII; Lane 3, pAN2 &oRV-PvuII; Lane 4, pMTl04 EcoRV-PvuII. 
3.4.5 Deletion studies of pAN2 and nucleotide sequencing 
In order to investigate the DNA regions responsible for the increased MTC and 











MTC and metronidazole sensitivity phenotypes of the various plasm ids were determined 
in E. coli AB 1886 (uvrA-) and AB 1885 (uvrB-) (Fig 3.4). Only E. coli transformed with 
plasmid pANBB, which contained the first 2500 bp of the insert, conferred the same level 
of resistance as those containing pAN2. Cells transformed with pANC, which contained 
the first 1400 bp of the pAN2 insert and pANH, containing the last 1900 bp of the insert, 
showed levels of resistance similar to those with the control plasmid pMT104. 
ORFl ORfl ORF3 





Figure 3.4 Deletion plasm ids of pAN2 showing MTC and metronidazole resistance phenotypes in E. coli 
AB 1886 (uvrA") and AB 1885 (uvrff): +, increased resistance as compared to E. coli transformed with 
control plasmid pMTl04; -, same level of resistance as with pMT104. Plasmids pANBB, pANC and 
pANH were derived by subcloning insert DNA fragments into pEcoR251 in the same orientation as pAN2. 
The pEcoR251 vector (thin black line) and the insert DNA (bold blue line) are shown. The arrows show the 
position and orientation of the 3 ORFs. 
The active insert DNA region m pANBB was fully sequenced on both strands by 
construction of subcIones in pSK(+) (not shown). This region contained an incomplete 
open reading frame (ORF1), truncated at the C-terminus; a complete ORF (ORF2) and a 
third ORF (ORF3) that was complete in pAN2, but only the N-terminus was present in 
pANBB (Fig 3.4). This suggested that ORF3 was not involved in conferring resistance 
since disruption of that gene did not affect the resistance phenotype (Fig 3.4, pANBB). 
Disruption of ORF2 caused loss of activity (Fig 3.4, pANC), implying the involvement of 
that gene in resistance, while the role of the truncated ORFI in resistance was not clear 











3.4.5.1 Genetic analysis of ORF2 
The percentage G+C of ORF2 was 39%, which was on the limit of the B. fragilis 
genomic DNA range of 39-48%, as determined by Holdeman et al. (1984). Translation of 
ORF2 started from a potential A TG start codon (nucleotide position 181) to a T AA stop 






























M SOL E N K T Q E E T P K K R P Y N L 
AGGGAGAAAAAAGAAAAGAAAGCTGCTTACCGGTCTTTGATCAGACCCGAATTGGCAGAT 
R E K K E K K A A Y R S L I R PEL A 0 
GAATTGTACGACAGAATCCTGAACATCATTGTTGTACAGAAGAAGTACAGAGACCCGGAC 
ELY 0 R I L N I I V v Q K K Y R 0 P 0 
TATTCAGCTAAGGATTTGGCTAAGGAACTGAAAACCAATACCCGTTATCTTTCAGCTGTA 
Y S A K 0 L A K ELK TNT R Y L S A V 
GTTAATTCTCGCTTTGGTATGAACTATTCTTGCCTGCTGAACGAGTACAGAGTAAAAGAT 
V N S R F G M N Y S C L L N E Y R V K 0 
GCTTTGCACTTGTTGACGGATAAAAGATATGCCGACAAGAATGTAGAGGAAATCAGTGCG 
A L H L L TD K R Y A 0 K N V EE I S A 
ATGGTTGGTTTCGCTAACCGTCAGTCTTTTTACGCTGCATTTTATAAAAACGTAGGTGAA 
M V G F AN R Q S F Y A A F Y K N V G E 
ACACCCAACGGATATCGTAAAAAACACGCAGAAAAAAAGAAATAATTGCATTTCTTGAAA 
T P N G Y R K K H A E KKK * 




Figure 3.5 Nucleotide sequence of ORF2. The deduced amino acid sequence is shown underneath the 
corresponding codon sequences. The conserved amino acids to the AraC/XylS family of transcriptional 
regulators are shown in red. The upstream promoter sequence is shown, indicating the putative -10 and -35 
promoter sequences. Arrows (black, blue and red) indicate inverted repeats in the promoter region. The 
downstream nucleotide sequence shows the putative factor independent terminator (pink arrows). 
ORF2 was 465 bp in size and was able to encode a putative protein of 154 amino acids 











AraC/XylS family of transcriptional regulators. This is significant since a number of 
these transcriptional regulators have been involved in multidrug resistance systems and 
response to alkylating agents (Gallegos et ai., 1997). 
No typical E. coli ribosomal binding site was found upstream of the start codon of ORF2 
(Shine and Dalgarno, 1974). Promoter sequences from various organisms differ slightly 
from the E. coli consensus promoter regions, but they have an overall similarity and 
conserved bases. However, due to their early evolutionary divergence from the main 
eubacterial branch (Woese, 1987), B. fragilis promoters contain unconventional motifs 
(Weisburg et ai., 1985). Weisburg et ai. (1985) identified Bacteroides ribosomal binding 
sites from the l6S rRNA sequences and found them to be identical to the consensus 
sequence of E. coli (5'-GGAGGAA). However, other B. fragilis genes lack the typical 
ribosomal binding sites, such as recA (Goodman and Woods, 1990), ginA (Hill et al., 
1989) and gdhB (Abrahams and Abratt, 1998). The promoter region of ORF2 revealed 
the presence of sequences similar to the B. fragilis promoter consensus sequences, a-I 0 
(TGAAA TTTG) and a -35 (GTTG) (Bayley et ai., 2000) (Fig 3.5). Three sets of inverted 
repeats were identified in the promoter region and these might be involved in 
transcriptional regulation of ORF2. Termination of transcription in E. coli is either factor-
dependent or factor-independent. A region containing a nearly perfect inverted repeat of 
17 bp separated by 11 bp was identified downstream of the stop codon, able to form a 
stem-loop structure. This was followed by aT-rich region, suggesting the presence of a 
factor independent terminator (Rosenberg and Court, 1979: Brendel and Trifonov. 1984). 
3.4.5.2 Genetic analysis of ORFI 
ORFI was situated upstream of ORF2 (Fig 3.4) and transcribed in the opposite direction, 
with a 213 bp intergenic region. The incomplete ORF I started with a potential A TG start 
codon (nucleotide position 181, Fig 3.6) and was 669 bp in size. The truncated ORF 1 
encoded a polypeptide of 223 amino acids, with sequence identity to the RecQ DNA 
helicases from prokaryotes and eukaryotes. The presence of a RecQ helicase may be 













































M N E K Y Q M I Q T L K T Y F G Y D S F 
CGTCCTTTGCAGGAAGAGATCATCCACAACCTGATAAGTAAAAAAGACTCACTGGTATTG 
R P L Q EEl I H N LIS K K D S L V L 
ATGCCTACGGGGGGAGGCAAATCAATCTGCTATCAGCTTCCGGCTCTGCTTATGGAAGGC 
M P T G G G K SIC Y Q L PAL L MEG 
ACAGCCATTGTTATTTCGCCCCTTATTTCACTGATGAAGGATCAGGTAGAAACTCTACGT 
T A I V I S P LIS L M K D Q VET L R 
GCCAACGGAATACCAGCAGGTGCACTAAACAGCAGCAATGACGAAACCGAAAATGCCAAC 
A N G I P A GAL N S S N D E TEN A N 
TTACGCAGAGCCTGCATCTCAGGACAACTTAAGCTCCTCTACATCTCGCCCGAGAAATTA 
L R R A CIS G Q L K L L Y I S P E K L 
CTGTCTGAAGCCGACTATCTGCTGAGAGACATGACTCTCTCACTGTTTGCAGTGGACGAG 
L SEA D Y L L R D M T L S L F A V D E 
GCCCACTGTATTTCACAATGGGGGCATGACTTCCGCCCGGAATATGCCCGGATGGGATTC 
A H CIS Q W G H D F R P E Y ARM G F 
TTACGCAACCAGTTCCCCAATGTGCCTATGATCGCCCTGACTGCTACGGCAGATAAAATT 
L R N Q F P N V P M I A L TAT A D K I 
ACCAGGGAGGATATCGTCCGCCAGTTGCAATTGAGACAACCGCAAATATTTATTTCATCG 
T RED I V R Q L Q L R Q P Q I F IS S 
TTCGACCGCCCCAACCTGAGCCTGTCTGTAAAAAGAGGCTATCAACCCAAGGAGAAAAGT 
F D R P N L S L S V K R G Y Q P K E K S 
AAAGCGATC 
K A I 
Figure 3.6 Nucleotide sequence of the incomplete ORFlas found in pAN2. The deduced amino acid 
sequence is shown underneath the corresponding codons. The upstream promoter sequence is shown, 
indicating the -10 and -35 promoter sequences. Arrows indicate inverted repeats in the promoter. 
No conventional ribosomal binding site was found upstream of the start codon of ORF I, 
but the -10 (T A TITTTG) and -35 (TTTG) promoter sequences similar to the B. fragilis 
consensus promoter sequences were identified (Fig 3.6). Since ORFI and ORF2 are 
separated by 213 bp and are transcribed divergently, the same three sets of inverted 











ORFI (Fig 3.6). As in ORF2, one set was found upstream of the -35 promoter sequence, 
while the other were located near the -35 and -10 promoter regions, which may once 
again involve a regulatory role. 
In order to obtain the complete nucleotide sequence of ORFl, a BLAST search of the 
preliminary genome sequences of B. fragilis 9343 and 638R 
(www.sanger.ac.ukiprojects/b fragilis) was done. The B. fragilis bfl 669 bp sequence of 
the truncated ORF 1 in pAN2 was 100% identical to the corresponding sequence of B. 
fragilis 9343 and 638R. Using these sequences, primers were designed and the complete 
B. fragilis bfJ ORFI was amplified. In all 3 B. fragilis strains, ORFI was found to be 
1824 bp in size and capable of encoding a protein of 607 amino acids with a predicted 
molecular mass of68.7 kDa. The G+C content ofORFl was 49%. 
3.4.5.3 Genetic analysis of ORF3 
The A TG putative start codon of ORF3 started 92 bp downstream of ORF2 and was 
transcribed in the same orientation (Fig 3.4). Disruption of this gene in pANBB (Fig 3.4), 
did not alter the resistance phenotype of E. coli uvrA- or uvrB- harboring this plasmid, 
suggesting that ORF3 was not involved in metronidazole or MTC resistance. The 
nucleotide sequence from pANBB identified an ORF of 1318 bp with no stop codon, 
suggesting that the sequence of ORF3 was incomplete. The preliminary genome sequence 
of B. fragilis 9343 was used to obtain the complete nucleotide sequence of ORF3. The 
complete ORF3 was found to be 2052 bp in size, with a T AA stop codon, and a G+C 
content of 46%. ORF3 was able to code for a protein of 683 amino acids with a molecular 
mass of 76.9 kDa. The predicted amino acid sequence of ORF3 was used to search for 
homology in the NCBI database using the BLAST function (www.ncbi.nlm.nih.gov). 
This revealed homology to dipeptidyl peptidase III of eukaryotes with the highest 
identities to dipeptidyl peptidase III from Leishmania major (23%), Drosophila 
melanogaster (23%), Rattus norvegius (24%) and Mus musculus (24%). Dipeptidyl 
peptidases are zinc metallopeptidases with a conserved zinc-binding domain, HELLGH 
(Fukasawa et al., 1999), which hydrolyse Arg-Arg-J3-naphthylamides (Fukasawa et al., 











(amino acid position 456), HECLGH (data not shown), confirming its possible function 
as a zinc metallopeptidase. 
3.4.5.4 Cloning and analysis of complete ORFI and ORF2 
The truncated ORF 1 alone was not able to confer resistance to the E. coli mutants (Fig 
3.4, pANC). In order to determine whether the complete ORFI or ORF2 were involved in 
resistance, the 2 genes were subcloned separately into pEcoR251 and transformed into 
the E. coli uvrA and uvrB mutants. ORF2 alone was sufficient to confer both 
metronidazole and MTC resistance to the E. coli uvrA- or uvrB- mutants (Fig 3.7). The 
fact that ORF2 had high sequence identity to the AraC family of transcriptional 
regulators suggested the possibility that it was regulating E. coli genes which were, in 
turn, causing the resistance phenotype. 
ORFl ORF1 ORFJ 





Figure 3.7 Deletion plasm ids of pAN2 showing MTC and metronidazole resistance phenotypes in E. coli 
AB 1886 (uvrA") and AB1885 (uvrlJ): +, increased resistance as compared to E. coli transformed with 
control plasmid pMTI 04; -, same level of resistance as with pMTl 04. The complete ORF 1 and ORF2 were 
amplified (red bold line) and subcloned into pEcoR251 (thin black line) to form constructs pRecQ and 
pE2Reg, respectively. The arrows show the position and orientation of the 3 ORF's. 
3.4.6 Analysis of tbe amino acid sequence of ORF2 
As mentioned in section 3.4.5, the deduced amino acid sequence of ORF2 revealed 












common families of positive regulators and it is characterized by a highly conserved 
region of 100 amino acid residues that constitutes the DNA binding domain (Gallegos et 
al., 1997). The consensus for the family is shown in Table 3.3. The B. fragilis bfl AraC 
regulator (ORF2) contained most of the amino acids from the consensus sequence (Table 
3.3 and Fig 3.8). 
Table 3.3 Comparison of the amino acid consensus sequence for the AraC family of transcriptional 
regulators and ORF2. 
AraC Family 
consensus· A ----S--L---F ---G----------R--A ---L-------IN -IN ----GFN ----F -FRIK --G-P---R 
ORF2 conserved A --------L---------G ----------R ---A ---L-------- V-- J ---- GF -----F---F ---- G~P---R 
residuesb 
a AraC family consensus sequence as described by Gallegos et al. (1997) where represents any 
amino acid. 
b ORF2 conserved amino acid residues from position 67 to 146 in Fig 3.8. 
From the multiple sequence alignment of AraC transcriptional regulators, it was clear that 
most ofthe above residues were highly conserved in the members of the family (Fig 3.8). 
The DNA binding regulatory domain of the AraC transcriptional regulators MarA and 
Rob from E. coli have been well studied. These proteins are involved in regulating 
transcription of stress tolerance genes. The DNA binding domain consists of 7 a.-helices 
that fold in such a way as to form two helix-turn-helix (HTH) motifs (Manzanera et al., 
2000; Rhee et ai, 1998; Kwon et ai., 2000). In all 3 proteins, helix-2 and 3, and helix-5 
and 6 form the HTH motifs, with helix-4 linking these two subdomains (Fig 3.8). The 
second HTH motif shows the highest homology between the members of the family 
(Manzanera et al., 2000, Gallegos et al., 1997). The crystal structure of MarA bound to 
its own promoter DNA showed the two HTH motifs binding to adjacent segments of the 
major groove causing a slight bend of the DNA (Rhee et al., 1998). The structure of 
Rob bound to micF promoter DNA showed a similar situation, where the first HTH 











DNA without bending the DNA (Kwon et al., 2000). However, the two HTH motifs of 
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Fig 3.8 Multiple sequence alignment of the B. fragilis bfl putative AraC regulator (ORF2) with other 
AraC/XyiS transcriptional regulators. A: B. fragilis bfl ORF2; B: B. thetaiotaomicron putative AraC 
regulator (accession number AA076954); C: Microbulbifer degradans putative AraC regulator 
(ZP _00316144); C: Vibrio cholerae putative AraC regulator (F82398); E: Xanthomonas campestris AraC 
transcriptional regulator (AAM43294); F: E. coli AraC (CAA23507); G: E. coli SoxS (P22539); H: E. coli 
MarA (BAA 15233); I: E. coli Rob (NP _ 418813); J: AraC Family conserved amino acid residues. The 
ORF2 residues forming a-helices are shown by a red line over them. The blue line shows the two helix-
tum-helix motifs of the AraC transcriptional regulators . Shading identityy is represented as 100% in black, 











Gallegos et al. (1997) proposed that the high degree of conservation of 17 residues 
extending over 75 amino acids suggests that the DNA binding domain of these regulators 
have identical tertiary structure. Analysis of the possible secondary structure of the 
putative B. fragilis bfl AraC regulator predicted the presence of 8 a-helices (Fig 3.8, red 
line above the amino acid residues). The first a-helix lay outside the region of homology, 
at the N-terminal of the protein. The other 7 a-helices (numbered I to 7 in Fig 3.8) were 
located within the conserved region. Helix-2 and 3 spanned over the region containing 
the HTH motif in the AraC regulators, suggesting the possibility of these helices forming 
a HTH motif. This suggestion was supported by the fact that this region followed most of 
the characteristics for a putative HTH motif, laid out by Brennan and Matthews (1989). 
In the same way, the end of helix-5 and helix-6 were situated in the same region as the 
second, highly conserved HTH motif and contained all the requirements for formation of 
a HTH motif, including a glycine residue at position 9 of the HTH motif. Since these 
transcription regulators are only highly conserved in their DNA-binding regulatory 
domain, comparison of the overall sequence of the bfl AraC regulator and other AraC 
transcriptional regulators revealed very low identities. The highest identities were to the 
putative AraC transcriptional regulators from B. thetaiotaomicron (95% overall amino 
acid identity), Microbulbifer degradans (32% identity over 140 amino acids of the 
conserved region), V. cholerae (32% identity over 110 residues of the conserved region) 
and X campestris (32% identity over 94 amino acids of the conserved domain). 
3.4.7 Analysis of the amino acid sequence of ORFI 
As mentioned in section 3.4.5, the deduced amino acid sequence of ORF I revealed 
similarity to the RecQ family of DNA helicases, found in both prokaryotes and 
eukaryotes. In this study, ORFI was not shown to be involved in the metronidazole 
resistance phenotype but since it may be involved in DNA repair, replication and 
suppression of illegitimate recombination in B. fragilis, it was analysed further. 
The RecQ proteins belong to the superfamily II of helicases which contain 7 highly 
conserved motifs, 1, la, II, III, IV, V and VI (Fig 3.8) (Gorbalenya et al., 1989). Motif I is 











consensus sequence A for the NTP- binding motif as described by Walker et al. (1982). 
The consensus sequence consists of the following amino acid residues: 
GxxxxGK(T)xxxxxx(l/V), where x is any amino acid, and is preceded by a basic residue, 
mostly K or R (Walker et al., 1982). In the helicases from superfamily II, the first 
conserved G from sequence A is replaced by a bulky residue, such as A or M, as is the 
case in the RecQ DNA helicases (Fig 3.9) (Gorbalenya et al., 1989). Motif I is thought to 
form a loop which binds one of the phosphates from the triphosphate (Hodgman, 1988). 
Motif II contains the DEAD/II box (Gorbalenya et al., \989). The DEAD box is found in 
a large family of RNA helicases (Linder et aJ., 1989). However a variant of this motif, 
DExil is found in other helicases of superfamily II (Gorbalenya et al., 1989). The 
conserved D residue of motif II is thought to interact with Mg2+, which in turn binds the 
other phosphate from the triphosphate. This is required for hydrolysis of A TP 
(Subramanya et at., 1996). Motifs la, Ill, IV and V are less strictly conserved 
(Gorbalenya et al., 1989). Motif la was identified by Lane (1988) and possibly interacts 
with the DNA (Subramanya et al., 1996). Motif III may be involved in coupling the 
process of ATP hydrolysis with helicase activity. Motif VI contains an abundance of 
positively charged residues that might be involved in nucleic acid binding (Gorbalenya et 
ai., 1989). The DExH family of helicases contains the sequence QxxGRxxR in motif VI, 
while the sequence for the DEAD family is HxxGRxxR. The DNA binding helicases 
contain a conserved tyrosine residue in motif VI (Hodgman, 1988). All the proteins in 
superfamily II contain a common activity of nucleic acid-dependent NTPase and helicase. 
The RecQ family members have three conserved regions: the Helicase domain, which 
spans from the N-terminus to motif VI; the RecQ-conserved domain (RecQ-CT), which 
is C-terminal to the Helicase domain; and the Helicase-and-RNase-D-C-terminal domain 
(HRDC), which is proposed to be involved in stable DNA binding (Morozov et ai., 1997; 
Bernstein and Keck, 2003). The Helicase and RecQ-Ct regions form a composite domain 
involved in the DNA-dependent ATPase and helicase activities (Bernstein and Keck, 
2003). Within that domain a novel RecQ Family N-terminal motif has been proposed, 
motif 0, which is also important for catalytic activity. Motif 0 starts at residue 19 of the E. 
coli RecQ protein (residue ] 0 of the B. fragilis bfl deduced amino acid sequence of 
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Figure 3.9 Multiple sequence alignment of the complete B. fragilis bfl RecQ homologue (ORF 1) with 
other RecQ DNA helicases. A: B. fragilis bfl ORF 1; B: Pasteurella multocida RecQ (accession number 
AAK035Il) ; C: Escherichia coli RecQ (AAA67618); B. fragilis bfl ORFI is truncated at amino acid 
residue 223 in pAN2, as indicated by the red arrow. Motifs 0 (brown), I (red), Ia (blue), II (green), III 











As shown in Figure 3.9, the amino acid sequence of the complete ORF I from B. fragilis 
bfl contained all 8 conserved motifs. Its sequence revealed high identities to both 
prokaryote and eukaryote DNA helicases. The highest identities are shown in Table 3.4. 
The truncated putative ORFI protein derived from pAN2 would only contain the first 220 
amino acid residues and the first 5 motifs, 0, 1, la, II and III (Fig 3.9, indicated by a red 
arrow). It is not likely that this truncated protein would be active since the complete 
Helicase and RecQ-Ct domain is necessary for ATPase and helicase activity (Bernstein 
and Keck, 2003) and the first 220 residues only represent two thirds of the Helicase 
domain. 
Table 3.4 Sequence identity and similarity of complete ORF I to RecQ homologues from other organisms. 
RecQ homologue % Identity8 0/0 Similarity!) 1 Length of protein 
(Amino acids)_ 
Bacteroides thetaiotaomicron 
VPI-5482 77% in 601 86% in 601 620 
(Xu et al., 2003) residues residues 
Accession N° AA076955 
Pasteurella multocida 44% in 579 63% in 579 
(May et al., 2001) residues residues 632 
I 
Accession N° AAK035 I 1 i 
E. coli 0157:H7 42% in 604 59% in 604 
! (Welch et al., 2002) residues residues 611 
~ccession N° BAB38175 
i H irif/uenzae Rd K W20 43% in 580 62% in 580 
I (Fleischmann et al., 1995) residues residues 619 
i 
Accession N° AAC22387 
Yersinia pestis KIM I 42% in 612 59% in 612 (Parkhill et al., 200 I) residues residues 610 
° i AcceSSIOn N CAC93301 
r---. E. coli K 12 ~ 
I (lrino et al., 1986) . 
~sion N° AAA67618_1 
Analysis using the preliminary genome sequences of B. fragilis 9343 and 638R 
(www.sanger.ac.ukiprojectslb fragilis) and the recently published genome of B. fragilis 
YCH46 (Kuwahara et at., 2004) revealed the presence of two additional open reading 













three B.fragilis RecQ homologues in both strains contained the 7 conserved motifs of the 
superfamily II of DNA helicases and were highly similar within the N-terminus up to 
motif VI. B. fragilis RecQ homologue #3 contained a stretch of approximately 180 amino 
acid residues following motif VI, with no similarity to the other two B. fragilis RecQ 
homologues or to the E. coli RecQ. E. coli as well as lower eukaryotes such as yeast 
contain a single RecQ helicase; however higher eukaryotes have multiple RecQ helicases, 
humans having 5 different ones (Bachrati and Hickson, 2003). The presence of three 
RecQ homologues in the B. fragilis genome is interesting and raises various questions of 
what their various roles might be. 
Table 3.5 Comparison of B. fragilis NCTC 9343 and B. fragilis YCH46 (Kuwahara et al., 2004) RecQ 
homologues. 
'-'.~.~---~--~~~~"-'-------
Name ofORF B.fragilis 0 
t-~~--.. ~-."-.~"-'.-~~----.~-i-- ~Jl0!!l~lo~ 
fragilis 9343 gene 
~----- ~-~---.~-.~-. --~~~.-~---q 
u~l __ ~~~~:;:~u~;i~_~ __ ~~~~~~;::~~~~;i~_. 
draft annotation BF 324 9 
~~--.~--~---~.~- "--.~-~ .. 
B.fragilis YCH46 
ene annotation BF 342 7 ---_ ..-
Length of predicted 
protein (amino 607 
r----___ a~c_id_s...<.) ____ ~___ ._._. ___ " 





Putative A rae 
nal transcriptio 
regulato r 
,---~"_~ ____ ~._.~ __ ~_ •• "_ •• "L.. __ (Q~F2 homo logue) 
BF 3892 BF3~~.----i . r----------. 
BF 4076 BF3933 
726 634 
39.6% 39.8% 
ORF with similarity ORF with similarity 
to B. subtilis inosine- to P. gingivalis single 
5' -monophosphate strand DNA specific 












E. coli nucleotide excision repair mutants have increased sensitivity to metronidazole 
(Yeung ef al., 1984; Jackson et al., 1984), suggesting the involvement of the nucleotide 
excision repair system in repairing metronidazole damage. Since mitomycin C is active in 
the presence of oxygen and the DNA damage caused is repaired by the nucleotide 
excision repair system (Van Houten et al., 1986), it was used to screen a B. fragilis 
genomic library in E. coli, aerobically. This was perhaps not the ideal selection method 
for B. fragilis genes involved in metronidazole resistance and future screening of those 
genes should be done in E. coli nucleotide excision repair mutants, anaerobically in 
metronidazole containing media. The availability of the B. fragilis 9343 and 638R 
incomplete genomes, as well as the recently published genome of B. fragilis YCH46 
(Kuwahara et aI., 2004) should also allow the direct cloning of targeted DNA repair 
genes and analysis of their possible involvement in metronidazole resistance. 
In the search for B. fragilis DNA repair genes involved in resistance to metronidazole, a 
construct from a B. fragilis genomic library was isolated. The construct, pAN2 contained 
3 open reading frames, ORFl, ORF2 and ORF3. ORF2 alone was able to confer both 
metronidazole and MTC resistance to E. coli uvrA- or uvrB-. The deduced amino acid 
sequence of ORF2 had homology to the AraC Family of transcriptional regulators. This 
family comprises largely of positive regulators involved in a diversity of functions, from 
carbon metabolism, to pathogenesis, to stress tolerance including multidrug resistance 
and DNA repair (Gallegos et aI., 1997). They are divided into 2 types, those in which the 
signal receptor is in the same polypeptide as the regulatory function and those in which 
the regulator and the signal receptor controlling expression of the regulator are found on 
separate genes. Examples of the former are AraC from E. coli involved in arabinose 
utilization and XylS from P. pUlida involved in benzoate catabolism. E. coli MarA, 
involved in multidrug resistance and SoxS, superoxide resistance, are examples of the 
latter type of regulators. The regulators involved in carbon metabolism stimulate 
transcription in response to effector molecules and are usually around 300 amino acids in 
length. They act as dimers and have a C-terminal conserved DNA binding domain and a 
N-terminal dimerisation and sugar-binding domain (Martin and Rosner, 200 I). Those 











environment (Gallegos et aI., 1 997). These are involved in adhesion, cell capsule, 
invasions, siderophores and other virulence factors. Stress tolerance regulators are 
involved in alkylation, oxidative stress, tolerance to antibiotics or organic solvents as well 
as transition from exponential to stationery phase. These need to be overproduced in 
order have a regulatory effect. They act as monomers and contain the DNA binding 
domain alone or have an additional domain (Martin and Rosner, 2001). There is a 
possibility that B. fragilis ORF2 is involved in stress tolerance and since it is only 154 
amino acid residues in length, the protein would probably be only a transcriptional 
regulator without a signal receptor domain. 
The fact that B. fragilis ORF2 on its own was able to induce resistance raises the 
possibility that B. fragilis ORF2 is regulating E. coli genes in a heterologous manner. E. 
coli MarA, SoxS and Rob are AraC transcriptional regulators involved in stress tolerance. 
MarA, involved in multidrug resistance, is a 129 amino acids protein (Cohen et ai., 
1993), and SoxS, responsible for oxidative stress tolerance, is a 106 residues polypeptide 
(Li and Demple, 1994). Rob, which binds to the right border of the oriC of E. coli as well 
as being involved in superoxide and drug tolerance, is 289 amino acid residues in length 
and unlike the other two, contains another domain apart from the conserved DNA binding 
domain (Skarstad et al., \993). These three regulators are homologous but not identical 
and have slightly different functions. They are independently regulated but they all 
regulate a common set of over 20 genes in the E. coli chromosome (Martin et aI., 1999) 
which result in multiple antibiotic resistance, superoxide resistance and organic solvent 
tolerance. Examples of the target genes are nfo, coding for the DNA repair endonuclease 
IV; micF, which causes reduction of OmpF, one of the major porins; acrAB, involved in 
antibiotic efflux,jpr, a NADPH:ferredoxin oxidoreductase and nJsA and nfnB, two of the 
E. coli oxygen-insensitive nitroreductases, among others (Martin and Rosner, 2002). The 
fact that 3 different AraC transcriptional regulators activate similar genes suggests the 
possibility that B. fragilis ORF2 is also regulating E. coli genes which are usually 
regulated by an E. coli AraC transcriptional regulator. In order to test this hypothesis in 
future work, microarray technology could be used to identifY E. coli genes which are 











which might be, directly or indirectly involved in metronidazole and mitomycin C 
resistance. 
The fact that pAN2 conferred metronidazole and mitomycin C resistance only to E. coli 
uvrA- and uvrB- and not uvrC nor recA- suggested that ORF2 was regulating a gene or 
genes which suppressed the uvrA and uvrB mutations. In E. coli, RecQ as well as UvrAB 
are involved in suppression of illegitimate recombination and it is thought that they share 
a pathway (Hanada et aI., 2000). In E. coli, RecQ is also involved in the alternative 
pathway for repair of double strand breaks, the type of DNA damage caused by 
metronidazole (reviewed in Section 1.3.1, Chapter I). ORF I was not involved in 
conferring metronidazole resistance on the E. coli DNA repair mutants, however, the 
presence of this recQ homologue, upstream of ORF2 and expressed divergently 
suggested the possibility that ORFI and ORF2 might interact at a regulatory level in B. 
fragilis itself. The regulation of both ORFI and ORF2 in B. fragilis and their possible 












Transcriptional Regulation of a B. Jragi/is gene involved in metronidazole resistance 
in E. coli 
4.1 ABSTRACT ........................................................................................................................................... 97 
4.2 INTRODUCTION ................................................................................................................................. 98 
4.3 MATERIALS AND METHODS .......................................................................................................... 99 
4.3.J BACTERIAL STRAINS, PLASM IDS GROWTH CONDITIONS .................................................................... 99 
4.3.2 GENERAL RECOMBINANT DNA PROCEDURES .................................................................................. 99 
4.3.3 RNA EXTRACTION ........................................................................................................................... 99 
4.3.4 PRIMER EXTENSION ANALySIS .......................................................................................................... 99 
4.3.5 CONSTRUCTION OF DNA PROBES FOR NORTHERN HYBRIUISATION ............................................... 100 
4.3.6 NORTHERN HYBRIDISATION ANALYSIS ........................................................................................... 101 
4.3.7 MEASUREMENT OF CELL SURVIVAL DURING METRONIDAZOLE TREATMENT ................................... 101 
4.3.8 MEASUREMENT OF CELL SURVIVAL DURING AND FOLLOWING METRONIDAZOLE TREATMENT ....... 1 0 I 
4.3.9 DETECTION OF SINGLE STRAND DNA BREAKS ............................................................................... 102 
4.3.10 RNA SLOT BLOT HYBRIDISATION ................................................................................................ 102 
4.4 RESULTS AND DiSCUSSiON .......................................................................................................... 103 
4.4.1 PRIMER EXTENSION ANALYSIS ....................................................................................................... 103 
4.4.2 NORTHERN HYBRIDISATION ANALYSIS ........................................................................................... 105 
4.4.3 MEASUREMENT OF CELL SURVIVAL AND IDENTIFICA nON OF DNA STRAND BREAKS AFTER 
METRONIDAZOLE TREATMENT ................................................................................................................. 107 
4.4.4 RNA SLOT BLOT ANALYSIS OF ORF2 AND ORF I ......................................................................... J 11 











The transcriptional regulation of the B. fragilis bfl ORF2 gene involved in mitomycin C 
and metronidazole resistance in E. coli uvrA- and uvrS- mutants was analysed, as well as 
the regulation of the B. fragilis bfl ORF 1 gene, found upstream of ORF2 and expressed 
divergently. Primer extension analysis identified the ORF2 transcriptional start site as an 
adenine, 59 bp upstream of the ORF2 start codon. Sequences resembling the B. fragilis 
promoter consensus motifs were identified upstream of the transcriptional start site and 
possible regulatory inverted repeats were recognised overlapping the -10 and -35 
promoter sequences. Expression of ORF2 in B. fragilis revealed a single 600 nucleotides 
transcript. Exposure of B. fragilis cells to metronidazole caused single stranded breaks, 
but there was no difference in the transcription of ORF2 before or after metronidazole 
treatment. Transcription of ORFI in B. fragilis was, however, dramatically decreased 












A B. fragilis bfl gene involved in metronidazole resistance in E. coli uvrA- and uvrB-
cells was isolated as described in Chapter 3. This gene encoded an AraC/XyIS 
transcriptional regulator, a family of regulators known to be involved in many cellular 
processes, including multidrug resistance and DNA damage repair (Gallegos et al., 
1997). The DNA sequence immediately upstream of this gene contained putative B. 
fragilis promoter sequences as well as possible regulatory inverted repeats. A recQ 
homologue was identified further upstream of this gene, and transcribed in a divergent 
manner. However, this homologue did not seem to be involved in conferring 
metronidazole resistance on the E. coli cells. 
There is a possibility that B. fragilis ORF2 was regulating E. coli genes which in turn 
confered increased metronidazole resistance on the E. coli. However, working in a 
heterologous host does not give insight on the function and regulation of ORF2, and 
whether ORF2 might also be involved in metronidazole resistance in B. fragilis. DNA is 
thought to be the main target of the reduced cytotoxic metronidazole intermediate 
(Edwards, 1977), reviewed in Section 1.2 of Chapter 1. It would, therefore, be interesting 
to study the in vivo effect of metronidazole on the DNA damage of B. fragilis DNA, as 
well as the response of the transcription of 2 putative target genes involved in 
metronidazole survival. 
This chapter reports the analysis of a putative transcriptional start and a putative promoter 
of the ORF2 gene, as well as identification of a transcript by Northern blot. The effect of 
metronidazole on B. fragilis cells was studied in vivo and the damage and possible repair 
on the DNA of metronidazole treated B. fragilis cells was analysed. Expression in B. 
fragilis of the ORF2 gene, involved in metronidazole resistance in E. coli DNA repair 











4.3 Materials and Methods 
4.3.1 Bacterial strains, plasm ids growth conditions 
B. fragilis was grown as described in Section 2.3.1. Metronidazole was added to the 
media at a final concentration of 10 j.lglml. E. coli JM 109 strain (Yanisch-Perron et al., 
1985) and LK 112A strain containing the relevant plasmid were grown as described in 
Section 2.3.1. Ampicillin was added at a final concentration of 100 j.lglml. Plasmids 
pAN2 and pMT 1 04 were described in Chapter 3 (Section 3.3.1). 
4.3.2 General recombinant DNA procedures 
These procedures were described in section 2.3.2. 
4.3.3 RNA extraction 
Total RNA from B. fragilis bfl and E. coli was isolated from 30 ml mid-exponential 
phase cultures according to the method of Aiba e/ al. (1981). The quality of the RNA was 
confirmed by electrophoresis in 1.5% denaturing formaldehyde agarose gel (Fourney et 
aI., 1988) and quantified using spectrophotometric methods. 
4.3.4 Primer extension analysis 
The transcriptional start site of ORF2 was identified by nonradioactive automated primer 
extension using a Cy5-labe\ed primer PEReg (5'-GTC GTA CAA TTC ATC TGC-3'), 
corresponding to positions + 132 to + 114 downstream of the putative A TG start codon of 
ORF2. B. fragilis bfl RNA (70 j.lg) was precipitated and dissolved in 100 !J.I of HP buffer 
(40 mM PIPES, pH 6.4; I mM EDTA, pH 8.0; 400 mM NaCI, 80% deionised 
formamide). PEReg primer (5 pmol) was added to the RNA and the nucleic acids were 
denatured at 95°C for 10 min and hybridized overnight at 42°C. The annealed nucleic 
acids were precipitated with ice-cold ethanol and resuspended in 20 j.ll of RTB buffer [4 
!J.1 AMV Reverse Transcriptase buffer (Promega), 0.5 mM dNTP's, 40 U RNazin (Roche 











20 U of AMV Reverse Transcriptase (Promega) at 42°C for 2 hours. Addition of 1 III O.S 
M EDT A (pH 8.0) terminated the reaction and the RNA was degraded with 10 Ilg RNase 
A at 37°C for 30 min. The cDNA was precipitated and resuspended in 5 III of TE buffer 
(10 mM Tris, I mM EDTA, pH 7.6). Amersham STOP buffer (S Ill) was added. The 
primer extension products were sequenced using the ALFexpress Automated DNA 
Sequencer (Pharmacia Biotech) and analysed together with the sequence products using 
the same primer PEReg. 
4.3.5 Construction of DNA probes for Northern hybridisation 
B. fragilis bfl 16S rRNA gene probe. The 16S rRNA gene from bfl was amplified using 
the universal bacterial primers for 16S rRNA, F I forward primer, 5' -AGA GTT TGA 
TCI TGG CTC AG-3' (positions 8-27) and R5 reverse primer, S'-ACG GIl' ACC TTG 
TTA CGA CTT-3' (positions 1512-1492). PCR amplification was done in SO III reaction 
volumes containing 100 ng of B. fragilis chromosomal DNA, 0.5 IlM of each primer, 1.5 
mM Mg2+, 150 f.lM deoxynucleotide triphosphates and 2.5U Taq I polymerase (Roche 
Diagnostics). The samples were amplified for 30 cycles as follows: 9S0C for 0.5 min; 
54.5°C for O.S min and 71°C for I.S min with a final elongation at 71 °C for 3 min. PCR 
products were purified using the High Pure PCR Product Purification Kit (Roche 
Diagnostics). The amplified product was cloned into the pGEM®-T Easy Vector 
(Promega). The B. fragilis 16s rRNA gene probe was released from the vector by 
digestion with restriction endonuclease Notl and DIG-labeled as described in section 
3.3.8. 
B. fragilis bfl ORFI probe. The ORF1 gene was amplified as described in section 3.3.10. 
An internal 1.29 kb PvuIl-EcoRV DNA fragment was isolated and DIG-labeled as 
described in Section 2.3.5. 
B. fragilis bfl ORF2 probe. ORF2 was amplified as described in section 3.3.10. A 200 bp 











4.3.6 Northern hybridisation analysis 
B. fragilis RNA (70 flg) and E. coli RNA (15 flg) were separated by electrophoresis in a 
1.5% denaturing formaldehyde agarose gel and visualized by ethidium bromide staining. 
The RNA was transferred onto a nylon membrane (Roche Diagnostics) using an adapted 
version of the transfer method by Koetsier et al. (1993), where 20X SSC (3 M NaCI; 300 
mM sodium citrate, pH 7.0) was used as the transfer solution. The transferred RNA was 
UV cross-linked using an Ultraviolet Crosslinker (RPN 2500/250 I, Amersham Life 
Sciences). Hybridization with the DIG-labeled ORF2 DNA probe was performed for 
overnight at 50°C 10 EasyHyb hybridi711tion butfer (Roche Diagnostics). 
Chemiluminescent signals were detected using CDP-StarfM (Roche Diagnostics), 
according to the manufacturer's instructions. 
4.3.7 Measurement of cell survival during metronidazole treatment 
Mid-logarithmic B. fragilis bfl cel1s were exposed to metronidazole at different 
concentrations (5-50 Ilglml) and incubated at 25°C. Samples were removed at various 
time intervals and suitable dilutions were plated on supplemented BHl agar. 
4.3.8 Measurement of cell survival during and following metronidazole treatment 
B. fragilis bfl cells were grown anaerobically to mid-logarithmic phase. Metronidazole 
(10 Ilglml) was added to the culture at time 0 (To) and incubated at 25°C for 15 min (T 15)' 
The culture was centrifuged at 5000 rpm for 5 min and the cell pellet was resuspended in 
fresh medium without metronidazole, and incubated at 37°C. Samples were removed 
after 45 min (T6O), 30 min (T90), and 60 min intervals (TI50, T210 and T270). Viable cell 
numbers were determined by making suitable dilutions of the samples and plating them 
on supplemented BHI agar. Cells were also processed for DNA and RNA extraction for 












4.3.9 Detection of single strand DNA breaks 
B. fragilis bft chromosomal DNA () f.lg) extracted at times To, T 15, T 60 and T 90 (Section 
4.3.7) was loaded on a 0.5% alkaline denaturing agarose gel. The gel was prepared in 
neutral buffer (50 mM NaCI, 1 mM EDTA) and once solidified equilibrated for 1 hour in 
alkaline buffer (30 mM NaOH, 2 mM EDTA). Alkaline tracking dye (0.12% 
Bromocresol green, 25% glycerol, 0.5 M NaOH added just before use) was used to load 
the samples. The samples were electrophoresed at 20 volts overnigh1 and the gel was 
neutralized in 0.1 M Tris buffer, pH 8.0 for 30 min followed by ethidium bromide 
staining. 
4.3.10 RNA Slot Blot hybridisation 
Equal amounts of B. fragilis RNA (20 f.lg) at times To, T15, T60 and T90 (Section 4.3.7) 
and E. coli RNA (10 f.lg) extracted from mid-logarithmic E. coli cells not treated with 
metronidazole, were loaded in duplicate into a slot blot apparatus (SI01Bl01, Hoefer 
Scientific Instruments, San Francisco) and transferred onto a nylon membrane (Roche 
Diagnostics). The transferred RNA was UV cross-linked. Hybridization with the DIG-
labeled DNA probes was performed overnight at 50°C in EasyHyb hybridization buffer 
(Roche Diagnostics). Signals were detected using chemiluminescent detection with 











4.4 Results and Discussion 
4.4.1 Primer Extension analysis 
In Chapter 3, putative B. fragilis promoter consensus sequences were identified upstream 
of the A TO start codon of ORF2 (Section 3.4.5). Primer extension analysis was 
performed in order to identifY the in vivo transcriptional start site of ORF2 and possibly 
confirm the typical Bacteroides promoter sequences. A single primer extension product 
(Fig 4.1a) identified the transcriptional start site to be an Adenine 59 bp upstream of the 
A TO start codon of ORF2 (Fig 4.1 c, noted as + 1). The B. fragilis promoter consensus 
10 motif was identified (OAAA TTTO), separated from the -35 motif (OTTO) by 20 
nucleotides (Fig 4.lc). Three sets of inverted repeats were identified in the promoter 
region, 5'-TTTTOAT-3' (nucleotide positions 51 and 67 in Fig 4.1c, black), 5'-
ATATAC-3' (nucleotide positions 76 and 93, Fig 4.1c, red) and 5'-AATTTOT-3' 
(nucleotide positions J 14 and 134, Fig 4.1c, blue). The first set of inverted repeats was 
located upstream of the -35 promoter sequence, while the last two sets spanned the -35 
and -10 promoter regions, respectively. 
In a study done by Bayley et al. (2000) on B. fragilis promoters, the preferred 
transcriptional initiation site was a purine, in most cases an Adenine. This supports the 
above result for the transcriptional start site of ORF2. The -10 promoter sequence of 
ORF2 had significant similarity to the -7 B. fragilis consensus motif (TAnnTTTO) 
described by Bayley et al. (2000). This motif was followed by a T, which once again is in 
accordance with the findings of Bayley et al. (2000) who found this motif followed by a 
T or C in most cases. The beginning of the -35 promoter sequence of ORF2 was found 
20 bp upstream from the en d of the -10 sequence, within the consensus spacing (Bayley 
et al., 2000). This promoter sequence once again was highly similar to the B. fragilis -33 
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1 TAAAAGTTAAATATTCTTATTAACGGCCCTTTTTACCTACTTT TCGACGATTTTGATTGT 
0( ~ ~ 0( -10 • 
61 TTTTATATCAAAAATATATACGAAAAAGTTGTGTATATCAAAATAATGTATGAAATTTGT 
121 GACATCTAAAGTTACAAATTAATAGTGATATTTAAAAACAAACCCTAACCAGTTAATTCA 
181 ATGAGTGATTTAGAAAACAAAAC CCAGGAAGAAACT CCTAAAAAACGC CCTTACAATT TA 
2 41 AGGGAGAAAAAAGAAAAGAAAGCT GC TTACCGGTCTTTGATCAGACCCGAATTGGCAGAT 
30 1 GAATTGTACGACAGAATCCTGAACATCATTGTTGTACAGAAGAAGTACAGAGACC CGGAC 
Figure 4.1 Identification of the B. fragilis ORF2 transcriptional start site by primer extension analysi s. (a) 
Primer extension reaction product (black line) and A, T and C sequencing reaction products (green, red and 
blue lines, respectively). The transcriptional start (+1) site is indicated by an arrow. (b) Chromatogram of 
the corresponding DNA sequencing reaction using the same primer PEReg (underlined in pink). (c) 
Nucleotide sequence of the putative promoter region of ORF2: the ATG start codon is underlined at 
position 181 , the transcription start site is in red (+ 1), the putative-I 0 and -35 motifs are underlined. The 3 











4.4.2 Nortbern bybridisation analysis 
Northern blot analysis of B. fragilis RNA was carried out, to investigate whether the 
mRNA transcribed from the transcriptional start site identified above contained the ORF2 
as a single transcript. B. fragilis total RNA hybridized to the PvuII-EcoRV 200 bp ORF2 
probe, resulting in a single band of approximately 600 nucleotides (nt) (Fig. 4.2A, Lane 
3). The ORF2 specific probe hybridized to RNA from E. coli JM109 containing pAN2, 
resulting in two bands of 600 nt and 1900 nt in size (Fig 4.2A, Lane 1). E. coli JM109 
transformed with pMTl 04 did not result in any hybridization signals (Fig 4.2A, Lane2). 
A 
MW (nt) 1 2 3 1 2 3 
1900 • 
600 • 
Figure 4.2 Northern blot analysis of expression of ORF2 mRNA in B. fragilis bfl and E. coli. Molecular 
mass markers are on the left (nt). The radiograph of total RNA probed with ORF2 probe (A), and the 
electrophoresed total RNA in a denaturing agarose gel (B). Lane I, E. coli JM109 (PAN2); Lane 2, E. coli 
JMI09 (pMTI 04); Lane 3, B.fragilis bfl. 
The ORF2 B. fragilis mRNA transcript was approximately 600 nucleotides in size. This 











start site to the putative rho-independent terminator discussed in Chapter 3, Section 
3.4.5.1. The same sized transcript was made in E. coli cells containing the ORF2 gene, 
implying that the E. coli transcriptional machinery recognized the ORF2 promoter. This 
is not always the case for B. fragilis genes in E. coli (Smith et al., 1992). Another 
transcript of 1900 nucleotides in size was expressed by the E. coli cells. This transcript 
was likely to be expressed from the A promoter found upstream of the insert in pAN2, 
containing approximately 500 nucleotides of pEcoR251 vector sequence from the A 
transcriptional initiation site to the beginning of the insert, 700 nucleotides of the 
truncated ORFI sequence and ORF2 sequence up to the putative terminator. 
To confirm that ORF2 was expressed in E. coli from its own promoter and not the A 
vector promoter, expression of the gene in E. coli LK 112A containing the repressor of the 
vector promoter was investigated. Expression ofORFl in E. coli was also studied. 
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Figure 4.3 RNA slot blot analysis of the ORF2 (A) and ORFI (B) genes in E. coli JM 109 and LK 112A.. A: 
RNA was probed with a 200 bp ORF2-specific probe. B: RNA was probed with a 1.29 kb ORFI-specific 
probe. Lane I, E. coli JM109 (pMTl04); Lane 2, E. coli LKII2A. (pMTl04); Lane 3, E. coli JMI09 
(PAN2); Lane 4, E. coli LKIl2A. (pAN2). 
The ORF2 and ORF1 genes were expressed in mid-logarithmic E. coli JMI09 and 
LKl12A cells containing pAN2 (Fig 4.3, Lanes 3-4A and 3-4B) and there was no 
hybridisation signal with E. coli JM109 and LKl12A carrying the pMTI04 control 
plasmid (Fig 4.3, Lanes 1-2A and 1-2B). E. coli LKl12A contains the Cro repressor 











confinned that the ORF2 transcript was made from its own promoter in E. coli. Due to its 
orientation in pAN2, ORFI could only be transcribed from its own promoter. This 
suggested that E. coli recognised both the ORF 1 and ORF2 promoters. The ORF2 and 
ORFI probes were specific for B.fragilis ORF2 and ORFI respectively, as shown by the 
negative signal in E. coli cells lacking pAN2. 
The presence of ORF2 in E. coli uvrA- and uvrB- cells grown in medium containing 
metronidazole causes increased metronidazole resistance (Chapter 3), most likely due to 
expression of ORF2. The above results show that ORF2 is expressed in E. coli and B. 
fragilis cells in the absence of metronidazole. It is, therefore, of interest to investigate the 
relationship between ORF2 expression and metronidazole treatment in B. fragilis cells. 
4.4.3 Measurement of cell survival and identification of DNA strand breaks after 
metronidazole treatment 
Exposure to metronidazole must be done on actively growing cells since metronidazole 
needs to get activated to cause DNA damage. B. fragilis cells were exposed to different 
concentrations of metronidazole to identify a sub-lethal concentration of metronidazole 
that would allow the study of the expression of ORF2 and ORFI without killing of the 
population. 
Exposure of B. fragilis cells to 50 Jlg/ml metronidazole caused complete death of the 
population within 30 min (Fig 4.4, (X ) symbols). Within 10 min of exposure to 
metronidazole at 20 Jlg/ml, there was I-log decrease in the population, with a 2-log 
decrease following 30 min exposure (Fig 4.4, ( ) symbols). Following 25 min 
metronidazole exposure at 10 Jlg/ml, there was approximately a I-log decrease in the 
surviving fraction (Fig 4.4, (_ ) symbols), while exposing cells to 5 Jlg/ml metronidazole 
for 40 min did not even cause a 1-log decrease in survival (Fig 4.4, (. ) symbols). In order 
to induce DNA repair genes, damage of the DNA is necessary without complete killing 
of the population. For this reason, a concentration of 10 Jlg/ml seemed high enough to 
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Figure 4.4 Survival of B. fragilis bfl cells exposed to metronidazole at 5 Ilglml ( . ); 10 Ilglml ( _ ); 20 
Ilg/m I ( ) and 50 Ilglml (X). The experiment was performed 3 times in duplicate. 
In order to investigate the expression of ORF2 in B. fragilis in response to the presence or 
absence of metronidazole, the effect of 10 f.!g/ml metronidazole treatment on the survival 
and DNA damage of B. fragilis cells, as well as the recovery of the population on 
metronidazole-free medium was investigated. Exposure for 15 min caused a 5-fold 
decrease in cell numbers (Fig 4.5, TIS ( _ ) symbols). After 135 min growth in fresh BHI 
medium, the cell numbers had increased 3-fold from TI S (Fig 4.5, T JSO ( _ ) symbols). 
After 255 min following metronidazole exposure, cell numbers had increased lO-fold 
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Figure 4.5 Survival of B. fragilis bfl cells after exposure to metronidazole at 10 J..lg/ml. B. fragilis cells 
were exposed to metronidazole for 15 min (black arrow), after which cells were resuspended in fresh 
medium and incubated anaerobically at 37°e. The experiment was performed 3 times in duplicate ( . ). 
Samples at To, T15, T60 and T90 were used for detection of single stranded DNA breaks and ORFI and 
ORF2 expression studies ( . ), and these were performed in duplicate. 
Survival of the population, during and after metronidazole treatment, is dependent on the 
rate of DNA damage versus the rate of DNA repair by those cells. Replication of 
undamaged actively growing cells also affects survival. As expected, exposure of B. 
fragilis cells to metronidazole decreased the number of cells approximately half a log. 
However, once in metronidazole-free medium, the population recovered. This was 
largely due to replication of undamaged cells, as well as repair of the DNA and recovery 











Since metronidazole causes single strand DNA breaks (Edwards, 1977; Knight et at., 
] 978; Rowley et al., 1979), the extent of damage was measured by visualization of the 
single strand breaks on a denaturing agarose gel. Single strand DNA breaks are held 
together by the double stranded DNA helix and are not detected on a normal agarose gel. 
However, alkaline denaturing gels separate the two strands of the helix and single strand 
breaks would result in low molecular weight DNA. 
Total DNA of B. fragilis bfl cells, grown in metronidazole followed by recovery in 
medium without metronidazole (Fig 4.5, ( . ) symbols), was extracted at times To, TIS, T60 
and T 90, and loaded on a denaturing agarose gel. Exposure to metronidazole of B. fragilis 
bfl culture resulted in a reduction in high molecular weight chromosomal DNA on the 
denaturing alkaline gel (Fig 4.6, Lane 2A). This damage was due to single strand DNA 
breaks since there was no DNA degradation of the same sample on the non-denaturing 
gel (Fig 4.6, Lane 2B). At T 60, following 45 min of repair, there was an increase in single 
strand breaks (Fig 4.6, Lane3A). After 75 min of recovery, at T 90, the smear caused by 
the low molecular weight single strand breaks started to decrease compared to T60 (Fig 
4.6, Lane 4A). 
Prior to metronidazole exposure, chromosomal DNA from B. fragilis cells was mostly 
high molecular weight in both denaturing and non-denaturing conditions, indicating 
minimal single strand and double strand breaks. Following 15 minutes of metronidazole 
exposure at 1 0 ~g/ml, lower molecular weight DNA fragments were present in the 
denaturing gel, indicating an increase in single strand breaks; however in the non-
denaturing gel, DNA was still intact, suggesting that metronidazole did not cause double 
strand breaks. Edwards (1977) found that metronidazole caused both single and double 
stranded DNA breaks in vitro, however Rowley et al. (1979) only found single strand 
breaks being produced in vitro. The B. fragilis cells were allowed to recover in 
metronidazole-free medium for 45 minutes; however there seemed to be an increase in 
single strand breaks. This could be attributed to the action of repair enzymes that either 
nick the DNA in order to remove and repair the damage, or degrade the damaged DNA 
such as in the nucleotide excision repair (reviewed in Section 1.3, Chapter 1). An 
increase in high molecular weight DNA was observed in the denaturing gel after 75 











that either the damaged DNA had been repaired orland the synthesis of new DNA by 
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Figure 4.6 Detection of single strand DNA breaks in genomic DNA from B. fragilis bfl cells. Denaturing 
alkaline gel (A) and non-denaturing agarose gel (8). Lane I, DNA extracted from untreated cells at To; 
Lane 2, DNA from cells exposed to metronidazole for IS min at TIs; Lane 3, DNA from cells at T60 ; Lane 
4, DNA from cells at T 90. (A) Linear 52 kb A. DNA was used as a marker of intact double stranded DNA. 
(8) PstI digested A. DNA was used as a size marker. 
4.4.4 RNA Slot Blot analysis of ORF2 and ORFl 
ORF2 is expressed in B. fragilis under mid-logarithmic growth conditions in nutrient-rich 
medium (Fig 4.2, Lane 3). RNA slot blot analysis was carried out in order to investigate 
whether the level of ORF2 expression was upregulated following metronidazole 











were exposed to sub-lethal levels of metronidazole (10 Ilglml) for 15 minutes and 
allowed to recover in BHI broth for 75 minutes after metronidazole exposure (Fig 4.5, ( . ) 
symbols). Total RNA was extracted from the same B. fragilis culture from which DNA 
was extracted for single strand break analysis and at the same time points To. TIs. T60 and 
T9o. 
A B C 
1 0.8 (0.16) 
2 l.0(0.2) 
3 0.8 (0.14) 
4 0.7 (0.14) 
Figure 4.7 RNA slot blot analysis of the ORF2 mRNA in B.fragilis bfl. A. RNA was probed with a 1.5 kb 
B. fragilis bfl 16S rRNA probe. B. RNA was probed with a 200 bp ORF2-specific probe. C. mRNA levels 
expressed as ratios of the ORF2-specific hybridisation signal to the 16S rRNA hybridisation signal. 
Experiments were performed in duplicate, and standard deviations are shown in parentheses. Lane 1: B. 
fragilis cells at To; Lane 2: B. fragilis cells at TIS; Lane 3: B. fragilis cells at T6o; Lane 4: B.fragilis cells at 
T9o. 
The ORF2 gene was expressed in B. fragilis cells, at the same level irrespective of 
metronidazole treatment (Fig 4.7, Lanes 1-4B and C). A B.fragilis bfl DNA probe of the 
16S rRNA gene was used as an RNA concentration control (Fig 4.7, Lanes 1-4A). There 
seemed to be a slight increase in expression of the ORF2 gene in B. fragilis following 
metronidazole treatment (Fig 4.7, Lane 2B and C), however the increase was not 
significant as shown by the standard deviation. The difference in ORF2 expression at the 
different conditions was negligible and there was no evidence of regulation of the ORF2 











The ORFI gene was expressed at low levels in mid-logarithmic B. fragilis cells (Fig 4.8, 
Lane 1 Band C) and these levels decreased following metronidazole exposure and during 
the 75-min recovery period (Fig 4.8, Lanes 2-4B and C). 
A B C 
1 0.7 (0.1) 
2 0.5 (0.04) 
3 0.44 (0.04) 
4 0.26 (0.02) 
Figure 4.8 RNA slot blot analysis of the ORFI mRNA in B.fragifis bfl. A. RNA was probed with a 1.5 kb 
B. jragifis bfl 16S rRNA probe. B. RNA was probed with a 1.29 kb ORFI-specific probe. C. mRNA levels 
expressed as ratios of the ORFI-specific hybridisation signal to the 16S rRNA hybridisation signal. 
Experiments were performed in duplicate, and standard deviations are shown in parentheses. Lane I: B. 
fragilis cells at To; Lane 2: B.fragilis cells at TIS; Lane 3: B. jragilis cells at T6o; Lane 4: B.fragilis cells at 
T9o · 
This suggests downreguiation of ORFI in response to metronidazole exposure, possibly 
due to the DNA damage. This contradicts the hypothesis that ORF 1 might be involved in 
DNA repair and suggests that its expression following DNA damage to the cell might be 












To gain more understanding on the B. fragilis putative AraC/XylS transcriptional 
regulator ORF2, regulation of the gene at the transcription level was analysed. The 
expression of this gene, as well as ORF I, the recQ homologue, was determined in B. 
fragilis. 
ORF2 was expressed in E. coli from a promoter upstream of ORF2 as well as from the A 
pEcoR251 vector promoter. This indicated that E. coli transcriptional machinery 
recognised the promoter sequences of ORF2. Transcriptional signals in B. fragilis are 
different from those in E. coli, and B. fragilis genes are sometimes transcribed 
inefficiently in E. coli if at all (Smith et al., 1992). However, this does not seem to be the 
case for ORF2. 
Mid-logarithmic B. fragilis cells expressed ORF2 at constitutive levels and there was no 
significant increased transcription of this gene following metronidazole treatment. There 
seemed to be a slight increase in expression of ORF2 immediately following 
metronidazole exposure, however, due to the errors encountered in the technique used, 
the difference was not significant. A more accurate technique for promoter expression 
analysis, such as the use of promoterless reporter gene systems, would demonstrate more 
specifically whether ORF2 expression was changed in response to metronidazole. The 
AraC transcriptional regulators involved in stress tolerance need to be overproduced in 
order to exert their regulatory effect (Gallegos et al., 1997). Certain stress signals cause 
overexpression of these regulators. In E. coli, ORF2 was present in a multicopy plasmid 
and its expression was, therefore, increased without an inducing signal. It is very likely 
that the conditions used for the RNA slot blot analysis in B. fragilis are not the stress 
signal needed to overexpress ORF2. Conditions for inducibility of metronidazole 
resistance in B. fragilis have yet to be established. It is possible that in B. fragilis, 
metronidazole is not the inducing signal for overexpression of ORF2. Identification of 
genes controlled by ORF2 might shed a light on the possible function of the ORF2 
regulator and might help to identify the stress signal which triggers ORF2 
overproduction. Overexpression as weB as construction of an ORF2 inactivated mutant in 











The expression of the recQ homologue ORF I was of interest due to the fact that ORF I 
and ORF2 share a divergent promoter and the possibility of the recQ homologue being 
involved in DNA repair. ORFI was also expressed in E. coli cells from its own promoter. 
In B. fragilis, expression of ORFI decreased following exposure of the cells to 
metronidazole and remained low during the recovery period. Following exposure to DNA 
damaging agents, DNA synthesis is temporarily inhibited in E. coli (Setlow et ai., 1963; 
Livneh et al., 1993). Some of the inhibition is due to the replication fork not being able to 
go beyond the DNA lesion. However, it is also due to inhibition of new rounds of 
replication from the origin of replication oriC (Verma et ai., 1989). This is not due to 
DNA lesions on oriC but occurs to allow the damage to be repaired and prevent errors 
when synthesizing new DNA. This inhibition of replication could be done by repression 
of genes involved in replication. It is possible that DNA replication in B. fragilis is also 
inhibited following DNA damage. This would explain a decrease in the transcription of 
the ORF I gene, if it had to playa role in replication of DNA. Humans have 5 different 
RecQ helicases and some of them are thought to act at different steps in DNA replication 
and interact with components of the DNA replication machinery (Bennet and Keck, 
2004). The conserved non-catalytic domain of the human RecQ helicase WRN has a role 
in DNA replication intermediate processing (Sharma el al., 2004). The fact that B. 
fragilis has three different RecQ homologues allows for the possibility that one of them, 
ORFI, might be involved in DNA replication. A more detailed analysis is required in 
order to establish whether ORFI and ORF2 do, in fact, playa role in the response of B. 













Metronidazole is the most widely used antibiotic in the treatment of anaerobic infections, 
including those caused by Bacteroides fragilis. The drug is activated into a cytotoxic 
intermediate under anaerobic conditions, and is thought to cause DNA damage leading to 
cell death. Research on the possible development of resistance has focused on the 
activation of the drug into its active intermediate, while very little work has been done on 
the mechanisms involved in repair of the metronidazole DNA damage. The aim of the 
study reported in this thesis was to identify Bacteroides genes involved in repair of the 
DNA damage caused by metronidazole. 
The initial stages of this study preceded the publication of the genomes of B. 
thetaiotaomicron VPI-5482 (Xu et aI., 2003) and B. frag;lis YCH46 (Kuwahara et al., 
2004), as well as the access to the completed but yet unpublished B. fragilis 9343 and 
638R genome (www.sanger.ac.uk/projects/b fragilis). Therefore, indirect identification 
approaches were used. These involved identification of genes implicated m 
metronidazole resistance or sensitivity in Bacteroides itself by construction of 
Bacteroides transposon mutants, and by identification of the Bacteroides genes in E. coli 
by multicopy suppression of E. coli DNA repair mutants. As genomic sequence 
information became available, this was integrated into the analysis of the experimental 
findings. 
Attempts to isolate B. frag;lis metronidazole mutants were not successful. The approach 
was then adopted of identifying the phenotypes in B. thetaiotaomicon mutants and then 
extrapolating the findings to B. fragilis. Isolation of B. thetaiotaomicron metronidazole 
mutants did result in the identification of genes involved in sensitivity or resistance to 
metronidazole. Some of the disrupted genes did not have close homologues in B. fragilis, 
and it was, therefore, not always possible to draw comparisons with B. thetaiotaomciron. 
Some of the B. thetaiotaomicron mutants isolated were, however, interesting and further 
analysis will be done on these. B. thetaiotaomicron metronidazole sensitive mutant B, 
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Bacteroides capsule might be involved in preventing entry of metronidazole into the cell. 
Disruption of the gene, coding for a protein with identity to enzymes involved in 
catalysing the first step in the synthesis of surface polysaccharide in various prokaryotes 
(Amer and Valvano, 2001) would, very likely, affect the synthesis of the B. 
thetaiotaomicron capsular polysaccharide synthesised by the products of the genes in that 
specific polysaccharide locus 4. The capsular polysaccharide of Bacteroides might 
prevent entry of metronidazole into the cell by acting as a physical barrier. Genes 
homologous to the B. thetaiotaomicron gene disrupted in mutant B, were found in 
various capsular polysaccharide biosynthesis loci in B. fragilis. Disruption of individual 
capsular polysaccharides in B. thetaiotaomicron and B. fragilis by site-directed 
mutagenesis, and metronidazole uptake studies of the resulting mutants might explain the 
role ofthe Bacteroides capsule in the uptake of metronidazole. 
One mechanism for metronidazole resistance in Bacteroides has been shown to be due to 
inefficient activation of metronidazole inside the cell. The enzyme thought to be involved 
in this is pyruvate:ferredoxin oxidoreductase. It is, however, possible that any metabolic 
enzyme involved in electron transfer might be able to donate electrons to metronidazole, 
activating it. Reduced activity of any of those enzymes might, therefore, increase the 
metronidazole resistance of the cell. This may be the case in B. thetaiotaomicron 
metronidazole resistant mutant D. Disruption of the intergenic region between fucO, 
coding for the lactaldehyde reductase enzyme, and the putative transcriptional regulator 
of the B. thetaiotaomicron rhamnose utilization gene cluster, might cause decreased 
lactaldehyde reductase activity. This might occur by decreased expression of the putative 
positive transcriptional regulator due to disruption of promoter sequences, which would 
then prevent expression of the fucO genes, as well as the other rhamnose utilisation 
genes. The rhamnose utilisation pathway of B. thetaiotaomicron has not been 
characterised, however, the genes identified suggest a similar pathway to E. coli. B. 
fragilis does not possess a rhamnose utilisation pathway, however it does have a fucose 
utilisation pathway containing the fucO gene. In E. coli, lack of activity of FucO would 
force the product of both L-fucose and L-rhamnose utilisation, L-Iactaldehyde into L-
lactate production, disrupting the normal electron flow of the cell. Metronidazole 











and Wilkinson, 1979, Narikawa el al., 1991). It is, therefore, possible that FucO might be 
involved in activation of metronidazole in Bacteroides. Alternatively, disruption of the 
electron flow in Mutant D might cause decreased activity of pyruvate:ferredoxin 
oxidoreductase (POR) and therefore, decreased activation of metronidazole. Site-
directed mutagenesis of the fucO gene in both B. thetaiotaomicron and B. fragilis would 
confirm whether the metronidazole resistant phenotype of B. thetaiotaomicron Mutant D 
is due to decreased expression of FucO. Lactate production assays, as well as 
measurement of the activity of FucO and POR are necessary to elucidate the mechanism 
of activation of metronidazole in Mutant D and the FucO-inactivated mutants. 
Since no DNA repair genes were isolated using the transposon mutagenesis approach, a 
different, indirect approach was proposed, making use of functional complementation of 
E. coli DNA repair mutants using a B. fragilis gene library. E. coli is very useful for the 
identification of B. fragilis DNA repair genes for various reasons. E. coli is a facultative 
anaerobe allowing experiments to be done both aerobically and anaerobically, which 
mimics the B. fragilis environment. The DNA repair systems of E. coli have been well 
characterized to date, and there are a large number of E. coli repair mutants available for 
complementation studies. In this study, E. coli nucleotide excision repair mutants were, 
therefore, used to screen for B. fragilis genes involved in the repair of DNA damage 
induced by metronidazole. 
Genes from B. fragilis bfl which conferred increased metronidazole resistance on E. coli 
uvrA and uvrB mutants were cloned on a recombinant plasmid pAN2. The gene ORF2 
was responsible for the phenotype, and encoded a putative protein of 154 amino acid 
residues and sequence identity to the AraC/XylS family of transcriptional regulators. 
These regulators are mostly positive regulators involved in diverse cellular functions such 
as metabolism, pathogenesis and stress tolerance (Gallegos et aI., 1997). In E. coli, there 
are AraC/XylS trancriptional regulators involved in DNA repair, such as Ada protein 












Although E. coli MarA, SoxS and Rob are non-identical AraC transcriptional regulators, 
with slightly different functions and regulation, they all regulate a common set of genes 
in E. coli. This demonstrates the flexibility of target genes in being regulated by a range 
of homologous AraC transcriptional regulators. AraC has highest identity to the E. coli 
SoxS, involved in superoxide resistance. It is possible that ORF2, expressed at high levels 
from a multicopy plasmid, is regulating E. coli genes, which are otherwise regulated by a 
homologous AraC transcriptional regulator, in a heterologous manner. Metronidazole 
causes single and double stranded breaks in the DNA (Edwards, 1977; Knight et al., 
1978) that are repaired in E. coli by the RecBCD pathway (reviewed in Section 1.3.1.3) 
or the RecE or RecF alternative pathways (reviewed in Section 1.3.1.4). The RecF 
pathway is known to work together with the nucleotide excision repair in repairing stalled 
replication forks (Courcelle et al., 1999). The RecQ protein is a member of the ReeF 
pathway and is involved in repair of double strand breaks (Courcelle and Hanawalt, 
1999), as well as being involved in suppression of illegitimate recombination together 
with UvrA and UvrB (Hanada et ai., 2000). Interestingly, upstream of ORF2 and 
transcribed divergent1y in the B. fragilis chromosome, lies a RecQ homologue, ORFI. In 
this investigation, the B. fragilis ORFI was not found to be involved in conferring 
metronidazole on the E. coli uvrA and uvrB mutants, however the presence of this RecQ 
homologue upstream of ORF2 is interesting. It is possible that ORF2 is regulating an E. 
coli repair gene, such as the E. coli RecQ, which would take over the function of either 
the UvrA or UvrB in repairing the DNA lesions caused by metronidazole, since they both 
share a pathway in suppression of illegitimate recombination (Hanada et ai., 2000). It 
would be interesting to identifY the E. coli genes affected by ORF2 and the function of B. 
fragilis ORF2 in the E. coli mutants. Microarray analysis of the E. coli uvrA and uvrB 
mutants containing ORF2 might allow identification of such genes in E. coli, as well as 
microarray analysis in B. fragilis overexpressing the AraC regulator. 
The function of ORF2 in B. fragilis and its possible role following metronidazole 
exposure are not clear. The AraC regulator ORF2 showed a minor increase in 
transcriptional expression following metronidazole exposure, however this increase was 
not significant. The method used, RNA slot blot analysis, was not accurate enough to 











such as using the ORF2 promoter fused to a reporter gene would allow such differences 
to be measured more accurately. 
It is interesting to note that the transcriptional expression of the RecQ homologue (ORFI) 
was decreased in B. fragilis following metronidazole exposure. During DNA damage, 
DNA replication is halted in E. coli (Setlow et ai., 1963) in order to give time for the 
damage to be efficiently repaired and prevent replication errors. There is a possibility 
that the same phenomenon occurs in B. fragilis and that genes involved in DNA synthesis 
might be downregulated. It is possible that ORF 1, a RecQ homologue, would be involved 
in DNA replication and during DNA damage, its expression would be decreased. The 
published genome sequence of B. fragilis YCH46 (Kuwahara et ai., 2004) and the 
incomplete sequence of B. fragilis 9343 (www.sanger.ac.uklProiects/B fragilis) revealed 
the presence of three different RecQ homologues. It is possible that the different B. 
fragilis RecQ homologues may have different roles in the protection of the genetic 
material of the cell, one of them being DNA replication. 
The functional complementation approach for identification of B. fragilis genes of 
interest will become more targeted in future due to the recent publication of the B. fragilis 
genome. This enables specific B. fragilis putative DNA repair genes to be cloned, using 
PCR techniques and their possible contribution to metronidazole resistance to be 
elucidated in E. coli repair mutants under anaerobic conditions. The DNA repair systems 
of Bacteroides have not been well-studied, especially in relation to metronidazole 
damage, but access to the B. thetaiotaomicron and B. fragilis genomes have allowed 
bioinformatic analysis to be done. Several candidate genes can now be identified and 
await functional investigation. Metronidazole causes single and double strand breaks in 
the DNA (Edwards, 1977), and it is known that E. coli nucleotide excision repair mutants 
have increased sensitivity to metronidazole (Yeung et ai., 1984; Jackson et al., 1984). As 
mentioned in Chapter 1, section 1.3.3, B. fragilis has been shown to have an excision 
repair system (Abratt et al., 1986), however, there is evidence that there might be another 
excision repair system involved in different types of DNA damage (Abratt et ai., (985). 
Both B. thetaiotaomicron and B. fragilis contain two uvrA homologues, as well as 











NC_004663; Bfragilis incomplete genome sequence www.sanger.ac.uk/Projects/ 
B fragilis; B. fragilis YCH46 genome Accession Number NC_006347), suggesting the 
presence of a Nucleotide Excision Repair system. 
A pathway similar to the RecF pathway of recombination might be present as shown by 
the fact that recF, recD and recR are present in both organisms. In E. coli, this pathway is 
involved in repair of daughter strand gaps as described in Section 1.3.1.2. Interestingly, 
the repair of double strand breaks, which in E. coli is repaired by the RecBCD pathway 
(Section 1.3.1.3) is likely to be repaired by a different system in Bacteroides. Even 
though both B. lhelaiotaomicron and B. fragilis have a recD homologue, one of the 
subunits of Exonuclease V involved in the RecBCD pathway, there are no homologues of 
recB or recC. Bacteroides might use an alternative pathway for the repair of this damage, 
as E. coli does in the absence of functional RecBCD, such as the altered RecF pathway 
(Section 1.3.1.4). This is supported by the fact that both Bacteroides species contain 
homologues of the RecN, Reel as well as the three different RecQ homologues. There is 
a possibility that one of the three RecQ homologues might be involved in repair of double 
stranded breaks. 
It is not yet clear what the interaction is between the E. coli uvrA and uvrB mutations and 
the B. fragilis ORF2 AraC transcriptional regulator, and whether there is a link between 
ORF2 and ORFI in B. fragilis. A better understanding of B. fragilis DNA repair systems, 
and the functions of these B. fragilis DNA repair components is necessary to gain insight 
into the mechanisms involved in repair of metronidazole DNA damage and the possibility 
of resistance. Access to the B. fragilis genome wi \I allow site-directed inactivation of the 
above-mentioned putative DNA repair genes to be performed. Studies can then be done 
on the effect of metronidazole on these mutants for elucidation of the possible role played 












Chemical Structure of 1-2'-hydroxyethyl-2-methyl-5-nitroimidazole (Courtesy of 1998-2005 
Galderma Laboratories, L.P. United States). 
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